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Mucosal associated invariant T-cells (MAIT) are a phylogenetically conserved subset 
of alpha/beta T-cells with natural killer-like (NK) activity.  MAIT are defined by the 
expression of an invariant T-cell receptor alpha (TCRα) chain; in mice and humans 
this chain uses the orthologous mVα19/hVα7.2-Jα33 genes respectively.  Available 
evidence indicates that MAIT are restricted by MR1, a highly conserved MHC class 
I-related molecule, and that their development is dependent on B lymphocytes.  They 
appear to constitute part of the innate immune response, but their precise functional 
role is poorly understood.  This study aimed to characterise MAIT and MR1 in 
ruminants, and to further the knowledge and understanding of these unique cells.   
Using PCR primers based on partial database sequences, orthologous full-length 
TCRα chains were identified in circulating bovine and ovine T cells.  The germline 
elements of the respective α chains were identified and their overall frequency of 
expression within the bovine TCRα repertoire determined.  Experiments using the 
orthologous TCRα chain as a marker for MAIT cells to examine expression in 
bovine and ovine blood and various tissues showed that spleen and mesenteric lymph 
nodes contained the highest frequency of MAIT cells.  Use of the same technique to 
study levels of this marker in cattle of different ages revealed very low numbers of 
MAIT cells in neonatal animals, followed by a marked increase in the first 3 weeks 
of life.  Analyses of MAIT TCRα expression in different T cell subsets showed that, 




 T-cell population, MAIT cells in bovine blood are predominantly CD8
+
.  Full-
length cDNAs were isolated for bovine and sheep MR1 and their sequences were 
found to display marked cross-species conservation. Using a specific PCR, MR1 was 
shown to be expressed in peripheral blood and by different lineages of Theileria-
transformed cells. Alternatively-spliced transcripts of MR1 were detected in both 
cattle and sheep and several of these retained an intact open-reading frame.  
Constructs of bovine MR1 and an MR1/MHC chimera were prepared in a eukaryotic 
expression vector but these failed to give detectable cell surface expression following 
transfection into Cos-7, despite positive intracellular expression.   
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1 General Introduction 
1.1 The Innate and Adaptive Immune Systems 
1.1.1 General Overview 
The host immune defence consists of two major, interacting, elements – the innate 
(non-specific) and adaptive (specific) immune systems.  These systems both consist 
of humoral and cellular components but play different roles in relation to defence 
from infection.  The innate immune response provides a rapid but non-specific 
response to challenge, mobilizing defences, many of which are constitutively-present 
and prepared, against a wide variety of organisms.  Physical and chemical barriers of 
the body also function as part of the innate immune system.  In contrast, the adaptive 
immune response is slower but more specific, reacting only against the original 
insulting antigen and further providing immunological memory and protection 
against repeated infection with the same organism.  Despite their differences there is 
interplay between the two systems and the innate immune system has an important 
role in stimulating the adaptive response to infection.   
 
1.1.2 The Innate Immune System 
The innate immune system provides an immediate response to infection.  The most 
immediate challenge is the „anatomical‟ barrier.  This consists of both the physical 
barrier of organs and cells, such as the skin and epithelial layer, and also the 
mechanical barriers within organs preventing micro-organism build-up or access, 
such as peristalsis within the gut, bronchial ciliary movement, or fluid and mucous 
on mucosal surfaces.  Further support to this anatomical barrier is provided by both 
biological factors, such as competitive commensal flora, and chemical secretions 
which can inhibit the growth of, and actively damage, invading micro-organisms.   
If the anatomical barrier is breached, then the humoral element of the innate system 
initiates an acute inflammatory response at the site of infection.  This is mediated by 
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humoral factors in serum or released at the infection-site, and results in a number of 
changes including oedema and recruitment and activation of phagocytic cells.  One 
of the major components of this barrier is the complement system.  This non-specific 
defence mechanism comprises a cascade of serum proteins, the final products of 
which are able to lyse bacteria, as well as opsonising bacteria for rapid phagocytosis.  
Complement also plays a role in recruiting phagocytic cells to the site of injury and 
increasing the permeability of the vascular membrane, causing oedema and allowing 
rapid access for these cells to the specific site of infection.  The coagulation system 
may also be activated as part of the innate immune system‟s humoral barrier – this 
attracts phagocytic cells and increases vascular permeability.  In addition, elements 
of the coagulation system can have direct antimicrobial effects.  Other components of 
the humoral innate response also provide direct antimicrobial or antiviral effects – 
lactoferrin and transferrin limit bacterial growth, lysozymes damage bacterial cell 
walls, interferon reduces viral replication within cells, and interleukin-1 stimulates 
the acute phase protein response.   
The principal part of the innate immune response is the cellular component, the 
major functions of which include phagocytosis of invading organisms and killing of 
intracellular pathogens.  The major cell-types involved in this are neutrophils and 
macrophages, both local tissue macrophages and circulating monocytes which 
mature into macrophages in response to infection.  Circulating cells are attracted by 
chemical signals from local innate inflammatory mediators and cross the vascular 
endothelial barrier by diapedesis.  The local chemical signals then attract these cells 
to the specific site of infection by chemotaxis and also stimulate them to provide 
enhanced phagocytic activity and killing.  Phagocytic cells bind to foreign or 
infectious agents and stimulate phagocytosis via a variety of cell-surface receptors, 
including complement receptors and scavenger receptors.  Activated macrophages 
also function through killing of intracellular pathogens by induction of nitric oxide 
and generation of free oxygen radicals.  Eosinophils can also be effector cells of the 
innate immune response by phagocytosing and killing some parasites.  Interaction of 
pathogens or their products with pattern recognition receptors (PRRs) including the 
Toll-like receptors (TLRs), which detect pathogen-associated molecular patterns 
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(PAMPs), results in activation of various signalling pathways that activate the cells 
and enables them to promote the induction of adaptive immune responses.   
Natural killer (NK) cells also play a major part in the cellular component of the 
innate immune response.  These are a type of large granular lymphocyte which do 
not express either the T-cell or B-cell antigen-specific surface receptors.  NK cells 
can undertake non-specific killing of infected or neoplastic cells. They kill cells by 
inducing apoptosis following release of perforin and granzymes, in a manner similar 
to CD8
+
 T cells.   
The innate immune system also stimulates and mediates activation of the adaptive 
immune system in response to infection, see section 1.1.4.   
(based on publications by Janeway 1993; Medzhitov and Janeway 2000; Janeway 
2001; Alberts et al. 2002; Janeway and Medzhitov 2002; Beutler 2004; Mayer 2007) 
 
1.1.3 The Adaptive Immune System 
The adaptive immune system is unique to jawed vertebrates.  It allows the immune 
system to recognise and remember specific pathogens and therefore mount a more 
rapid and effective immune response to subsequent infections from the same 
pathogen.  This specific immune system has the ability to detect millions of different 
antigens due to its large and extremely diverse antigen-receptor repertoire.   
The main effector cells of the adaptive immune system are T and B lymphocytes, 
each of which comprises cells expressing a repertoire of structurally-unique antigen-
receptors.  If an individual lymphocyte encounters an antigen that can bind to its 
receptor, the cell is activated and induced to proliferate and differentiate, thereby 
providing a specific response to the pathogen.  B-cells and T-cells are derived from 
the same pluripotential haematopoietic stem cell and together compose roughly 20-
40% of the human leucocyte population, which continuously recirculate between the 
blood and the lymphatic system.  These cells can either be in a naïve state, having 
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not yet encountered an appropriate antigen, an effector state, when actively 
responding to foreign antigen, or a memory state, having reverted to a resting state 
following previous activation (publications by Janeway 2001; Alberts et al. 2002).   
B-cells are the major cells of humoral immunity, being primarily involved in the 
production of antibodies.  B-cell surface receptors (immunoglobulins) recognise and 
bind to antigens in their native state which, along with co-stimulation from „helper‟ 
T-cells, stimulates differentiation of the B-cell into an „effector‟ plasma cell, 
producing specific antibody.  Most antibody-producing cells are short-lived but a 
small proportion of them survive as long-lasting „memory‟ cells, allowing a more 
rapid antibody response following re-infection with the same pathogen.  
T-cells are the principal cells involved in specific cell-mediated immunity.  Each T-
cell possesses a surface T-cell receptor (TCR) which recognises processed antigenic 
peptides presented in association with major histocompatibility complex (MHC) 
molecules (Zinkernagel and Doherty 1974) on the surface of antigen presenting cells 
(APC).  All nucleated cells can theoretically function as APC, although the 
properties of dendritic cells (DC) and B-cells enable them to be highly effective APC 
and they are therefore termed „professional‟ APC (reviewed by Banchereau and 
Steinman 1998).  T-cells undergo development in the thymus and give rise to several 
phenotypically distinct subsets of T-cells.  CD8
+
 T-cells, when activated, secrete a 
number of immuno-regulatory cytokines and mediate killing of virus-infected or 
neoplastic cells.  These cells recognise antigenic proteins processed through an 
endogenous pathway and presented by MHC class I molecules (reviewed by Harty et 
al. 2000).  In contrast, CD4
+
 T-cells recognise antigenic proteins (usually taken up 
from the extracellular environment) processed through an exogenous pathway to 
generate peptides that are presented by MHC class II molecules (Fearon and 
Locksley 1996).  Upon activation CD4
+
 T-cells release a range of cytokines which 
influence the cell activity of many other cells, including the original APC and 
cytotoxic T-cells.  The CD4
+
 T-cell response can vary depending on the antigenic 
stimulus; the two extremes of function are classified as Th1 or Th2 responses and are 
defined by the cytokines they produce.  Th1 responses are primarily induced against 
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intracellular pathogens (virus/bacteria/protozoa), and are characterised by the 
production of interferon-gamma (IFNγ) and tumour necrosis factor-alpha (TNF-α).  
They can stimulate signalling pathways in the target cells that result in intracellular 
killing of pathogens.  In contrast the Th2 response is more effective against 
extracellular bacteria, parasites and toxins, and is characterised by production of 
cytokines interleukin 4 (IL-4), IL-5 and IL-13, which mediate inflammatory 
responses and changes at mucosal surfaces that facilitate expulsion of parasites.  
CD4
+
 T cells also play an important role in providing help for generating antibody 
responses and different cytokines influence the isotypes of antibodies that are 
produced (Murray 1998; Kidd 2003).   
An additional αβ T-lymphocyte subset are the „regulatory‟ T-cells, which play a 
major role in limiting and suppressing the host immune response and controlling 
excessive inflammation and autoimmunity (Beissert et al. 2006).   
Gamma/delta T-cells form a separate subpopulation expressing a different TCR 
composed of gamma and delta chains.  These cells share properties of helper T-cells, 
cytotoxic T-cells and NK cells, and therefore function as part of both the innate and 
adaptive immune responses.  Their TCR repertoire is more limited than αβ T-cells 
due to a much more limited range of δ variable-region genes (Raulet 1989; Hein and 
Mackay 1991).   
 
1.1.4 Links between the innate & adaptive immune systems 
The innate immune system plays a vital role in the control and activation of the 
adaptive immune response.  Recognition of antigen via the specific surface receptor 
is a key event in stimulating a B or T cell response.  However, in the case of T cells, 
binding of the antigen-receptor alone is not sufficient to stimulate a response.  Co-
stimulation by engagement of other surface molecules, such as CD80 and CD86, 
with ligands on antigen presenting cells, is also required, while the local cytokine 
environment can also significantly affect the nature of T-cell response induced 
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(reviewed by Medzhitov and Janeway 2000; Beutler 2004).  The principal cell type 
involved in presenting antigen to T cells during primary responses is the DC, which 
is capable of expressing high levels of co-stimulatory ligands and MHC molecules.  
However, up-regulation of co-stimulatory ligands, as well as cytokines involved in 
triggering T cell activation, on DCs is dependent on activation of the DC via one or 
more cell receptors (either on the cell surface or within endosomes) that recognise 
PAMPs.  The latter is a key component of the innate immune response and involves 
a number of PAMP receptors, including the TLRs, which recognise different 
molecular patterns, such as bacterial lipopolysaccharide (endotoxin), flagellin, or 
peptidoglycan, as well as double-stranded RNA, or unmethylated DNA, associated 
with viruses.   The particular innate receptors that are activated influence which DC 
surface co-receptors and cytokines are up-regulated.  In this way, the innate immune 
response also affects how the T cells differentiate and therefore the nature of the T 
cell response.  Hence, the innate response plays a key role both in promoting the 
adaptive response but also ensuring that the responses generated are appropriate for 
the particular pathogen (reviewed by Banchereau and Steinman 1998; Reis e Sousa 
2004).   
NK cells, in addition to recognising infected or neoplastic cells, can also interact with 
DCs, and this NK-cell/DC crosstalk plays a significant role in the coordination of 
innate
 
and adaptive immune responses.  Activated NK cells can either induce DC 
maturation directly, or in association with suboptimal levels of microbial signals; this 
is dependent on both cell-cell contact, and local cytokine release, including TNFα 
and IFNγ.  These direct influences on DC activation can therefore indirectly 
influence the T cell response (Walzer et al. 2005).   
A more recently hypothesised link between the innate and adaptive immune systems 
has been provided by the discovery of small subsets of T-cells defined by the use, in 
each case, of an invariant TCR chain (Lantz and Bendelac 1994; Han et al. 1999; 
Allez et al. 2002).  The highly conserved structure of the TCRs expressed by these 
subsets, and their relatively high frequency compared to individual conventional T-
cell TCR specificities, may allow them to generate rapid responses and function 
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essentially like cells of the innate immune system, such as NK cells.  The presence of 
NK markers on the cell surface of some of these subsets may also confer similar 
innate properties to these T-cells.  The TCRs of these T-cell subsets also show 
marked conservation between mammalian species, suggesting that they play a 
significant evolutionarily conserved role in the host‟s immune defence.   
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1.2 The T-cell 
As described in 1.1.3, T-lymphocytes are divided into subsets according to effector 
function.  Development of these lineages occurs within the thymus during the 
process of TCR gene rearrangement when T cells are selected based on their affinity 
for class I or class II MHC proteins with bound self peptides.  Hence the defining 
molecule on these cells is the TCR, which functions both in antigen recognition and, 
by associating with a number of other polypeptides (CD3), in mediating activation of 
the T-cell upon antigen recognition.   
 
1.2.1 The αβ TCR  
1.2.1.1 TCR Composition and Interaction with MHC 
The TCR is a heterodimeric cell surface protein composed of two di-sulphide linked 
polypeptide chains.  The majority of T-cells that recognise antigenic peptides express 
an α and a β chain, while a second type of TCR made up of γ and δ chains defines a 
separate subset of T-cells which account for <10% of peripheral human T-cells but 
up to 30-50% of peripheral T-cells in neonatal ruminants (Clevers et al. 1990; Hein 
and Mackay 1991). The precise antigenic specificity of these γδ T cells is still poorly 
defined. The α and β polypeptide chains have similar domain structures, each being 
composed of a short cytoplasmic tail, a trans-membrane region, a constant (C) 
domain and an N-terminal variable (V) domain.  The variable domains combine to 
form the antigen recognition site, which is composed of six superficial loops, three 
contributed by each chain, that interact with the antigenic peptide and/or the 
presenting MHC molecule. The α and β chain transcripts contain short hypervariable 
segments, referred to as complementarity determining regions (CDR), which encode 
the antigen-binding loops.   The constant and trans-membrane domains form a short 
„hinge‟ region at their junction which is the site of one of the cysteine residues 
forming the inter-chain disulphide bonds; the other is within the variable domain.  At 
the cell surface the entire αβ TCR is non-covalently linked via its trans-membrane 
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domain to the invariant accessory chains of the CD3 complex which function in 
signal transduction following ligation of the TCR (Allison and Lanier 1987; Chothia 
et al. 1988; Davis and Bjorkman 1988).   
T-cell receptors are encoded by four distinct gene families: α, β, γ, δ, contained 
within three chromosomal loci: α/δ, β, γ.  The TCR genes consist of separate 
germline segments that are somatically rearranged and joined during T-cell 
differentiation to encode the variable and constant domains of the TCR.  Variable 
region genes are assembled from three distinct germline segments - variable (V), 
diversity (D) and joining (J) – except for the α chain, which uses V and J only.  The 
CDR loops, which interact with the MHC molecule and the antigen it presents, are 
encoded either within the V gene itself (CDR1 and CDR2) or by the conjunction of 
V (D) and J (CDR3) which allows maximal utilisation of the sequence 
polymorphism within the TCR chains (Allison and Lanier 1987; Davis and Bjorkman 
1988; Glusman et al. 2001; Mackelprang et al. 2006).   
The CDR3 regions from either chain are sited at the centre of the TCR combining 
site, flanked by their respective CDR1/2 regions.  The inter-CDR3 region can either 
be flat or contain a hollow which can entirely engulf side-chains of MHC-presented 
peptides (Garcia et al. 1998).  The overall combining site surface of the TCR is 
relatively flat and this is consistent with the flat/undulating surface of the MHC 
(Garcia et al. 1996; reviewed by Garcia et al. 1999).  MHC/peptide complexes 
present a complex surface of peptide and MHC atoms to the TCR „combining site‟, 
in which only about one-third of the bound peptide surface is exposed, and the TCR 
interacts with this whole complex of MHC and peptide.  The TCR is orientated 
diagonally across the MHC surface, which accords a relatively constant orientation 
of the Vα and Vβ domains and CDR regions (Garboczi et al. 1996; reviewed by 
Bjorkman 1997; reviewed by Garcia and Adams 2005).  The CDR3 loops of both 
chains interact with the MHC-bound peptide – the Vα CDR3 interacts with a central 
position of the peptide, while the Vβ CDR3 lies over the peptide‟s C-terminal region 
either as a flat surface or engulfing the peptide in a central hollow (Garboczi et al. 
1996; Bjorkman 1997; Hennecke and Wiley 2001).  The CDR2 regions lie directly 
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on top of the MHC α2 (Vα CDR2) and α1 (Vβ CDR2) helices and do not contact the 
peptide.  The CDR1 regions lie between the helices and are able to contact both the 
MHC and the bound peptide (Garboczi et al. 1996; Garcia et al. 1998).  This 
positioning ensures that the hypervariable CDR3 regions directly contact the peptide, 
while the less variable, germline-encoded, CDR1 and 2 regions interact with the 
more conserved MHC structure, see figure 1-1.  The TCR α chain is thought to 
control TCR-MHC orientation and mediate most of the TCR‟s interaction with the 
MHC (review by Garboczi and Biddison 1999; review by Garcia et al. 1999).   
Binding kinetics demonstrate a two-step binding process during TCR/MHC 
interaction and T-cell activation.  The conserved MHC α-helical areas allow initial 
weak TCR engagement (CDR2, CDR1) regardless of the particular antigenic peptide 
identity, enabling the TCR CDR3 to scan the peptides of multiple MHCs (Manning 
et al. 1998; Wu et al. 2002).  Positive CDR3/peptide interaction stabilises the binding 
and enables T-cell activation (Borg et al. 2005).   
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Figure 1-1: A) αβTCR/MHC-class-I structure and interaction.  CDR regions are coloured: 
CDR1α magenta, CDR2α purple, CDR3α yellow, CDR1β cyan, CDR2β navy blue, CDR3β 
green, HV4 orange.  The bound peptide (yellow) is central to the MHC α-helices (adapted from 
Garcia et al. 1998).  B) CDR region placement over the peptide (yellow) and MHC α helices 
(grey).  CDR2 bind to MHC only, CDR3 to peptide only, while CDR1 can interact with both 
(adapted from Hennecke and Wiley 2001).  C) αβTCR/MHC-class-I interaction showing the 
predominance of the MHC α-helices (yellow) at the binding site.  MHC-bound peptide is orange 
(adapted from Teng et al. 1998).   
 
Chapter 1: General Introduction 
Characterisation of Mucosal Associated Invariant T-cells and MR1 in Ruminants 12 
1.2.1.2 TCR Genomic Organisation 
The TCRα locus is located on chromosome 14 in humans and mice (Boysen et al. 
1997; Bosc and Lefranc 2003; Giudicelli et al. 2005), and chromosome 10 in cattle 
(Fries et al. 2001; Van Rhijn et al. 2007), and the genomic organisations of different 
species are relatively similar (Glusman et al. 2001).  In each, the TCRδ genes are 
contained within the TCRα locus, both consisting of non-contiguous V, (D in the 
case of δ), J and C segments with interspersed disrupted (pseudogene) segments and 
locus-specific repeats.  The α locus contains approximately 50 (human) and 104 
(murine) Vα gene segments (including pseuedogenes) and 61 Jα gene segments 
(human).  The δ locus is situated between the Vα and the Jα and Cα segments and in 
humans consists of 3 specific Vδ, 4 Dδ, and 4 Jδ gene segments and the four exons 
of the single Cδ gene.  Gene rearrangement at this site is highly regulated, and TCRδ 
genes are rearranged early in thymic ontogeny.  Later, α locus gene rearrangements 
result in the deletion of the δ locus.  The C region genes for each chain consist of 
four separate exons which encode (i) the extracellular constant domain, (ii) a short 
„hinge‟ region, (iii) the transmembrane and cytoplasmic regions, and (iv) 3‟ 
untranslated sequences (Satyanarayana et al. 1988; Takihara et al. 1988; Boysen et 
al. 1997; Scaviner and Lefranc 2000; Haynes and Wu 2004; Haynes and Wu 2007).  
The TCRα/δ locus is located adjacent to a number of olfactory receptor genes, two of 
which (OR10G2 and OR4E2) lie adjacent to the first Vα segments (between Vα7.1 
and Vα7.2, and between Vα7.2 and Vα11.1, respectively) (Haynes and Wu 2007).   
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Figure 1-2: Overview of the TCRαδ locus (adapted from Glusman et al. 2001).  The human (H) 
and murine (M) TCR loci are compared showing arrays of V segments in orange, other TCR 
elements in red, and non-TCR genes in blue.  Gene symbols are indicated where available: 
M6A, a putative methyltransferase; ZNF, a zinc-finger protein; OR, olfactory receptor genes; 
DAD1, defender against cell death. Grey triangles indicate the locations of species-specific, 
processed pseudogenes.  
 
 
Figure 1-3: TCRαδ locus gene structure (adapted from Glusman et al. 2001).  The genomic 
organisation of human (left) and murine (right) TCR genes, α (red) and δ (green), showing 
clusters of V, D, J and C gene segments aligned vertically.   
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1.2.1.3 TCR Nomenclature 
TCR genes that are present as multiple gene segments in the genome (e.g. the V 
genes) were originally given numerical identification corresponding to their order of 
discovery.  These sequences were classified into subfamilies, which in the case of the 
V genes included genes that shared over 70% nucleotide sequence identity.  
Comparisons between species have demonstrated that orthologues of many of the 
subfamilies are identifiable in the different species, indicating that the subfamilies 
arose prior to divergence of the species.  Some subfamilies contain only a single 
member while others contain multiple members, the latter having arisen through later 
gene duplication events.  Differences in the extent of gene duplication together with 
gene deletions in some species result in differences between species in the total 
complement of V genes.  The World Health Organization – International Union of 
Immunological Societies (WHO-IUIS) published the first official nomenclature 
designation system for TCRs (Kazatchkine 1995).  This was designed to unify the 
prefixes given to individual gene segments, but was complicated by the fact that the 
human and mouse TCR genes had been numbered independently, meaning that 
orthologous subfamilies rarely had corresponding subfamily numbers.  Following 
sequencing of the human TCR genome loci, a second nomenclature system was 
introduced in 1999 by the creation of the IMmunoGeneTics (IMGT) database, 
http://imgt.cines.fr (Lefranc et al. 1998; Giudicelli and Lefranc 1999).  This renamed 
the V subfamilies as subgroups and re-numbered them in the order in which they 
appear in the (human) genome locus, starting at the 5‟ end.  This system was 
approved by the Human Genome Organization (HUGO) nomenclature committee 
and is now considered official (Glusman et al. 2001). In general, comparisons 
between species have shown a very similar organisation and order of V genes.  
However, because of differences between species in the number of V gene subgroups 
(due to gene deletions), this system still often results in orthologous subgroups being 
assigned different numbers.  In species where the genome assemblies are incomplete 
(e.g. cattle) the V gene subgroups have generally been assigned numbers 
corresponding to their orthologues in humans (using either the IMGT or IUIS 
systems). 
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1.2.1.4 TCR genes in domestic animal species 
TCRα genes equivalent to those in humans and mice have been described for a 
number of animal species, including horse (Schrenzel and Ferrick 1995), swine 
(Uenishi et al. 2003), cattle (Ishiguro et al. 1990) and sheep (Hein et al. 1991).  The 
C genes show a relatively high degree of sequence conservation, and V gene 
subfamilies orthologous with those in humans are readily identifiable.  Interestingly, 
although assembly of the bovine TCRαδ locus is incomplete, over 300 Vα and over 
100 Vδ genes have already been identified.  Analysis of the Vα gene sequences 
revealed 11 (of 41) human sub-families which are not represented in cattle and 
similarly 11 bovine sub-families which are not represented in the human genome 
(Reinink and Van Rhijn 2009).  The overall 3-5 fold increase in Vα repertoire in 
comparison to mouse and human could potentially afford markedly increased 
diversity to the bovine αβ TCR repertoire.   
 
1.2.2 TCR Diversity & Repertoire 
Host defence in mammals relies on the ability of the adaptive immune system to 
recognise and respond to a diverse array of pathogens.  Hence, the size and diversity 
of the available antigen-receptor repertoires, T-cell and B-cell, are crucial for the 
host immune defence.   
 
1.2.2.1 T-cell development in the thymus 
Lymphocytes differentiate from haematopoietic stem cells, early lymphoid 
progenitors within the bone marrow.  Precursors of T-cells migrate to the thymus and 
undergo development including acquisition of TCR expression to generate the naïve 
T-cell population.  Early thymocytes are negative for CD4 and CD8 and TCR 
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) and undergoes somatic rearrangement of TCR genes to 
achieve TCR expression.  The TCR β locus is rearranged first, bringing together V, 
D, J and C gene segments to encode a TCRβ chain, which forms a complex with an 
invariant pre-TCRα chain and, together with CD3 polypeptides, enables low-level 
expression on the double positive thymocytes.  Stimulation through this pre-TCR-
CD3 complex causes these cells to cease β locus rearrangement and actively 
proliferate within the thymus, before initiating rearrangement of the α locus (Levelt 
et al. 1995; Xu et al. 1996).  Rearrangement of α V, J and C gene segments results in 
α chains that can pair with the expressed β chains to form a TCR.  This continual α 
locus rearrangement is aided by the locus structure, which allows multiple V/J 
recombination events on the same allele which result in the excision of the prior 
recombined DNA (Starr et al. 2003).   
Cells expressing a TCR undergo rigorous selection for their ability to interact with 
MHC containing bound self peptides in the thymus.  Cells unable to bind MHC-
peptide die by neglect while those cells that bind to MHC-peptide with high avidity 
are also eliminated (Mathis and Benoist 2004).  Less than 2% of thymocytes survive 
the selection process (Huseby et al. 2005).  During this process, those cells that 
interact with class I MHC lose expression of CD4 and those interacting with class II 
MHC lose expression of CD8.  These single-positive TCR
+
 cells are exported from 
the thymus to form the naïve T-cell population (Goldrath and Bevan 1999; reviewed 
by Sebzda et al. 1999; Schlissel 2003; Starr et al. 2003; Turner et al. 2006).   
 
1.2.2.2 Contribution of TCR gene re-arrangement to TCR diversity 
The following elements are important in determining the extent of the TCR 
repertoire: (i) Multiple germline gene segments – the high number of different V 
(D) and J germline segments at each locus; (ii) Combinatorial diversity of V (D) & 
J joining – the massive number of possible different V (D) and J combinations for 
each chain; (iii) Junctional diversity (& N-region diversification) – random and 
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programmed nucleotide insertion, deletion and mutation at gene fusion sites on each 
chain; (iv) Combinatorial association of random pairing of α & β chains – the 
random pairing of both chains of the complete TCR (Allison and Lanier 1987; Davis 
and Bjorkman 1988; Glusman et al. 2001).   
The generation of junctional diversity, which adds substantially to the TCR 
repertoire, is a consequence of the re-arrangement process.  The rearranging TCR 
gene segments are flanked by recombination signal sequences (RSS), adjacent to the 
3‟ end of V segments, the 5‟ end of J segments, and both ends of D elements in the β 
locus.  These consist of highly conserved heptamer and nonamer motifs separated by 
a spacer of either 12 or 23 nucleotides (+/- 1).  Gene segments of each particular type 
are all flanked by RSS with the same spacer length, and efficient recombination only 
occurs between RSS sequences of different spacer lengths, the „12/23 rule‟ (Akira et 
al. 1987).  V(D)J recombination is initiated when the complex of lymphocyte-
specific recombination-activating gene 1 (RAG1) and RAG2 binds to the RSS.  
These cleave the DNA at the gene-segment/RSS-heptamer junction, leaving „coding 
ends‟ of covalently closed DNA hairpins, and blunt, phosphorylated „signal ends‟ 
(McBlane et al. 1995; Livak and Schatz 1996).  The promiscuously-expressed non-
homologous end-joining (NHEJ) proteins, in combination with RAG1/RAG2, open 
the coding ends (by nuclease activity), then process and join these ends to form a 
„coding joint‟.  This step is imprecise, and both nucleotide removal by deletion, and 
insertion via either palindromic duplications (P-segments) or non-templated 
nucleotide additions (N-regions, introduced by terminal deoxynucleotide 
transferase), can significantly alter the original germline sequence at this site 
(Cabaniols et al. 2001).  The positioning of the CDR3 region across the V(D)J 
junction, at the site of this junctional diversity, ensures that it incorporates maximum 
sequence hypervariability.  (reviewed by Schlissel 2003; Livak 2004; Schatz 2004) 
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Figure 1-4: T-cell receptor αβ structural diversity (adapted from Nikolich-Zugich et al. 2004).  
Functional TCR chains are created by somatic V(D)J rearrangement from the TCR loci, of 
Variable (V) and Joining (J) genes for the TCRα chain, and V, Diversity (D), and J genes for the 
β chain.  The random deletion, insertion or mutation of nucleotides at the site of gene joining (N-
region) furthers increases the hypervariability of each chain sequence, particularly within the 
Complementarity Determining Region (CDR) 3.  The massive diversity of the immature thymic 
T-cell population is vastly reduced by maturation, involving positive and negative selection 
within the thymus, to the peripheral naïve T-cell population.   
 
The combination of different gene segments is not always random, especially within 
the TCRαδ locus, suggesting higher levels of control of V(D)J recombination.  
Rearrangement of specific V and J segments appears to be affected by several local 
factors, including control of access of the recombination „machinery‟ to the TCR 
locus and the specific RSS sequences flanking gene segments (Krangel et al. 2000; 
Probst et al. 2004).  Overall regulation mechanisms for TCR loci recombination are 
also apparent (Schlissel 2003): (i) Lineage specificity ensures recombination is only 
possible within the lymphoid lineage via the controlled expression of RAG proteins 
by transcriptional regulators.  (ii) Order within a lineage, meaning that TCRβ 
rearrangement must precede TCRα rearrangement.  (iii) Allelic exclusion ensures 
that a functional T-cell only generates one functional allele from each locus.  This 
stage is less certain for the TCRα chain which undergoes processive rearrangement 
(see above).  Although the presence of a productive TCRβ rearrangement prevents 
further β locus rearrangement (Uematsu et al. 1988), TCRα translation does not 
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strictly control α locus rearrangement, and evidence has been shown for some cell 
clones expressing two TCRα chains on the cell surface (Borgulya et al. 1992; Heath 
and Miller 1993; Padovan et al. 1993).  Overall, α locus rearrangement terminates 
with the cessation of RAG expression associated with the positive selection of 
developing T-cells by thymic ligands.   
The circulating T-cell repertoire has been estimated to contain 2 x 10
7
 different TCRs 
in humans (Arstila et al. 1999), and 2 x 10
6
 in mice (Casrouge et al. 2000). These 
estimates are much smaller than the theoretical mathematical estimate of 1 x 10
15
 
TCRs obtained for human (Turner et al. 2006).  This discrepancy is due both to 
limitations of different combinations to generate functional receptors and to the 
massive negative selection of rearranged T cells in the final stage of thymic 
development.   
 
1.2.2.3 T-cell Repertoire Homeostasis   
The pool of mature naïve T-cells and previously-activated memory T-cells circulate 
through the secondary lymphoid organs.  The number of cells remains reasonably 
stable during health, although both populations undergo separate homeostasis and 
balanced loss and replacement.  A number of different mechanisms are involved in 
T-cell homeostasis including controlling the rate of production, division of mature 
cells, trafficking and cell-death.  These processes need to preserve not only the 
number of cells, but also both the immune system‟s „memory‟ response to previously 
encountered pathogens and a wide diversity of antigen-receptors to new potential 
pathogens.  Most naïve T-cells are maintained in the periphery without proliferating 
and survive for a number of weeks in the absence of antigen stimulation (Goldrath 
and Bevan 1999; Correia-Neves et al. 2001; Takada and Jameson 2009).  In contrast, 
„memory‟ T-cells are stable long-term, and display both qualitative and quantitative 
changes which ensure they can respond to repeat infections with enhanced kinetics 
(McHeyzer-Williams and Davis 1995; Savage et al. 1999; Blattman et al. 2000; Kedl 
et al. 2002).   
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Age-related changes in the T-cell repertoire cause a gradual decline in the number of 
naïve T-cells and increase in „memory‟ phenotype T-cells, resulting in a narrowing 
of the TCR repertoire (Hosono et al. 1995; Sunderkotter et al. 1997).  An attributing 
cause of this change has been hypothesised as the gradual involution of the thymus, 
which is particularly apparent following puberty, and decline in thymic export of 
naïve T-cells (Steffens et al. 2000).   This loss of thymic activity does not affect the 
overall number of cells in the peripheral T-cell population, which undergoes thymus-
independent homeostasis and is maintained by self-renewing memory cells and long-
lived naïve T-cells (Lustig et al. 2009).  However, some thymic function has been 
shown to continue, despite involution, throughout life, providing new naïve T-cells 
to the circulation (Cunningham et al. 2001; Dominguez-Gerpe and Rey-Mendez 
2003).  Inherent restrictions in possible TCRα locus V-J rearrangements of animals 
of different ages have also been hypothesised following a study which showed that 
V-J combinatorial diversity was restricted in both newborn and adult mice, yielding a 
trend from 5'-3' TCRα-J gene usage with age (Thompson et al. 1992).   
 
1.2.3 The Major Histocompatibility Complex 
The human MHC, a 3.6-Mb genetic region with over 100 genes, many of which have 
an immunological function, is one of four regions within the human genome that 
contain MHC-like genes.  These are referred to as MHC-paralogous regions and they 
appear to have been created by two rounds of chromosomal duplication 
(polyploidisation) from a common ancestor (Abi-Rached et al. 2002).  Current 
evidence indicates that approximately one third of MHC genes possess duplicated 
copies in, at least, one of the three paralogous regions.  The MHC is located on 
chromosome 6, at 6p21.3-p22.2, and its three paralogous regions at 1q21-q25, 9q33-
q34, and 19p13.1-p13.4, respectively.  Of these, the 1q21-25 region is most 
phylogenetically related to the MHC region, and is the only paralog that contains true 
class I MHC-like genes, CD1 and MR1.  The majority of genes identified in this 
chromosomal region also possess an immunological function, and it has been 
hypothesised that the 1q21-q25 region may represent another antigen-presentation 
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gene cluster (reviewed by Kasahara 1999; reviewed by Flajnik and Kasahara 2001; 
Shiina et al. 2001).  Similar MHC paralogues have also been identified within the 
murine genome (Kasahara et al. 1996).   
The human MHC is composed of three regions – class I, class II and class III.  The 
class I and II regions contain a variety of highly-polymorphic genes within a well-
conserved framework of gene clusters.  The class I region contains 3 highly 
polymorphic classical class I genes, which encode the heavy chains of human 
leucocyte antigen (HLA)-A, -B and -C, as well as two clusters of non-classical class 
I genes, and various non-immunologically related genes.  HLA-A has more than 80 
alleles, HLA-B has over 180, while HLA-C has over 40.  Both alleles of each locus 
are codominantly-expressed, resulting in the expression of up to six different MHC 
class I molecules (Gromme and Neefjes 2002).  Non-classical class I genes generally 
show no or little polymorphism and in most cases their function is less well-defined 
than the classical class I genes.  The class II region contains genes encoding the α 
and β chains of HLA-DM, -DP, -DQ, and -DR, as well as genes for TAP and 
components of proteasomal complex which are involved in the class I antigen 
processing pathway.  The extended class II region also contains the gene encoding 
tapasin, a class I molecular chaperone (reviewed by Bjorkman and Parham 1990; 
reviewed by Beck and Trowsdale 2000; reviewed by Kelley et al. 2005).  The Class 
III region, which in humans is a gene-dense area located between the class I and 
class II regions, contains a large number of structurally-unrelated genes, some of 
which encode proteins involved in the innate immune system, such as complement 
components and TNF-α (Yung Yu et al. 2000; Xie et al. 2003).   
The extreme polymorphism of classical class I and class II MHC genes provides the 
capacity for selective pressures generated by repeated encounters with pathogens 
during evolution.  Allelic variations in these genes primarily include nucleotide 
substitutions in those regions that encode the peptide binding groove of the MHC 
proteins (reviewed by Bjorkman and Parham 1990; reviewed by Beck and Trowsdale 
2000).   
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The bovine MHC, or BoLA (Bovine Leucocyte Antigen), is sited on chromosome 
23, and exhibits overall a similar organisation to that of the HLA.  However, the 
bovine class II region has been split into two subregions by a chromosomal 
inversion, giving rise to one component containing class II genes of unknown 
function lying outside the MHC locus but on the same chromosome (Band et al. 
1998).  Whereas the human class I MHC has 3 expressed polymorphic classical class 
I genes, cattle have multiple (six or more) classical class I genes (Birch et al. 2006), 
but none of these is consistently expressed, and various combinations of between one 
and three different class I genes are expressed on different haplotypes (Ellis and 
Ballingall 1999; Ellis et al. 1999; reviewed by Ellis 2004).  The combination of 
allelic diversity and diversity in gene number and combination affords greatly 
increased polymorphism to the cattle MHC repertoire; however, the significance of 
this increased diversity is as yet unclear.   
 
1.2.3.1 Structure and function of MHC molecules 
Class I and II MHC molecules function as antigen-presenting proteins, binding 
antigenic peptides that are presented to T-cells. The TCR recognises the entire MHC-
peptide complex.  Two subsets of T-cells distinguished by expression of the T-cell 
co-receptors CD4 and CD8 recognise antigens presented by class II and class I MHC 
proteins respectively.   
Both MHC class I and class II molecules are heterodimers expressed on the cell 
surface.  MHC class I molecules are composed of a heavy chain non-covalently 
associated with an invariant light chain, β-2-microglobulin (β2M), which is encoded 
by a gene lying outside the MHC.  The heavy chain has an intracellular cytoplasmic 
tail and transmembrane region, while the extra-cellular portion is composed of three 
domains, α1, α2 and α3, each formed from discrete exons.  The membrane-proximal 
α3 domain interacts with β2M, with which it is structurally homologous.  The T-cell 
co-receptor, CD8, also interacts with the α3 domain during MHC – T-cell binding.  
The α1 and α2 domains contain two anti-parallel α-helices which form the sides of a 
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deep cleft that functions as the peptide-binding site.  Typically MHC class I 
molecules present antigenic-peptides of 8-11 residues, which are bound in an 
extended conformation and include 2 or 3 residues that bind via side chains into 
pockets in the MHC groove.   
The MHC class II proteins are heterodimers consisting of α and β chains which are 
non-covalently linked on the cell surface.  Each chain has  cytoplasmic and 
transmembrane domains and two extracellular domains.  The membrane-distal 
domains of each chain (α1 and β1) combine to form a peptide binding groove similar 
to that of the class I.  However, the ends of the groove are open, allowing the MHC 
class II molecule to present longer peptides (10-15 residues) in extended 
conformation (Maenaka and Jones 1999) (reviews by Bjorkman and Parham 1990; 
Bjorkman 1997; Rudolph et al. 2006; Takeshima and Aida 2006).   
 
 
Figure 1-5: 3-dimensional structure of MHC class I and class II.  (A)/(D) molecular composition 
of β-pleated sheets as well as α-helices forming the peptide-binding groove on the membrane-
distal surface; (B)/(C)/(E)/(F): Close-up of the peptide-binding groove, formed by two 
antiparallel α-helices on a „bed‟ of β-pleated sheets (of class I α1/α2 and class II α1/β1), and 
interaction with a peptide (adapted from Bjorkman 1997).   
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1.2.3.2 Antigen-Processing Pathways 
MHC class I molecules are expressed on most nucleated cells and typically allow the 
immune system to monitor these cells for viral infection or neoplastic change by 
presentation of peptides derived from intracellular breakdown of cytosolic protein.  
To do this, the immune system utilises the cell‟s normal mechanisms of protein 
turnover and catabolism, including the proteasome complex, which degrades 
ubiquitinated proteins, and the action of aminopeptidases in the endoplasmic 
reticulum (ER).  Peptides are translocated from the cytoplasm into the ER by a 
heterodimeric protein known as the transporter associated with antigen processing 
(TAP).  The ER contains newly-synthesised MHC class I heavy chains which are 
assembled with β2M and initially associates with molecular chaperones, including 
tapasin and calreticulin.  Along with TAP and other ER proteins, this forms the 
protein loading complex which aids optimal peptide loading of the MHC molecule.  
Successful peptide binding stimulates release of the MHC class I - peptide complex 
from the loading complex and transport via the Golgi apparatus to the cell surface 
(Rock 1996; Rock et al. 2002; reviewed by Yewdell et al. 2003; Rock et al. 2004; 
reviewed by Koch and Tampe 2006).  This is a highly selective process which sees 
most of the oligopeptides generated from protein catabolism recycled and degraded 
within the cell rather than binding to MHC molecules (reviewed by Yewdell et al. 
2003).   
Expression of MHC class II molecules is mostly restricted to specialized antigen 
presenting cells such as macrophages, DC and B-cells.  These molecules typically 
present exogenously-derived peptides which have undergone proteolysis within 
endosomal compartments.  Exogenous antigens are endocytosed by these cells and 
digested by proteases, particularly cathepsins, into multiple small oligopeptides.  
MHC class II molecules synthesized within the ER of the cell are initially prevented 
from binding peptides by associating with a molecular chaperone, the class II 
invariant chain (Ii).  This polypeptide occupies the peptide-binding groove and aids 
transport of the class II molecule, via the Golgi and trans-Golgi network, to late 
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endocytic vesicles.  Here, endosomal cysteine proteases progressively degrade Ii 
until only the class-II-associated invariant-chain peptide (CLIP) remains in the 
peptide binding groove.  This molecule is swapped for suitable antigenic peptide, 
under the control of another class II protein, DM, and the MHC-peptide complex is 
then transported to the cell-surface (Benaroch et al. 1995; Bryant and Ploegh 2004).   
 
 
Figure 1-6: Comparison of the MHC class I pathway for presentation of endogenous protein, 
and the MHC class II pathway for presentation of exogenous antigen.  (Image from 
http://kugi.kribb.re.kr/KUGI/Pathways/BioCarta/h_mhcPathway/, Korean Unigene database, 
December 2009).   
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1.2.3.3 Non-classical class I MHC molecules 
In contrast to classical class I genes, non-classical class I MHC genes (or class Ib 
genes) exhibit limited or no polymorphism and tend to be expressed on a more 
limited number of cell types (Fischer Lindahl 1993).  The MHC class Ib molecules 
also include a number of non-MHC-encoded class I-like proteins, such as the CD1 
family, the neonatal Fc receptor FcRn, and MR1 (reviewed by Braud et al. 1999).   
The function of several of the human non-classical class I molecules has been 
identified.  HLA-E, which is ubiquitously expressed, has been shown to regulate NK 
cell function by interacting with the cell-surface CD94/NKG2 receptors.  It also 
presents hydrophobic peptides to a small subset of CD8
+
 T cells known as NK-CTL, 
which exhibit non-MHC-restricted killing.  HLA-G is expressed at the 
maternal/foetal barrier and is hypothesised to regulate the immune response against 
the foetus.  HFE (formerly HLA-H) has a narrowed peptide-binding groove and 
performs a non-immunological function in iron metabolism.  Other non-classical 
molecules have a less similar structure to classical class I MHC, including lack of 
requirement for β2M.  Zn-α2-glycoprotein (ZAG) has a large binding groove and is 
potentially involved in lipid catabolism.  The MICA/MICB genes are encoded in the 
MHC class I region but have no function in antigen presentation and have been 
identified as general cellular-stress sensors – these encode proteins which act as 
ligands for the NKG2D type II receptor and stimulate the cytolytic response of NK 
cells, CD8
+
 αβ T-cells and γδ T-cells expressing this receptor (reviewed by Braud et 
al. 1999; Maenaka and Jones 1999; Steinle et al. 2001; Stephens 2001; reviewed by 
Rudolph et al. 2006; Pietra et al. 2009).   
The class I-like genes in humans, encoded outside the MHC, include the CD1 family 
and MR1, which map to the MHC-paralogous region on chromosome 1.  Both 
display remarkably high conservation of the α1 and α2 domains across mammalian 
species.  Human CD1 molecules are characterised by their ability to present non-
protein antigen to T-cells, due to their deep, narrow, hydrophobic binding groove 







 αβ T-cells, while CD1d, which is expressed on all 
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bone-marrow-derived cells, also binds lipids.  CD1d (Godfrey et al. 2000) and MR1 
(Treiner et al. 2003) molecules have been identified as the restriction elements for 
two distinct subsets of „invariant‟ T-cells, invariant Natural Killer T (iNKT) cells and 
Mucosal Associated Invariant T (MAIT) cells, respectively (see section 1.3).   
Functional counterparts of HLA-E, FcRn, HFE, the CD1 family, including CD1d, 
and MR1 have also been identified in mice (Braud et al. 1999) and in the case of 
CD1d and MR1 a high degree of conservation in sequence is observed between the 
species, suggesting that they have an evolutionarily-conserved function (Blumberg 
1998; reviewed by Braud et al. 1999; Treiner et al. 2003; reviewed by Rudolph et al. 
2006).   
In cattle, in addition to the classical class I genes, the MHC contains four MIC genes, 
and four other non-classical class I genes of unknown function, three near the MIC 
genes and one near the classical class I region, as well as a number of non-classical 
psuedogenes (Birch et al. 2008; Birch et al. 2008).  Outwith the MHC, CD1 genes 
have also been identified, but to date a functional CD1d gene has not been identified 
(Van Rhijn et al. 2006).   
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1.3 T-cell subsets expressing invariant TCRα chains 
T-cell populations characterised as bearing invariant TCRα chains are iNKT cells 
and MAIT cells.  The TCRα chains of these T cells were first identified as occurring 
at a higher than expected frequency among sequences of human TCRα cDNAs.  This 
led to the identification two distinct subsets of T-cells known as invariant NK T-cells 
(iNKT) and mucosal associated invariant T-cells (MAIT) (Porcelli et al. 1993).  T-
cell subsets expressing invariant TCRα chains encoded by the orthologous V and J 
gene segments have also been identified in mice (Tilloy et al. 1999).   
 
1.3.1 Invariant NKT-cells and CD1d 
The human iNKT-cell TCRα chain utilises the Vα24 and Jα18 gene segments and 
has a highly conserved CDR sequence; this chain is frequently paired with a TCRβ 
chain utilising the Vβ11 gene segment (Dellabona et al. 1994).  The corresponding 
invariant murine TCRα chain utilises the orthologous V and J gene segments (Vα14 
and Jα18) and preferentially pairs with TCRβ chains utilising the Vβ8, Vβ7, or Vβ2 
gene segments (most frequently Vβ8.2) (Lantz and Bendelac 1994).  The cells in 
mice were named NKT cells because they were originally identified as expressing 
the NK cell marker CD161/NK1.1 (Makino et al. 1995).. These invariant T-cells 
were later shown to be restricted by the non-classical MHC Ib molecule CD1d 
(Godfrey et al. 2000), in a β2M-dependent, TAP-independent manner.  Accordingly, 
the term „NKT-cells‟ has now come to encompass the CD1d-restricted T-cell 




 T cells were subsequently shown to contain 
subsets not restricted by CD1d and with diverse TCRα repertoires, which were re-
named „NKT-like cells‟ (Gumperz and Brenner 2001; Godfrey et al. 2004).  Human 
and murine NKT cells have recently been re-classified as either „classical‟/„type I‟ 
NKT-cells, (or „invariant NKT-cells‟, iNKT), with invariant TCRα and restricted 
TCRβ repertoire, or „non-classical‟/„type II‟ NKT-cells, which are CD1d-restricted 
but do not use the invariant TCRα chain (Seino and Taniguchi 2005; Roy et al. 
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) populations, which appear to have distinct functions 
(Seino and Taniguchi 2005).   
Both human and murine iNKT-cells recognise glycolipid antigens, as well as 
bacterial lipids, in association with CD1d molecules (Kawano et al. 1997; Zhou et al. 
2004; Fox et al. 2009).  Activation of iNKT-cells results in rapid cytokine release – 
in humans; CD4
+
 iNKT cells produce both Th1 and Th2 cytokines, such as IL-4, IL-
10, and IFN-γ, while CD4
-
 iNKT cells selectively produce the Th1 cytokines IFN-γ, 
TNF-α, and also upregulate perforin (Gumperz et al. 2002; Lin et al. 2006).  iNKT 
cells have been shown to mediate diverse protective and regulatory immune 
functions, including tumour rejection, protection against infectious microbes, and 
suppression of autoimmunity, by altering the Th1/Th2 balance (reviewed by Linsen 
et al. 2005; Seino and Taniguchi 2005; Kim et al. 2008).  Activated iNKT cells also 
induce DC and B-cell maturation, and NK cell activation, effectively bridging the 
adaptive and innate immune responses (reviewed by Cerundolo et al. 2009).   
iNKT cells are more abundant in mice than in humans (Treiner and Lantz 2006), 
accounting for <1% of mouse peripheral T cells (and up to 50% of liver and bone 
marrow T-cells) (Bendelac 1995; Ishihara et al. 1999) compared to 0.2% (0.01% - 
0.92%) of human peripheral blood T-cells (Linsen et al. 2005; Montoya et al. 2007).  
Full-length iNKT cell TCRα transcripts displaying a high level of similarity to the 
human and mouse sequences have been identified in other species, including horse, 
pig, rabbit, and African elephant.  However, functional CD1d appears absent from 
some ruminant species, including Bos taurus cattle.  Instead, two CD1d psuedogenes 
are formed with mutations in the start codon and first intron (Van Rhijn et al. 2006; 
Looringh van Beeck et al. 2009).  The lack of a functional CD1d gene may suggest 
the absence of iNKT cells in these species, or that another gene product performs the 
equivalent function.   
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Table 1-1: Comparison of the main features of CD1d- and MR1-restricted T-cells (adapted from 
Treiner and Lantz 2006)   
 
 
1.3.2 MAIT Cells and MR1 
MAIT cells are characterised by expression of an invariant TCRα chain, and their 
restriction by the MHC class I-like molecule, MR1.  They have been described in 
mice, humans and cattle and the TCRα sequence is highly conserved between the 
species.  The MAIT rearranged TCRα gene utilises the orthologous V and J gene 
segments in each species - murine Vα19-Jα33, human Vα7.2-Jα33 and bovine Vα19-
Jα33.  They also have a highly conserved CDR3 region of constant length (Tilloy et 
al. 1999; Treiner et al. 2003).  Interestingly, the MAIT TCRα V gene is located at the 
immediate 5‟ end of the TCRVα locus and is interspersed between olfactory receptor 
genes; its presence as the first (mice, cattle) or second (human) Vα gene in the locus 
appears to be consistent between species (Reinink and Van Rhijn 2009).  The MAIT 
TCRα chain is preferentially associated with TCRβ chains containing a limited 
repertoire of V genes – Vβ6 and Vβ8 in mice, and Vβ2 and Vβ13 in humans.  The 
repeated use of the same TCRα and β junctional re-arrangements in different cells 
from the same subject, and the fact that these were absent in other subjects, 
demonstrated the oligoclonal nature of this repertoire, relating to the peripheral 
clonal expansion of circulating MAIT cells.  (Porcelli et al. 1993; Tilloy et al. 1999; 
Treiner et al. 2005).   
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 DN T-cell population of humans, mice and cattle.  MAIT TCRα 
transcripts were measured by quantitative PCR, and quantified in relation to total 
TCRα measured using C-region specific primers.  MAIT TCRα transcripts were also 
detected at significant levels in the human CD8αα
+
 and the murine CD4
+
 T-cell 





 T-cells.  However, sequencing of multiple cDNAs revealed 
that the invariant Vα19Jα33 chain was abundant in bovine DN T-cells (Tilloy et al. 
1999).  A more recent publication studied MAIT cells by using monoclonal antibody 
against the Vα7.2 chain; since this antibody was not exclusively specific for MAIT 
TCRα (but instead all T-cells bearing Vα7.2), all results were confirmed by 
sequencing of the full TCRα chain.  This study demonstrated abundance of MAIT 
cells within the human CD8αβ
+




 lymphocytes, the study 
found that MAIT cells represented 40% of DN/CD8αα
+
 T-cells, 8% of CD8αβ
+
 T-
cells, but <1% of CD4
+
 T-cells (Martin et al. 2009).  Correspondingly, TCRα CDR3 




, and DN subsets of human T-cells, as well as 
overall peripheral blood mononuclear cells (PBMC), revealed that the invariant 
Vα7.2 CDR3 sequence was over-represented in all αβ T-cell subsets; this was highest 
in the DN and CD8
+ 
subsets, at 4.3 or 3.5 times expected frequency, respectively 
(Han et al. 1999).   
MAIT cells are 5-10 times more abundant in humans than mice (Treiner et al. 2005).  
Kinetic ELISA PCR study demonstrated them as accounting for 0.1-0.2% of all 
human peripheral T-cells (Tilloy et al. 1999); however, a definitive murine figure for 
comparison has not been published.  Further kinetic ELISA PCR studies showed that 
MAIT cells represent 15% of human circulating DN T-cells, but only 2% of murine 
lymph node DN T-cells (Tilloy et al. 1999), although these figures cannot allow 
direct comparison between species.  More recently, the use of monoclonal antibody 
against human Vα7.2  suggested that MAIT cells represented as much as 1-4% of 
human peripheral T-cells (Martin et al. 2009).   
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Analyses by quantitative PCR originally demonstrated high levels of MAIT TCR 
transcripts in PBMC and lymph nodes.  Subsequent analyses of T cell subsets 
purified by flow cytometry demonstrated that MAIT TCRα transcripts were highly 
abundant in intestinal mucosa and were enriched in cells expressing the gut-specific 
α4β7 integrin. They were particularly prominent in the intestinal lamina propria, and 
to a lesser extent within the Peyer‟s patches and mesenteric lymph nodes; virtually 
no MAIT cells were detected within intestinal epithelium.  Expression within the 
lamina propria was roughly ten-times that within the mesenteric lymph node.  MAIT 
TCRα transcripts have also been detected in human and murine lung tissue (Tilloy et 
al. 1999; Treiner et al. 2003; Treiner et al. 2005).   
 
1.3.2.1 MAIT Cell Development and Phenotype 
Initial studies had shown that MAIT cell development was dependent on a thymus, 
as MAIT cells were absent in athymic nude mice (Tilloy et al. 1999), and that their 
selection was dependent on interaction with ligands expressed on haematopoietic-
derived cells (rather than thymic epithelium) (Treiner et al. 2005).  MAIT cells were 




 knock-out mice, suggesting that they were 
selected and/or restricted by MR1 (Treiner et al. 2003).  However, although MAIT 
cells were not detected within cord lymphocytes, thymus or spleen of neonatal 
animals, large numbers of MAIT cells were detected in peripheral lymphoid organs 
of older animals, and these demonstrated an oligoclonal Vβ repertoire suggesting 
peripheral population expansion (Tilloy et al. 1999).  Additionally, MAIT cells were 
also absent from both B-cell deficient humans and mice, as well as from gnotobiotic 
mice, suggesting that their selection and/or expansion was dependent on B-cells and 
commensal flora (Treiner et al. 2003).   
These findings were clarified by a recent study using antibody against human Vα7.2, 
which showed that MAIT cell development is a stepwise process of initial thymic 
selection followed by peripheral expansion (Martin et al. 2009).  Intra-thymic MAIT 
cells exist only in low numbers and have a naïve phenotype.  The positive effect of 
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MR1 on foetal thymic organ culture and double iTCRα and TCRβ transgenic RAG 
knockout mice demonstrated that thymic selection of MAIT cells was dependent on 
both MR1, and a non-B-cell, non-T-cell, haemopoietic-derived cell-type.  Since MR1 
was shown to be absent from thymic epithelial cells, the outstanding likelihood is 
that this represents MR1 expression on thymic dendritic cells or macrophages.  This 
thymic selection was neither dependent on B cells nor on commensal bacterial flora, 
whereas the subsequent large-scale peripheral expansion of MAIT cells was 
dependent on both B-cells and commensal flora.  This process was confirmed by 
adding back B cells (expressing MR1) to mice engineered to only express MAIT 
TCRα at the surface of all T-cells; this resulted in a 10-fold increase in MAIT cell 
population.  Interestingly, B cells lacking the MR1 molecule were also able to 
stimulate MAIT cell expansion (to a lesser degree), suggesting that MR1/TCR 
interaction in the periphery may not be necessary for MAIT development (Treiner et 
al. 2005; Martin et al. 2009).   
As with NKT cells, the majority of MAIT cells express NK cell surface markers, 
particularly CD161 (NKR-P1A), which was present on the large majority of human 
blood MAIT cells detected using a monoclonal antibody specific for TCR Vα7.2.  In 
contrast, NK1.1 was detected on less than 30-50% of murine MAIT cells (Martin et 
al. 2009).  A number of studies have shown that circulating human MAIT cells 











































 (Martin et al. 2009)).  Interestingly, 







, although the majority are CD161
+
 at this stage.  This suggests that these 
cells acquire CD161 expression within the thymus and retain a naïve phenotype until 
they undergo peripheral expansion (Martin et al. 2009).   
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1.3.2.2 MR1 as a restriction element for MAIT cells 
The non-classical class I gene MR1 is a single copy gene located in the MHC-
paralogous region on human chromosome 1q25.3 and in mice at chromosome 1H1, 
near the CD1 family (Hashimoto et al. 1995; Yamaguchi et al. 1997).  Orthologous 
MR1 genes have been detected in a number of other species, including rat and non-
human primates (Walter and Gunther 1998; Parra-Cuadrado et al. 2001).  The 
sequences of MR1 in different species show a high level of conservation both at the 
nucleotide and amino acid levels (human and mouse MR1 show around 90% amino-
acid identity of the α1 and α2 domains) (see table 1-2).  This inter-species similarity 
is the highest observed for any non-classical MHC class I molecule, and suggests an 
evolutionarily-conserved function.   
 
Table 1-2: Percentage similarity of amino-acid and nucleotide (in parentheses) sequences of 
various MHC class I-related molecules between human and mouse (adapted from Yamaguchi et 
al. 1997).   
 
L: Leader peptide, TM: Trans-membrane domain, CY: Cytoplasmic domain. 
 
Despite lying outside the MHC, the MR1 gene bears a high degree of sequence-
similarity to classical class I MHC genes – the highest of any non-classical MHC 
class Ib molecule.  The MR1 heavy chain associates with β2M and the α1 and α2 
domains are predicted to form a groove similar to the peptide-binding groove of 
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classical class I proteins (Hashimoto et al. 1995; Yamaguchi et al. 1997; Yamaguchi 
and Hashimoto 2002; Miley et al. 2003).  MAIT cells were shown to be absent in 
β2M-deficient mice (Tilloy et al. 1999). 
Studies using PCR and Northern blotting have demonstrated ubiquitous transcription 
of MR1 amongst different murine organs and human cell-lines of various different 
lineages (Hashimoto et al. 1995; Riegert et al. 1998).  This revealed a number of 
differently-sized transcripts, which were later shown by sequencing to represent 
alternatively spliced isoforms in both humans and mice.  Two of the three identified 
human alternatively-spliced transcripts exhibited omission of the entire α3 region 
while retaining the open reading frame; the third transcript exhibited in-frame 
truncation of the α3 region.  The five murine isoforms contained in-frame truncation 
or omission of the α1 region.  The α2 domain was conserved in all splice variants, 
except one murine isoform which contained an intron insert (Riegert et al. 1998).   
Cell surface expression of MR1 has yet to be demonstrated consistently in ex vivo 
tissues or in cell lines, and has been difficult to achieve in cells transfected with MR1 
in vitro.  In transfected P388 and L cell lines, MR1 protein was produced, but was 
retained intracellularly.  However, human Hela cells and B6/WT-3 cells transduced 
with MR1 showed low levels of expression of the molecule at the cell surface.  By 
using antibodies shown to be specific for open and folded configurations of MR1, 
both forms were detected on the cell surface and evidence was obtained that only 
MR1 in the folded conformation was able to activate MAIT cell hybridomas.  This 
led to the hypothesis that MR1 is dependent on endogenous ligand for folding and 
surface expression (Huang et al. 2005; Treiner et al. 2005; Hansen et al. 2007).   
Since MAIT cells fail to undergo peripheral expansion in B-cell-deficient mice 
(Treiner et al. 2003), it has been suggested that MR1 is presented to MAIT cells on 
the surface of B-cells, although this has not been proven.  The failure to expand 
MAIT cells in B-cell deficient mice has been further linked to the B2 B-cell subset 
which include the cells that produce IgA in the gut (Treiner et al. 2005; Huang et al. 
2008).  Other recent work has supported the link with B cells, demonstrating low 
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 plasma cells or plasmoblasts derived 
from human gut mucosa (Gozalbo-Lopez et al. 2009).   
 
1.3.2.3 MR1 Antigen-Presentation to MAIT Cells 
1.3.2.3.1 Putative Ligands 
Although there is evidence that MR1 activates MAIT-cells in a ligand-dependent 
manner (Hansen et al. 2007), the nature of this ligand has yet to be determined.  
Previous studies (section 1.3.2.2) have suggested that cell-surface expression of MR1 
may be controlled by a ubiquitously-expressed endogenous ligand.  Further, it has 
been hypothesised that the commensal flora in the gut may either provide exogenous 
or induce endogenous ligands for MR1, or induce translocation of MR1 to the cell 
surface via a cellular „stress‟ signal (Treiner et al. 2003; Illes et al. 2004; Huang et al. 
2005; Treiner et al. 2005; Croxford et al. 2006; Hansen et al. 2007; Huang et al. 
2008).   
The α1 and α2 domains of MHC class I and class I-like molecules define the binding 
groove of these molecules, and hence their ability to bind ligands.  This is 
specifically reflected in the conserved residues involved in anchoring peptide 
termini, particularly the A and F pockets of classical class I molecules (formed by 
five and four residues respectively) which allow binding to peptide-chain amino and 
carboxyl termini (Bouvier and Wiley 1994).  This region varies dramatically in 
different class I-like molecules, enabling them to take on unique functions.  MR1, 
however, has one notable change and five conservative substitutions within these 
residues, resulting in loss of typical A- and F-pocket chemistry.  Hence it is unlikely 
that MR1 binds a protein ligand, or if so it must use a different binding paradigm to 
classical class I molecules (Miley et al. 2003; Hansen et al. 2007).   
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Although molecular modelling suggests the ligand-binding groove of MR1 is 
hydrophilic (Treiner and Lantz 2006), the partially-hydrophobic synthetic glycolipid 
α-mannosyl ceramide (α-ManCer) has been shown to activate MAIT cells (Okamoto 
et al. 2005).  This compares with the activation of iNKT cells by synthetic α-GalCer 
(Kawano et al. 1997; Pellicci et al. 2009).  α-ManCer was a potent stimulator for 
MAIT cell activity, and minor alterations in the structure of its glycolipid chain 
affected the Th1-Th2 polarisation of the cytokine response (Shimamura et al. 2007).  
These findings suggest the likelihood that, as with CD1d and iNKT cells, MR1 
presents lipid antigens to MAIT cells (Schumann and De Libero 2007).   
 
1.3.2.3.2 MR1 Antigen-Presentation Pathways 
The pathways through which MR1 presents ligand/antigen to MAIT cells are 
unclear.  MR1 was shown to associate with the peptide-loading complex in the 
endoplasmic reticulum, but MAIT cell development appears to be independent of 
TAP and Ii, as MAIT cells are present in animals deficient in these molecules (Tilloy 
et al. 1999; Miley et al. 2003; Treiner et al. 2003).  Unusually, despite its similar 
molecular structure to MHC class I molecules, transport of MR1 has been shown to 
follow an endocytic pathway.  In this pathway, MR1 is transported from the Golgi to 
a late endosomal compartment before cell surface expression.  Experimental 
inhibition of vacuolar acidification of the endosomal compartments and of 
endogenous Ii expression both dramatically inhibited MAIT cell activation by MR1; 
however, this did not reduce MR1 surface expression.  It is hypothesised that MR1 
may leave the ER when associated with a chaperone (possibly Ii), which traffics it to 
the late endosomal compartment to obtain a ligand for surface expression.  This may 
include the „recycling‟ of MR1 from cell-surface to endosomes as seen with CD1 
molecules (Huang et al. 2008).   
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1.3.2.4 Activation and Function 
MAIT cells produce a rapid and diverse cytokine response upon activation.  This is 
predominantly a Th2 response including IL-4, IL-5, and IL-10, but can also include 
IFNγ and TGFβ.  Activation of MAIT cells then additionally triggers the release of 
pro-inflammatory cytokines from bystander cells.  The role of MAIT cells in 
regulation of (autoimmune) inflammation is suggested by their ability to polarise 
their cytokine response, particularly towards Th2; similar polarisation has been 
demonstrated in iNKT cells (Kawachi et al. 2006).  When MAIT cells are over-
represented, or when the intensity and duration of MAIT cell TCR-engagement is 
increased, the ratio of Th2 cytokines such as IL-4, IL-5 and IL-10 is markedly 
increased in comparison to the production of pro-inflammatory cytokines IFNγ and 
IL-17 (Croxford et al. 2006; Shimamura et al. 2008).  This mimics the ability of 
different derivatives of the exogenous ligand α-ManCer to polarise the Th1/Th2 
cytokine response of MAIT cells (Schumann and De Libero 2007).  The 
heterogenous cytokine production in mice has been attributed to two potentially 
different groups of MAIT cells – one which produces IFNγ, IL-4 and IL-5 after TCR 
ligation, and another, predominantly NK1.1
-
, which produces IL-10 and the 
costimulatory molecule ICOS (Kawachi et al. 2006; Hansen et al. 2007; Peterfalvi et 
al. 2008).   
MAIT cells have been shown to be involved in the pathology of central nervous 
system inflammation, and accumulate in human multiple sclerosis (MS) lesions, as 
well as in the cerebrospinal fluid of MS patients.  Development of experimental 
autoimmune encephalitis, a mouse model of MS, was shown to be inhibited in 
transgenic mice over-expressing T-cells bearing the MAIT TCRα, and exacerbated in 
MR1-deficient mice.  MAIT cells have also been discovered in peripheral nerve 
biopsies from humans with chronic inflammatory demyelinating polyneuropathy.  
The authors of these studies proposed that MAIT cells were acting to reduce 
inflammation in these lesions through the release of Th2 cytokines, particularly IL-4 
and IL-10 (Illes et al. 2000; Illes et al. 2004; Croxford et al. 2006).  MAIT TCRα 
expression was also detected within human kidney and brain tumours at much higher 
levels than in the peripheral blood (Peterfalvi et al. 2008).   
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In addition to their proposed general immunoregulatory function, it has been 
suggested that MAIT cells may play a positive role in the homeostasis of intestinal 
mucosal immunity.  Since mucosal tissues provide the largest area of contact 
between the body and the outside world, MAIT cells may play a role in the 
determination of commensal versus pathogenic bacteria on the mucosal surface, or 
perhaps in the production, or feedback control, of the large levels of protective IgA 
on these surfaces (Huang et al. 2005; Treiner et al. 2005; Treiner and Lantz 2006; 
Huang et al. 2008).   
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1.4 Aims of the Project 
The purpose of this project was to study expression of the orthologous MAIT TCRα 
chain in cattle and sheep, to provide a marker that would allow further 
characterisation of MAIT cells in these species with respect to their tissue 
distribution, phenotype and potential function.  This study also aimed to identify the 
putative restriction element for MAIT cells, MR1, and examine its expression both in 
vivo and in vitro.  The specific objectives of the project were: 
 To identify the orthologous MAIT TCRα in cattle and sheep and 
analyse cross-species conservation of the gene sequence.  
Furthermore, to determine the frequency of use of each germline 
element of the MAIT TCRα within the bovine TCRα repertoire.   
 To develop a robust qPCR assay to provide a quantitative estimate of 
MAIT cell number in T-cell populations in order to examine the tissue 
distribution and phenotype of these cells.   
 To identify the putative restriction element, MR1, in cattle and sheep 
and to study the cross-species conservation of this gene.   
 To investigate the expression of bovine MR1, both with regards to 
tissue distribution of transcript, and surface expression of MR1 
protein.   
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2 Materials and Methods 
2.1 Experimental animals 
Bovine peripheral blood was collected from ten adult Friesian-Holstein Bos taurus 
cattle.  Ovine peripheral blood was collected from adult Blackface-cross ewes.  
Cattle blood and tissue samples were collected from Friesian-Holstein calves at the 
ages specified in chapter 4.  Sheep blood and tissue samples were collected from two 
Blackface ewes aged 6 months.  All animals were in normal health at time of 
sampling.  Ovine lymph samples were taken from 10-month old Blackface-cross 
ewes during the course of an experiment to monitor the effect of Telodorsagia 
circumcincta infection on the abomasum (see section 2.1.2).   
 
2.1.1 Post-mortem and collection of tissue samples 
Ovine and calf tissue samples (from thymus, peripheral lymph node, mesenteric 
lymph node, spleen, and small and large intestinal walls) were collected immediately 
post-mortem following euthanasia by captive-bolt and pithing.  Tissue samples were 
obtained aseptically, using clean gloves and sterile cutting instruments, to avoid 
potential contamination.  Slices of tissue <5mm thickness were prepared and 
collected in RNAltr (Applied Biosystems, Warrington, UK).  Samples were stored in 
RNAltr at 4°C until further processing (within 24hours), and stored longer-term in 
RNAltr at -20°C.   
 
2.1.2 Cannulation of the efferent gastric lymph duct 
Efferent gastric lymph samples were collected from sheep as part of an experiment 
conducted by Dr. W. D. Smith, Moredun Research Institute, Roslin, to study local 
responses to Telodorsagia circumcincta infestation of the abomasum.  Experimental 
sheep had undergone surgical implantation of a cannula into the common gastric 
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lymph duct, from which lymph samples were collected daily into sterile storage tubes 
(Smith et al. 1981).  Total RNA was provided from these and stored at -80°C.   
 
2.2 Chemicals, solutions and plastic ware 
All laboratory plastic ware used in preparation and analysis of nucleic acid was 
sterile, DNase/RNase-free and disposable.  Laboratory glass and plastic ware were 
sterilised by autoclaving under pressure at 124°C for 15 minutes.  Stock solutions 
and buffers were prepared using either MilliQ ion-exchange purified water 
(Millipore Milli-RO60 Plus, Millipore, Watford, UK) or sterilised distilled water.  
Laboratory chemicals used were of analytical or molecular biology grade and were 
obtained from Sigma-Aldrich (Sigma-Aldrich Co. Ltd., Dorset, UK) unless otherwise 
stated.   
 
2.3 Cellular techniques 
2.3.1 Cell culture 
2.3.1.1 Isolation of Peripheral Blood Mononuclear Cells from blood 
Blood was collected by jugular venepuncture into an equal volume of Alsever‟s 
solution (Appendix A 8.1.1), which served as an anti-coagulant and diluent.  
Peripheral blood mononuclear cells (PBMC) were harvested using a published 
protocol (Boyum 1968; Goddeeris and Morrison 1988).  Aliquots of 30ml 
blood/Alsever‟s mixture were carefully overlaid onto 20ml Ficoll-Paque Plus (GE 
Healthcare Life Sciences, Buckinghamshire, UK) and centrifuged at 900 x g for 30 
minutes.  The visible layer, containing PBMC at the Alsever‟s/Ficoll interface, was 
transferred to a fresh tube and centrifuged at 450 x g for 10 minutes; the resulting 
cell pellet was washed three times using Alsever‟s solution.  Following the final 
Chapter 2: Materials and Methods 
Characterisation of Mucosal Associated Invariant T-cells and MR1 in Ruminants 43 
wash, the cell pellet was resuspended in 5 or 10ml of Alsever‟s solution to facilitate 
counting.   
In cases where excessive contamination of the cell pellet by red blood cells (rbc) was 
apparent, rbc-lysis was performed during the pellet-washing process.  The cell pellet 
was resuspended in 2-5ml of rbc-lysis buffer (Appendix A 8.1.2) pre-heated to 37°C, 
and incubated for 1-5 minutes at 37°C before the washing process was continued as 
above.  PBMC not for immediate use were centrifuged to pellet the cells and excess 
supernatant poured off before the cell pellets were resuspended and cells were lysed 
by adding 1ml Tri-Reagent per 5-10 x 10
6
 cells and repeat pipetting.  Lysed cells 
were stored at -70°C for up to 1 month.   
 
2.3.1.2 Cell counts 
The cell-suspension was diluted 1:10 with 0.4% trypan blue stain (Gibco, Paisley, 
UK).  The cell chamber of an improved Neubauer haemocytometer was filled with 
the diluted sample and examined under a microscope at 100x magnification.  The 
cell counts within the central square and four corner squares were recorded, and their 
mean determined.  The concentration of cells/ml was calculated with the following 
formula:  




2.3.1.3 Generation and maintenance of hybridomas 
Hybridoma cell-lines producing IL-A12, IL-A51, IL-A105, and CC15 (see section 
2.3.3.1, table 2-1), as well as murine thymocytes, were retrieved from liquid nitrogen 
storage.  Samples were incubated in a 37°C water bath, until just defrosted, and 
transferred into 10ml of standard culture medium (SCM) (Appendix A 8.1.3), before 
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centrifugation at 450 x g for 5 minutes to pellet the cells.  The supernatant was 
removed and hybridoma cells were diluted in 2ml alternative SCM containing 20% 
foetal bovine serum, while thymocytes were diluted in 2ml SCM.  Samples were 
plated out in 24-well plates at a density of 2 x 10
6
 cells/ml, incubated in humidified 
5% CO2 at 37°C, and monitored for growth/infection over 36 hours.  After this 
period, thymocytes were added at a density of 1 x 10
5
 cells/ml to the hybridoma 
samples.  Cells were maintained in the log growth phase by regular passage, splitting 
1:5 (removal of 80% of medium and cells, and replacement with fresh SCM) just 
prior to confluence.  100mls of supernatant were harvested from each hybridoma cell 
type by centrifuging the cultured cell suspensions at 450 x g for 5 minutes to pellet 
cells, allowing the removal of the supernatant, which was stored at -20°C.   
Supernatants harvested from hybridoma cells were assessed for presence of 
antibodies by flow cytometry analysis (as described in section 2.3.3.2) of bovine 
PBMC.  IL-A12, IL-A51, IL-A105 and CC15 supernatants were used for primary 
antibody staining of PBMC at serial two-fold dilutions from neat to 1 in 256.  
Secondary staining was with a fluorescein isothiocyanate (FITC)-labeled anti-mouse 
IgG antibody (Invitrogen Ltd., Renfrew, UK).  Final dilutions of 1:5 or 1:10 were 
used for subsequent flow cytometry analyses.   
 
2.3.1.4 Generation and maintenance of Theileria-transformed cell-lines 
Theileria-transformed T-cell, B-cell, and macrophage cell-lines were provided by Dr. 
Niall MacHugh, University of Edinburgh, and had been generated and maintained 
according to published protocols (Goddeeris and Morrison 1988).  Cell lines used 
were: 592TPM, a B-cell line infected with T. parva; 663TA/B, a B-cell line infected 
with T. annulata; 592TAA and 663TA, macrophage cell lines infected with T. 
annulata; 109TPM, a CD8 T-cell line, 158TPM, a T-cell line of mixed CD8/γδ 
phenotype, 951TPM, a γδ T-cell line – all T-cell lines were infected with T. parva.  
RNA was extracted from harvested cells using Tri-Reagent (Sigma-Aldrich Co. Ltd., 
Dorset, UK) according to manufacturer‟s instructions (see section 2.4.1.1).   
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2.3.2 Gene transfer  
2.3.2.1 Cos-7 cells and cell passage 
The monkey fibroblast cell line Cos-7 (provided by Dr. Jane Hart, University of 
Edinburgh) was used for transient expression of the bovine MR1 gene and a MR1-
chimaeric construct.  Cos-7 cells were cultured in DMEM-Cos medium (Appendix A 
8.1.4) in T75 cm
2 
tissue culture flasks (Costar, Corning Incorporated, Corning, USA) 
incubated in humidified 5% CO2 in air at 37°C.  Cells were passaged by splitting 1:5 
just prior to confluence; medium was removed and the cells were washed with 
PBS/EDTA (Appendix A 8.1.5), before addition of 5ml 0.25% trypsin-EDTA (1X 
trypsin solution) (Gibco, Paisley, UK) and incubation at 37°C for 5 minutes to lift off 
the adherent cells.  10ml DMEM-Cos media was added to dilute the trypsin, and the 
cell suspension transferred to a 15ml tube and cells pelleted by centrifugation at 450 
x g for 5 minutes.  The cell pellet was resuspended in 5ml, and 1ml transferred back 
to the original T75 flask along with 18ml fresh DMEM-Cos medium.   
 
2.3.2.2 Transfection 
Full-length and chimaeric MR1 and MHC cDNAs cloned into the pcDNA3.1/V5-
His-TOPO (Invitrogen Ltd, Renfrew, UK) and pFlag-CMV-3 plasmid vectors 
(Sigma-Aldrich Co. Ltd., Dorset, UK) (see section 2.4.4) were transfected into Cos-7 
cells using FuGENE HD Transfection Reagent (Roche Applied Science, Burgess 
Hill, UK).  Cos-7 cells were plated in a flat-bottomed 96-well plate 24 hours 
previously at 2 x 10
4
 cells in 100µl DMEM-Cos medium per well, and incubated at 
37°c in 5% CO2; Cos-7 cell surface-cover confluence at the time of transfection was 
approximately 80%.  A transfection reaction was initially prepared by warming all 
reagents to room temperature (RT).  For each 10 wells to be transfected, 500µl 
(serum-free) DMEM and 1µg DNA were combined in a 1.5ml Eppendorf tube.  3µl 
FuGENE HD was directly added into the solution, and the reaction was incubated at 
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RT for 15 minutes.  DMEM-Cos medium was removed from the pre-prepared 96-
well plate, and 50µl of the transfection reaction was added to each well.  The plate 
was further incubated at 37°C, in 5% CO2 for 4 hours, before the transfection 
reaction solution was removed and replaced with 100µl DMEM-COS medium, and 
incubation continued.  Cos-7 cells were analysed 48 hours after transfection either as 
cell suspensions by flow cytometry or as fixed adherent cells by fluorescence 
microscopy.   
 
 
2.3.3 Expression analysis 
2.3.3.1 Antibodies 
Primary antibodies used for flow cytometry analysis were either derived from 
hybridoma culture supernatants, which were used at a dilution of 1:5 or 1:10 in 
FACS medium (Appendix A 8.1.6), or from mouse ascitic fluid, which was diluted 
1:1000 for use.  Primary antibodies used are listed in table 2-1.  Secondary antibodies 
for phenotypic analysis of PBMC were R-Phycoerythrin (R-PE) or FITC-labelled 
goat anti-mouse immunoglobulin isotype-specific antibodies (IgG1, IgG2a or 
IgG2b), or labelled anti-mouse IgG antibody, (Invitrogen Ltd., Renfrew, UK / 
Southern Biotech, Birmingham, Alabama, USA).  Secondary antibody used for 
analysis of MR1 expression in Cos-7 cells was FITC-labelled polyvalent anti-mouse 
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Table 2-1: Bovine monoclonal antibodies used for primary antibody staining for flow cytometry 
analyses.   



















IL-A88 Bovine MHC Ia heavy chain
g
 IgG2a 





MR1 26.5 Human MR1
i
 ND 
W6-32 Human MHC Ia and some 










M2 pFlag-CMV-3 Vector tag
m
 ND 
Specifities: a) (Davis et al. 1993) b) (Bensaid and Hadam 1991) c) (MacHugh and Sopp 1991) d) 
(MacHugh and Sopp 1991) e) (Morrison and Davis 1991) f) (Davis et al. 1996) g) (Toye et al. 
1990) h) (Bensaid et al. 1989) i) (Huang et al. 2009) j) (Maziarz et al. 1986) k) & l) were provided 
by Dr. Shirley Ellis, Institute for Animal Health, Compton; their specificities are unpublished 
m) (Sigma-Aldrich Co. Ltd., Dorset, UK).  Isotype ND = not determined; a FITC-labelled anti-
mouse immunoglobulins secondary antibody was used for detection of these primary antibodies.   
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2.3.3.2 Flow cytometry analysis 
Flow cytometry was used to identify populations of T-cells in PBMC of cattle and 
sheep, and to study surface expression of transfected genes on Cos-7 cells.  PBMC 
were isolated from fresh blood samples and counted as in section 2.3.1.1/2, and 
prepared in a round-bottomed 96-well plate at a concentration of approximately 1 x 
10
6
 cells/well (in 50ul FACS medium).  Cos-7 cells were harvested as described 
above and were suspended at 2 x 10
7
 cells/ml and 50ul added to each well. 
Aliquots of 25-50µl of primary monoclonal antibody were added to each well, and 
the plate incubated at 4°C for 30 minutes, before cells were washed three times in 
200µl FACS medium.  The same procedure was repeated for secondary antibody.  
Following the third wash in FACS medium, cells were resuspend in FACS medium 
and analysed on a BD FACSCalibur Flow Cytometer (BD Biosciences, San Jose, 
California, USA).   
 
2.3.3.3 Purification of cells by flow cytometry 
Cell subsets within bovine PBMC were purified by flow cytometry according to their 
cell-surface phenotype.  Between 10-30mls of isolated PBMC at a density of 
approximately 1 x 10
7
 cells/ml were stained by indirect immunofluorescence with 
cell subset-specific antibodies as described for cell phenotyping and separated into 
distinct phenotypic populations using a BD FACSAria Flow Cytometer (BD 
Biosciences, San Jose, California, USA) and FACSDiva software version 5.02.  
Once separated, samples were reanalysed by flow cytometry to assess purity.    
 
2.3.3.4 Immunofluorescence microscopy 
Cos-7 cells were analysed for gene expression 48 hours after transfection by 
immunofluorescence staining of adherent cells and microscopic examination with a 
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Leitz ''Laborlux K'' microscope (Esselte UK Ltd., Uxbridge, UK) and a Zeiss 
Axiovert 25s (Carl Zeiss Ltd., Welwyn Garden City, UK) microscope, equipped with 
epi-fluorescence.  Cells were prepared for analysis in two ways:  
(i) Cytospins – Transfected cells were harvested from the wells of flat-bottom 96 
well plates by treatment with trypsin-EDTA as described above (section 2.3.2.1) and 
transferred to the wells of a U-bottom 96-well plate.  An additional 100µl DMEM-
Cos medium was added to each well and after centrifugation of the plate at 450 x g 
for 5 minutes, the medium was flicked off and the cells were resuspended in 200µl 
DMEM-Cos medium.  Double cytofunnel cuvettes (Shandon, Thermo Fisher 
Scientific Inc., Waltham, MA, USA) were mounted onto superfrost microscope 
slides in metal holders; 200µl cell suspension was transferred to either side of the 
cuvette, and the cuvette centrifuged at 800rpm for 3 minutes in a Cytospin3 
centrifuge (Shandon, Thermo Fisher Scientific Inc., Waltham, MA, USA).  Slides 
were carefully extracted and allowed to air-dry, before being fixed in an acetone bath 
for 5 minutes and air-dried again.  Cytospin blot perimeters were sealed with Liquid 
Blocker Super Pap Pen (Daido Sangyo Co. Ltd., Tokyo, Japan).  20-50µl of primary 
antibody was applied to the cytospin blot, and the slide incubated for 30 minutes in a 
humidified box, after which it was rinsed twice in a PBS (Appendix A 8.1.7) bath.  
The same procedure was repeated for secondary antibody.  Following the second 
PBS wash, fluorescent-mounting medium (Dako UK Ltd., Ely, UK) was used to add 
a cover-slip to the slide, and cytospins were examined by fluorescence microscopy.   
(ii) Immunostaining within wells – Medium was removed from the 96 well plate 
and the cells were washed by addition and removal of 200µl PBS per well.  100µl of 
an acetone/ethanol mixture was added per well to fix the cells, and the plate was 
incubated at RT for 5 minutes.  Acetone/ethanol was flicked off, and the cells 
washed with 200µl PBS.  50µl primary antibody was added to each well, and the 
plate incubated for 30 minutes at 4°C.  Following incubation, cells were washed 
three times in 200µl FACS medium.  The same procedure was repeated for 
secondary antibody.  After the final rinse in FACS medium, 50µl PBS was added to 
each well, and cells in the wells examined by immunofluorescence microscopy.   
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2.4 Molecular techniques 
2.4.1 Preparation of nucleic acids 
2.4.1.1 RNA extraction from PBMC 
Total RNA was extracted from cell pellets of PBMC using Tri-Reagent (Sigma-
Aldrich Co. Ltd., Dorset, UK).  Cell pellets were resuspended in 100μl of Alsever‟s 
solution in Eppendorf tubes, and cells were lysed by adding 1ml Tri-Reagent per 5-
10 x 10
6
 cells and repeat pipetting, followed by incubation at RT for 5 minutes.  
Chloroform (0.2ml per 1ml of Tri-Reagent) was added to the solution, vortexed for 
15 seconds, and incubated at RT for 15 minutes.  The solution was centrifuged at 
12,000 x g for 15minutes at 4°C to separate it into three phases – an organic (protein) 
phase, an interphase (DNA), and an aqueous phase (RNA).  The RNA phase was 
collected and isopropanol (0.5ml per 1ml Tri-Reagent) added, incubated at RT for 10 
minutes, and centrifuged at 12,000 x g for 10 minutes at 4°C to precipitate the RNA.  
The RNA pellet was washed twice using 1ml 75% ethanol and allowed to air-dry.  
Once the ethanol had evaporated, the pellet was resuspended in 25μl of nuclease-free 
water.  RNA was stored at -70°C.   
 
2.4.1.2 RNA extraction from tissue 
(i) Homogenisation of tissue: 100mg of (thymus, spleen, peripheral lymph node, 
mesenteric lymph node, small intestinal wall, ileal wall) tissue was weighed and 
diced into small pieces using autoclaved, RNA-zapped instruments.  This tissue was 
placed in a FastRNA ProGreen matrix tube (MP Biomedicals, Solon, Ohio, United 
States) containing 1ml RLT-β-Mercaptoethanol (100μl 2-Mercaptoethanol/1ml RLT) 
(Sigma-Aldrich Co. Ltd., Dorset, UK).  The sample was processed in the FastPrep 
instrument (MP Biomedicals) in runs of 40 seconds at a speed setting of 6.0, 
applying 1-3 runs of processing, depending upon the tissue-sample, and a cooling 
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period of 10 minutes between each run.  The resulting liquid upper layer in the 
matrix tube was transferred to a Qiashredder tube (Qiagen, Crawley, UK) and 
centrifuged to filter the RNA lysate and remove any remaining debris.   
(ii) Extraction of RNA: RNA extraction from tissue samples was done using the 
RNeasy mini-kit (Qiagen, Crawley, UK).  1400μl of RNA lysate was mixed with an 
equal volume of 70% ethanol and run through an RNeasy column, which was 
centrifuged to trap the RNA in the RNeasy filter.  The trapped RNA was then 
washed by passing 700μl of RW1 buffer through the column, followed by two 
washes with 450μl RPE/ethanol buffer.  The column was transferred to a “no stick” 
Ambion eppendorf tube, and the RNA eluted by adding 50μl nuclease-free water to 
the column, and centrifugation.   
 
2.4.1.3 Preparation of plasmid DNA 
(i) Mini-preps: E. coli competent cells containing transformed DNA were expanded 
in 6ml of Luria-Bertani (LB) medium by incubation overnight at 37°C while shaking 
at 220rpm.  Plasmid DNA was recovered using either Wizard Plus SV MiniPreps 
DNA Purification System or Pure Yield Plasmid MiniPrep System (Promega, 
Hampshire, UK).  3ml of the expansion culture was pelleted by centrifugation at 
10,000 x g for 5 minutes and the supernatant removed.  200μl cell resuspension 
solution, 200μl cell lysis solution, and 200μl neutralisation solution (all provided 
with the Promega kit) were added to the pelleted bacteria, the contents were mixed 
and then centrifuged to pellet waste products.  The clear supernatant was added to 
1ml DNA resin and passed through a mini-column to allow DNA to bind to the mini-
column resin.  2ml of column wash solution was passed through the mini-column, 
and the resin dried by centrifugation.  50μl of nuclease-free water was added to the 
resin, and the mini-column centrifuged to elute the DNA.   
(ii) Maxi-preps: E. coli competent cells containing transformed DNA were 
expanded for 5 hours in 6ml of LB medium, then overnight in 200ml LB medium in 
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a wide-based beaker.  Plasmid DNA was recovered using the Qiagen Endofree 
Plasmid Maxi Kit (Qiagen, Crawley, UK) as per the manufacturer‟s instructions.  
Briefly, 200ml of the expanded bacterial culture was pelleted by centrifugation at 
6000 x g for 15 minutes at 4°C, and the supernatant removed.  Pellets were 
resuspended in 10ml solution P1, then 10ml solution P2 was added, and the reaction 
mixed and incubated at RT for 5 minutes, before 10ml solution P3 was added and 
vigorously mixed.  The reaction was incubated at RT for 10 minutes, and insoluble 
proteins were filtered out by passage through a QIAfilter Maxi Cartridge.  2.5ml ER 
buffer was added to the filtered lysate, mixed, and incubated on ice for 30 minutes.  
During this incubation a Qiagen-tip 500 column was prepared by filtration of 10ml 
buffer QBT through the column matrix.  The lysate/ER was then added to the column 
and DNA allowed to bind to the column resin by gravity flow.  Two washes of the 
column with 30ml buffer QC were performed, and the DNA eluted by allowing 15ml 
buffer QN to flow through the resin.  The DNA was precipitated by centrifugation 
with 10.5ml 100% isopropanol at 15000 x g for 30 minutes at 4°C and then 5ml of 
endotoxin-free 70% ethanol at 15000 x g for 10 minutes at 4°C.  The DNA pellet 
was then air-dried and dissolved into 100µl TE.   
 
2.4.1.4 DNase treatment of RNA for qPCR 
RNA from PBMC and tissue samples to be analysed by qPCR was treated with RQ1 
RNase-free DNase (Promega, Hampshire, UK) as per the manufacturer‟s 
instructions.  2µg RNA were mixed with 1µl RQ1 10X Reaction Buffer, 2µl RQ1 
DNase (1u/µl), and made up to 10µl with nuclease-free water.  This mixture was 
incubated at 37°C for 30 minutes in a hot-lid thermal-cycler, before 1µl RQ1 DNase 
Stop Solution was added, and the reaction incubated at 65°C for 10 minutes.  Final 
RNA concentration for reverse transcription was 1µg in 5.5µl.   
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2.4.1.5 Restriction endonuclease digestion of DNA for cloning 
DNA was cloned into the pFlag-CMV-3 expression vector (Sigma-Aldrich Co. Ltd., 
Dorset, UK) through restriction endonuclease digestion of the vector and appropriate 
inserts.  Vector restriction endonuclease sites not present in the insert sequence were 
selected; these were added to either end of the sequences to be inserted by 
incorporation into the PCR primers used to amplify the sequence, each flanked by six 
additional random nucleotides to aid the digestion reaction.  The pFlag-CMV-3 
vector and full-length MR1 cDNA insert were digested with HindIII (New England 
Biolabs (NEB) Ltd., Hitchin, Herts., UK) and XbaI (NEB) as per the manufacturer‟s 
guidelines.  Briefly, 500ng DNA was prepared with 5µl 10X NEB Buffer 2, 0.5µl 
Bovine Serum Albumin (BSA), 1µl HindIII, 1µl XbaI, and made up to 50µl with 
nuclease-free water.  This reaction was incubated at 37°C for 3 hours, then 65°C for 
20 minutes.  The components of the MR1 chimaeric insert were digested with 
HindIII and BsiWI (NEB) for the MR1 component, and XbaI and BsiWI for the 
MHC component.  Reactions were set-up with 500ng insert DNA, 5µl 10X NEB 
Buffer 2, 1µl HindIII (cMR1) or 1µl XbaI and 0.5µl BSA (cMHC), and nuclease-free 
water to a volume of 50µl  This mixture was incubated at 37°C for 3 hours, then 
65°C for 20 minutes.  1µl BsiWI was then added to the reaction mixture, and further 
incubations at 55°C for 3 hours then 80°C for 20 minutes performed.   
Digested DNA was purified using the QIAQuick PCR Purification Kit (Qiagen, 
Crawley, UK) as per the manufacturer‟s guidelines – 250µl buffer PB was added to 
the reaction mixture and passed through a QIAQuick spin column to allow DNA 
fragments over 80bp to attach to the column membrane.  The membrane was washed 
in buffer PE, before being allowed to dry, and DNA eluted by passage of 30µl of 
nuclease-free water across the column membrane.  Product DNA was quantified and 
cloned as in section 2.4.4.   
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2.4.2 Polymerase chain reactions 
2.4.2.1 Reverse Transcription (RT)-PCR for cDNA synthesis 
cDNA was synthesised from RNA using the Reverse Transcription System 
(Promega, Hampshire, UK).  1μg of RNA was incubated at 70°C for 10 minutes.  A 
reaction mixture of 4μl 25mM MgCl2, 2μl Reverse Transcription 10X buffer, 2μl 
10mM dNTP mixture, 0.5μl recombinant RNAsin ribonuclease inhibitor, 15u avian 
myeloblastoma virus reverse transcriptase (AMV-RT), 0.5μg oligo(dT)15 primer, was 
created, the 1μg of RNA added to this, and the volume made to 20μl with nuclease-
free water.  This reaction was incubated at 42°C for 1 hour to create cDNA, heated to 
95°C for 5 minutes, then incubated at 0°C for 10 minutes to inactivate the AMV-RT.  
cDNA was stored at -20°C.   
 
2.4.2.2 Amplification of DNA by PCR 
Working stock primers were used at 10pmol/μl.  Unless stated otherwise, PCR 
reactions were run in a total volume of 20µl (or multiples thereof) composed of 
10pmol forward primer, 10pmol reverse primer, 2µl ABgene custom PCR master 
mix SM-0005 (Appendix A 8.1.8) (ABgene, Epsom, Surrey, UK), 0.2µl (5units/µl) 
BIOTAQ DNA polymerase (Bioline, London, UK), 1µl cDNA, and made up to 20ul 
with sterile water.  Hot-lid thermal-cyclers were used, either PTC-100 (MJ Research 
Inc, Watertown, Mass, USA) or G-Storm (GRI Ltd., Essex, UK) machines.  The 
standard cycling protocol for PCR was incubation at 95°C for 10 minutes, 35 cycles 
of (95°C for 1 minute, specific annealing temperature for 1 minute, 72°C for 1 
minute), and 72°C for 10 minutes, except where specified.  Specific annealing 
temperatures are listed within each chapter.   
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2.4.2.3 RACE PCR 
RACE (5‟ and 3‟ Rapid Amplification of cDNA Ends) PCR was performed using the 
SMART RACE cDNA Amplification Kit (Clontech Laboratories, Inc.).  SMART 
(Switching Mechanism at 5‟ end of RNA Transcript) first-strand cDNA synthesis 
allows generation of RACE-ready full-length cDNA through reverse transcription.  
The dC-tailing action of Moloney murine leukaemia virus reverse transcriptase 
(MMLV-RT) through terminal transferase activity allows annealing of the SMART 
II A oligonucleotide to the original RNA sequence, which serves as an extended 
template for creation of cDNA through further reverse transcription.  RACE-ready 
cDNA is subsequently used directly in RACE PCR reactions, in combination with 
gene-specific primers and universal primer mix (UPM, which contains two primers, 
short and long universal primers (SUP/LUP)) which suppress inverted repeat 
elements and allow gene-specific DNA synthesis.  The resulting RACE products 
were purified, cloned and sequenced to create a library of gene transcripts.   
(i) First strand cDNA synthesis: was performed as per the Clonetech Laboratories, 
Inc. protocol.  Briefly, 1µg of RNA was mixed with 1µl 5‟-CDS primer A and 1µl 
SMART II A oligo, and made up to 5µl with sterile water.  This preparation was 
incubated at 70°C for 2 minutes, then incubated on ice, before adding 2µl 5X First-
Strand Buffer, 1µl 20mM DTT, 1µl 10mM dNTP mix and 1µl Primescript MMLV 
Reverse Transcriptase (Takara Bio Inc, Japan).  The reaction was mixed and 
incubated for 90 minutes at 42°C in a PTC-100 thermal cycler.  Reaction product 
was diluted by adding 100µl tricine-EDTA buffer (10mM tricine-KOH at pH8.5; 
1.0mM EDTA) and incubated at 72°C for 7 minutes.  cDNA produced was stored at 
-20°C.   
(ii) Rapid Amplification of cDNA Ends: cDNA was amplified as per the Clonetech 
protocol.  Briefly, reaction master mix was created using 34.5µl sterile water, 5µl 
10X Advantage 2 PCR buffer, 1µl 10mM dNTP mix, 1µl 50 Advantage 2 
Polymerase mix, and mixed well.  2.5µl 5‟-RACE-ready cDNA, 5µl 10X UPM, and 
1µl 10µM bovine TCRα constant region primer BovC4r were mixed in a separate 
tube, and the master mix added giving a total volume of 50µl.  Two negative controls 
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were also run – one without 10X UPM, and one without BovC4r.  Reactions were 
incubated in a PTC-100 thermal cycler for 5 cycles of (30 seconds at 94°C, 3 minutes 
at 72°C), 5 cycles of (30 seconds at 94°C, 30 seconds at 70°C, 3 minutes at 72°C), 
and 25 cycles of (30 seconds at 94°C, 30 seconds at 68°C, 3 minutes at 72°C).   
 
2.4.2.4 „Real-time‟ quantitative PCR 
„Real-time‟ quantitative PCR was used to compare expression of the MAIT TCRVα 
gene to that of the TCRα constant region, identifying the relative abundance of 
MAIT cells within the overall αβ T-cell population.  RNA was isolated from ovine 
and bovine tissues using RNeasy Protect kit (see section 2.4.1.2) and DNase-treated 
using Promega RQ1 RNase-free DNase (section 2.4.1.4).  cDNA synthesis was 
performed using AMV reverse transcriptase, as in section 2.4.2.1.  The qPCR used 
primers (bovine: “I”/“Jr”; ovine: “boovUntr3f”/“CorovC3r”), designed to anneal to 
the TCRα V segments that are used by bovine/ovine MAIT cells and the respective α 
constant chains, yielding 750bp PCR products (for primer sequences, see section 
3.2.3).  These were sequenced to confirm MAIT TCRα identity and used as positive 
controls and to generate qPCR standard curves.   
For the MAIT-cell V-region-specific qPCR the following primers/probe were used – 
forward (both species): “boovAV19f”; reverse (bovine): “boovAJ33r”; reverse 
(ovine): “ovAJ33r”; probe (both species): “boAV19”.  For the α chain constant-
region-specific qPCR, primers “NGconst-f” and “NGconst-r”, and probe “NGconst” 
were used for both cattle and sheep.  Primer sequences are provided in chapter four.  
Primers and probes were made by Applied Biosystems, Warrington, UK.  qPCRs 
were performed in a 20µl reaction volume containing 500nM of each primer, 250nM 
of probe, and 3μg of cDNA in Taqman Gene Expression Master Mix (Applied 
Biosystems, Warrington, UK).  Reactions were run in an ABI7500 qPCR machine 
(Applied Biosystems, Warrington, UK) under the following cycling conditions: an 
initial incubation of 2 minutes at 50°C, an incubation for 10 minutes at 95°C, and 50 
cycles of 10 seconds (ovine 15 seconds) at 95°C and 1 minute at 53°C.  All standards 
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and samples were run in triplicate, and results expressed as the mean value with 
standard error provided.  Results were analysed using Applied Biosystems 7500 Fast 
System SDS software, version 1.4 (Applied Biosystems, Warrington, UK).   
In chapter four, qPCR results for two 3-month old calves were provided by Dr. Ildiko 
Van Rhijn, University Utrecht, Netherlands.  Specific method for these results is 
described in chapter 4.   
2.4.2.5 Primer design and production 
Standard and RACE PCR primers were designed either manually or using DNASIS 
software (see 2.5.2) and ordered from Eurofins MWG Operon (Ebersberg, 
Germany).   
 
2.4.3 Analysis of nucleic acids 
2.4.3.1 Quantification of RNA and DNA 
Quantification of RNA and DNA was performed using either the Nanodrop 
spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA, USA), or the 
GeneQuant spectrophotometer (GE Healthcare Life Sciences, Buckinghamshire, 
UK).  Samples were diluted with nuclease-free water, and absorbance readings taken 
at 260nm/280nm wavelengths.  Concentrations were assessed using the following 
formulas: 
 RNA (ng/μl) = 260nm reading x dilution factor x 40 
 DNA (ng/μl) = 260nm reading x dilution factor x 50 
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2.4.3.2 Housekeeping genes 
GAPDH and G3PDH were used as housekeeping genes for ovine and bovine cDNA, 
respectively.  Primers used to detect these were “ovGAPDHf” (5‟-AAG GCA GAG 
AAC GGG AAG-3‟) and “ovGAPDHr” (5‟-ACT GTC CAC GCC ATC ACT-3‟), 
used at annealing temperature (Tm) 56°C; and “G3PDH1” (5‟-GAT GCT GGT GCT 
GAG TAT GTA GTG-3‟) and “G3PDH2” (5‟-CTC CCA ACG TGT CTG TTG 
TGG AT-3‟) at Tm: 60°C.   
 
2.4.3.3 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to study the molecular weight of PCR products 
as a guide to reaction success and PCR product identity.    
(i) 1.5% gel solution of agarose (Bioline, London, UK) in 1 x TAE buffer 
(Appendix A 8.1.9) was used to create gels for standard analysis in a midi-gel system 
(Flowgen, Ashby de la Zouch, Leics., UK).  PCR products were mixed 2:1 with 
loading buffer (Appendix A 8.1.10) and loaded into a gel placed in 1 x TAE buffer, 
through which an 80-120V charge was run for 30-120 minutes, as appropriate.  1µg 
of 1Kb Plus DNA Ladder (Invitrogen Ltd., Renfrew, UK) was used to calibrate the 
sizes of different PCR products.  DNA staining was either performed using Biotium 
GelRed 10,000X (Cambridge BioScience, Cambridge, UK) at 1:10,000 dilution 
within the agarose gel solution, or by staining the gel in an ethidium bromide bath 
(0.5µg/ml in 1 x TAE buffer) for 30 minutes following completion of 
electrophoresis.  Stained gels were visualised using a BioRad Gel Doc 2000 or 
BioRad Molecular Imager FX Pro Plus, and BioRad Quantity One software (Biorad, 
Hercules, CA, USA).   
(ii) 3% Metaphor gel solution was used to differentiate small, similarly-sized 
fragments of DNA.  MetaPhor agarose (Lonza, Rockland, ME, USA) in 1 x TAE 
buffer was used to create gels for analysis.  Gel Red was added to the gel solution to 
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stain DNA product.  PCR products were mixed 2:1 with loading buffer and loaded 
into a gel placed in 1 x TAE buffer, through which a 120V charge was run for 3.5 
hours.  1.5µg 50bp DNA Step Ladder (Promega, Hampshire, UK) was used to 
estimate molecular weight of products.  Gels were visualised using a BioRad 
Molecular Imager FX Pro Plus and Quantity One software.   
 
2.4.3.4 DNA extraction from agarose 
DNA samples were extracted from agarose gels using either a Geneclean II kit 
(Qbiogene, Cambridge, UK), Qiagen MinElute Gel Extraction kit (Qiagen, Crawley, 
UK), or QIAQuick Gel Extraction kit (Qiagen), as per the manufacturers‟ 
instructions.  DNA bands were excised from agarose gel using sterile instruments 
and weighed to estimate volume (0.1g = 100μl).  The Geneclean II kit was used for 
the vast majority of reactions - three times the gel volume of chaotropic salt NaI was 
added to keep the Na concentration above 4M (thus forcing the DNA into the 
silicate).  This solution was incubated at 55°C in a water bath until the gel had 
dissolved.  15μl of glassmilk (silicate) was added and the solution incubated at RT 
for 10 minutes to allow DNA binding to the silicate.  The DNA/silicate was pelleted 
by centrifugation and washed three times in 700μl new wash solution.  The 
supernatant was removed and the pellet allowed to air dry thoroughly.  DNA was 
eluted by resuspending the pellet in 15μl nuclease-free water – this lowers the Na 
concentration releasing the DNA into the supernatant.  The solution was centrifuged 
and the supernatant collected; this process was repeated twice to remove as much 
silicate as possible.  Supernatant containing DNA was stored at -20°C.   
 
2.4.3.5 PCR product purification  
PCR products were purified for cloning by removing primers and salts, using the 
Wizard PCR Preps DNA Purification System (Promega, Hampshire, UK).  100μl of 
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direct purification buffer and approximately 100μl of PCR product were mixed, and 
1ml of DNA resin added before vortexing the solution vigorously three times within 
one minute.  The resulting homogenate was passed through a Wizard PCR Preps 
DNA Purification System mini-column to adhere the product DNA to the mini-
column resin.  The resin was subsequently rinsed with 2ml of 80% isopropanol and 
dried by centrifugation.  40μl of nuclease-free water was used to elute the DNA from 
the resin by centrifugation.   
 
2.4.3.6 DNA Sequencing 
Sequencing of small numbers of DNA samples was performed by DBS Genomics at 
Durham University, UK, using an Applied Biosystems 3730 DNA Analyser (Applied 
Biosystems, Warrington, UK).  Samples were either purified PCR product (as 
described in section 2.4.3.5) with appropriate primers, or purified plasmid DNA (see 
section 2.4.1.3) with specific or vector primers as appropriate.   
2.4.3.7 96-well plate sequencing reactions 
Colonies transformed with plasmid vector containing product from RACE-PCRs 
were sequenced in a 96-well plate format, using DNA extraction methods and 
sequencing reaction provided by Dr. T. Connelley, University of Edinburgh, which 
was based upon a BigDye Terminator v3.1 (Applied Biosystems, Warrington, UK) 
protocol adapted from that provided by the Sequencing Unit of the Department of 
Zoology, University of Oxford.   
Sample Preparation: Colonies were transferred into wells containing 20µl 
nuclease-free water within a 96-well PCR plate, filling 90 wells per plate and leaving 
6 wells as negative controls.  Plates were sealed and incubated at 95°C for 10 
minutes in a hot-lid thermal-cycler to denature DNA, before centrifugation at 600 x g 
for 5 minutes to pellet bacterial debris.  Supernatant containing DNA was transferred 
to a new 96-well plate.  To purify the DNA, 60µl of 20% polyethylene glycol (PEG) 
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MW8000/2.5M NaCl (Appendix A 8.1.11) was added to each well, and the plate 
vortexed and incubated either overnight at 4°C or at RT for 30 minutes.  The plate 
was sealed and centrifuged at 2250 x g for 1 hour at 4°C to pellet (larger) DNA.  
Supernatant was removed by centrifugation of the inverted plate at 500 x g for 1 
minute.  Two washes with 150µl ice-cold 70% ethanol were performed, before the 
pellet was air-dried and resuspended in 50µl sterile water.  Samples were stored at     
-20°C.  At this stage, a sample from each well was mixed with loading buffer and run 
on a 1.5% agarose gel to confirm the presence of product.   
Sequencing Reaction:  Each reaction was composed of a master mix of 4µl of 
0.67pmol/µl sequencing primer BovCintr (5‟- TGC TCA ACA TGG AGA TCC TG-
3‟), 2µl 5X CSA buffer (Appendix A 8.1.12), 0.25µl BigDye Terminator v3.1, and 
1.75µl nuclease-free water, to which 2µl of purified PCR product was added.  The 
reactions were prepared in 96-well plate format, and the plate sealed and incubated 
for 30 cycles at (96°C x 10 seconds, 50°C x 5 seconds, 60°C for 2 minutes).  15µl 
nuclease-free water, 50µl absolute ethanol and 2µl of 3M NaOAc pH5.2 (Appendix 
A 8.1.13) were added to each well, the plates sealed and vortexed, and incubated at 
RT for 45 minutes.  Sequencing products were pelleted by centrifugation at 2250 x g 
for 75 minutes at 4°C, and supernatant discarded as described earlier.  DNA pellets 
were washed once in 150µl ice-cold 70% ethanol before air-drying.  Prepared 96-
well plates were sent to the Sequencing Unit, Department of Zoology, University of 
Oxford for analysis using an Applied Biosystems 3730xl DNA Analyser (Applied 
Biosystems, Warrington, UK).   
 
2.4.4 Cloning into plasmid vectors 
2.4.4.1 Vectors used 
(i) Standard sub-cloning of PCR products was performed using the pGEM-T 
Easy System (Promega, Hampshire, UK), which contains a 3015bp vector 
(Appendix A 8.2.1).   
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(ii) Cloning of MR1 and a MR1-chimaera was performed into a 5‟-tagged 
6kb vector, pFlag-CMV-3 expression vector (Sigma-Aldrich Co. Ltd, 
Dorset, UK ) (Appendix A 8.2.3).  The original vector was transformed 
directly into JM109 cells to allow expansion and extraction (see section 
2.4.1.3) of vector DNA.   
(iii) Plasmid DNA from a bovine classical MHC class I (N*02401) 
transformed into a TOPO TA 5.5kb expression vector (Appendix A 8.2.2) 
using the Invitrogen pcDNA3.1 / V5-His TOPO TA Expression Kit 
(Invitrogen Ltd, Renfrew, UK), was provided by Dr. Jane Hart, 
University of Edinburgh.   
2.4.4.2 Ligation and cloning 
(i) Purified PCR product was ligated into pGEM-T Easy vector using a 
reaction mixture of 5μl 2X rapid ligation buffer, 1μl pGEM-T Easy 
vector, 3μl PCR product, 1μl T4 DNA ligase (3 weiss units/µl).  This 
reaction mixture was incubated either for 1 hour at RT or overnight at 
4°C.   
(ii) Vector DNA and insert DNA were prepared by restriction endonuclease 
digestion (see section 2.4.1.5).  A ligation reaction of insert DNA and 
vector DNA at a ratio of 4 : 1 was mixed with appropriate volumes of T4 
DNA ligase (to provide 3 Weiss units per 10µl total reaction volume) and 
2X rapid ligation buffer (to provide 50% of total reaction volume).  The 
reaction mixture was incubated for 1 hour at RT then overnight at 4°C.   
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2.4.5 Transformation and analysis of transformed E. coli 
2.4.5.1 Transformation and competent cells 
(i) PCR products in pGEM-T Easy vector were transformed into JM109 
High Efficiency Competent Cells (Promega, Hampshire, UK).  50μl of 
JM109 cells were carefully added to 5μl of the ligation product, and 
incubated at 4°C for 1 hour, before being heat-shocked for 45 seconds in 
a 42°C water bath and returned to 4°C for a further two minutes.  950μl of 
Super Optimal broth with Catabolite repression (SOC) medium 
(Appendix A 8.1.14) was added and the solution incubated at 37°C for 1 
hour while shaking at 150rpm.  A prepared Luria-Bertani (LB) agar 
medium plate containing 100µg/ml ampicillin (Sigma-Aldrich Co. Ltd, 
Dorset, UK) (Appendix A 8.1.15) was coated with a mixture of 100μl of 
100mM isopropyl-β-D-thiogalactopyranoside (IPTG) (Bioline, London, 
UK) and 20μl of 50mg/ml 5-bromo-4-chloro-3-indolyl-b-D-galactosidase 
(X-Gal) (Bioline, London, UK), and dried.  100-120μl of the 
transformation solution was spread onto the agar plate and incubated at 
37°C overnight to allow colony growth.   
(ii) Full-length MR1 and MR1 chimaera in pFlag-CMV-3 vector were 
transformed into JM109 as in section 2.4.5.1(i), except that IPTG/X-Gal 
was omitted from the agar plate.   
 
2.4.5.2 Selection and growth of antibiotic-resistant colonies 
(i) Antibiotic-resistant colonies were selected on the basis of colour, where 
white colonies indicated that the expression of the pGEM-T Easy vector 
Lac Z gene had been interrupted by the insertion of a DNA fragment, thus 
preventing β-galactosidase formation and hydrolysation of X-Gal to a 
blue colour.  Alternately, blue colonies represented Lac Z gene expression 
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indicating absence of insert.  White colonies were tested for insert size by 
PCR with either gene-specific primers using appropriate parameters, or 
vector primers T7 and SP6 using an annealing temperature of 55°C and 
standard cycling protocol (see section 2.4.2.2).   
(ii) Antibiotic-resistant pFlag-CMV-3 vector colonies were tested for insert 
size by PCR with vector primers N-CMV-30 (5'-AAT-GTC-GTA-ATA-
ACC-CCG-CCC-CGT-TGA-CGC-3') and C-CMV-24 (5'-TAT-TAG-
GAC-AAG-GCT-GGT-GGG-CAC-3') using an annealing temperature of 
55°C and standard cycling protocol (section 2.4.2.2).   
In each case, positive colonies were selected and transferred to a numbered grid on a 
second agar plate, and incubated for 6-18 hours at 37°C.  Colonies to be amplified 
for extraction of plasmid DNA were grown in LB medium with 50µg/ml ampicillin 
(Sigma-Aldrich Co. Ltd, Dorset, UK) (Appendix A 8.1.16) by overnight incubation 
at 37°C while shaking at 224rpm.   
 
2.4.5.3 Preparation of glycerol stocks 
To create a frozen stock of each plasmid, 150μl of sterile glycerol was added to 
750μl of the overnight expansion culture, vortexed briefly, and immediately stored at 
-70°C.   
 
2.5 Sequence data and analysis 
2.5.1 Sequence databases & search engines 
Original sequence data and published gene data were obtained using the online 
sequence databases of the National Center for Biotechnology Information (NCBI, 
http://www.ncbi.nlm.nih.gov/), Ensembl, a joint operation between the European 
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Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute 
(http://www.ensembl.org/index.html), and „IMGT‟, the international 
ImMunoGeneTics information system (http://imgt.cines.fr/).  Within these sites, the 
Basic Local Alignment Search Tool (BLAST) was used to detect matches to known 
sequence within the published human, murine, bovine and ovine gene databases.   
 
2.5.2 Sequence analysis 
The computer software DNASIS MAX, Version 2.07.000.001, 2006 (Hitachi 
Software Engineering Company, Ltd.) was used for analysis and study of gene 
sequences and sequencing data.  Internal databases were established using DNASIS 
software to allow BLAST analysis of multiple sequences.  The DNASIS primer 
design functions were also used for designing the majority of PCR primers used.    
 
2.5.3 TCR sequence nomenclature 
Current TCRVα nomenclature is designed to follow the genomic order of the genes 
on the TCRα locus.  However, it is not yet possible to apply this nomenclature to 
cattle due to the incomplete assembly of the genome, including the bovine TCRαδ 
locus.  Therefore to avoid confusion, and in conjunction with all current literature on 
this topic, the previous nomenclature system defined by WHO-IUIS and based on the 
work by Arden et al (Arden et al. 1995), is used for all species throughout this study.  
In this system, V genes were numbered in the order in which they were discovered; 
orthologous V genes in the different species therefore have different numbers.   
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3 Molecular Cloning and Characteristics of Ruminant MAIT 
3.1 Introduction 
Mucosal associated invariant T (MAIT) cells are characterised by the expression of 
an invariant TCRα chain.  In humans and mice these chains are encoded by the 
Vα7.2-Jα33 and Vα19-Jα33 gene segments respectively.  These sequences show a 
high level of cross-species conservation, suggesting an evolutionarily-conserved 
function for these cells.  Previous studies also demonstrated a homologous bovine 
partial TCRα chain sequence, again displaying marked conservation of sequence 
with human and mouse (Tilloy et al. 1999).  This sequence had been identified in an 
earlier study during analyses of randomly selected bovine TCRα chains (Ishiguro et 
al. 1990).  Apart from these observations, all of the work on characterisation of 
MAIT cells has been done in mice and humans.  MAIT cells are more abundant in 
humans than in mice, representing up to 4% of circulating T-cells, and up to 15% - 




 T-cell population; in mice they 




 T-cells (Tilloy et al. 1999; Treiner et al. 2005; Martin 
et al. 2009).   
The adaptive immune system relies upon a broad antigen-receptor repertoire to 
rapidly recognise any of the potential pathogens with which it may be presented.  
Accordingly, the size and diversity of an animal‟s TCR repertoire have been linked 
to efficient protection against pathogens and disease (recent reviews by Nikolich-
Zugich et al. 2004; Turner et al. 2006).  A number of genetic features contribute to 
the ability to produce a diverse TCR repertoire during the normal genesis of T-cells.  
Thus, the functional gene encoding each of the two polypeptide chains of the TCR is 
generated during T cell development by rearrangement of V, D (β chain only) and J 
segments, drawn from a genomic library of these gene segments.  Further diversity is 
created by N-region junctional addition and deletion of nucleotides.  This allows the 
generation of a very large repertoire of clones with distinct receptors.  Since these 
clones undergo little, if any, peripheral expansion in the absence of antigen, they are 
each present at a very low frequency within the naïve T cell repertoire.  However, the 
Chapter 3: Molecular Cloning and Characteristics of Ruminant MAIT 
Characterisation of Mucosal Associated Invariant T-cells and MR1 in Ruminants 67 
invariant T-cell subsets, MAIT cells and iNKT cells, differ in this regard in that they 
are detected at a much higher frequency than expected in the naïve repertoire.  
Hence, they theoretically can respond more rapidly upon exposure to their respective 
ligands. 
The work described in this chapter set out to characterise MAIT TCRα sequences of 
cattle and sheep, in order to provide tools that could be used to identify and quantify 
MAIT cells in these species and to allow further analyses of the conservation of the 
MAIT TCRα between species.  The experiments initially exploited the availability of 
partial MAIT TCRα sequence data (Tilloy et al. 1999) to generate full-length 
sequences for this species, which were then used to derive a sequence from sheep.  
PCR assays designed on the basis of these sequence data were employed to 
investigate expression of the constituent V and J gene segments, as well as the 
rearranged MAIT sequence, in bovine PBMC.   
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3.2 Materials and Methods 
3.2.1 Experimental animals 
Peripheral blood samples were obtained from healthy, adult Holstein-Friesian cattle 
and Blackface-cross sheep as described in section 2.1.  Peripheral blood mononuclear 
cells (PBMC) were prepared as in section 2.1.1; these were used for total RNA 
extraction and cDNA synthesis (see sections 2.4.1.1 and 2.4.2.1) and for cell subset 
purification and analysis by flow cytometry (section 2.3.3).   
 
3.2.2 Online resources and sequence analysis 
Online sequence databases from the National Center for Biotechnology Information 
(NCBI), Ensembl, and „IMGT‟, the international ImMunoGeneTics information 
system, were used to obtain original sequence data and search for published gene 
data.  Sequence analysis, and comparison to „in-house‟ databases, was performed 
using DNASIS software (Hitachi Software Engineering Company, Ltd.) (see section 
2.5).  Sequence motifs used for definition of the TCRVα gene CDR3 were based on 
published definitions (Moss and Bell 1995).   
 
3.2.3 PCR primers and reaction conditions 
The PCR primer sequences used are listed in tables 3-1 and 3-2.  PCR assays were 
performed using reaction conditions and reagents as described in section 2.4.2.2.  
Optimal cycling conditions were assessed for each individual reaction; a standard 
reaction was then used, consisting of 10 minutes at 95°C, 35 cycles of (1 minute at 
95°C, 1 minute at a specific annealing temperature, 1 minute at 72°C), and a final 
extension period of 10 minutes at 72°C.  Optimal annealing temperatures for each 
primer combination are listed in tables 3-1 and 3-2.  PCR products were analysed on 
1.5% agarose gels, as described in section 2.4.3.3.   
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Table 3-1: Primers used in PCR to amplify the bovine and ovine MAIT TCRα sequences, and 
optimal annealing temperature (Tm) for each reaction.  Vα19-Jα33 is taken to represent the 




5‟ sequence 3‟ 
Reverse 






































































* These primers were designed by Dr Ildiko van Rhijn, University of Utrecht.   
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Table 3-2: Primers used in PCR to amplify plasmid DNA extracted from clones derived from 




5‟ sequence 3‟ 
Reverse 








TGC TCA ACA TGG AGA TCC TG 
58°C 
Vα19 gene in 
combination with 











Jα33 gene in 
combination with 







3.2.4 PCR product cloning, transformation and selection for 
expansion 
DNA from appropriate PCR products was either purified directly (see section 
2.4.3.5) or extracted from bands in agarose gels (2.4.3.4).  These DNA samples were 
cloned into pGEM-T Easy vector, and used to transform Promega JM109 high 
efficiency competent cells (see section 2.4.4).  Transformed E. coli colonies were 
selected on the basis of antibiotic resistance and absence of beta galactosidase, and 
tested by colony PCR using either pGEM-T Easy primers, T7 and SP6, or primers 
specific to the insert.   
 
3.2.5 Sequencing of plasmid DNA 
Colonies of interest were grown overnight in LB medium and plasmid DNA 
extracted (see section 2.4.1.3).  Sequencing of plasmid DNA from single clones was 
performed by DBS Genomics, Durham University, UK (see section 2.4.3.6).  RACE-
PCR product clones which were processed in 96-well plates were prepared and 
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sequenced in an alternate manner – colonies were denatured, inserts amplified by T7-
SP6 PCR, and sequencing reactions performed within the 96-well plates using 
BigDye Terminator v3.1, using the protocol described in section 2.4.3.7.  The 
specific sequencing primer used was based near the 5‟ end of the TCRα constant 
region: “BovCintr” – 5‟-TGC TCA ACA TGG AGA TCC TG-3‟.  Sequencing was 
performed by the Sequencing Unit of the Department of Zoology, University of 
Oxford, UK.   
 
3.2.6 RACE – primers and reaction conditions 
The basis of RACE PCR, and general primers and cycling conditions, are described 
in section 2.4.2.3.  5‟ RACE PCR was used to amplify TCRα sequences from 
different fractions of T-cells purified by flow cytometry.  The reverse gene-specific 
primer used for TCRα amplification was based in the middle of the TCRα constant 
region: BovC4r – 5‟-TCC AAG AGC AAC GGG ATA GTG ACC TG-3‟.  RACE 
PCR products were assessed by agarose gel electrophoresis, purified, cloned into 
pGEM-T Easy vector and used to transform competent cells, as described for regular 
PCR products (sections 3.2.3 and 3.2.4).   
 
3.2.7 Analysis and purification of cells by flow cytometry 
Staining of cell suspensions by immunofluorescence for phenotyping and analysis by 
flow cytometry using a BD FACSCalibur Flow Cytometer (BD Biosciences, San 
Jose, California, USA) are covered in section 2.3.3.  Primary monoclonal antibodies 
used for staining were MM1A for CD3, IL-A12 for CD4, IL-A105 for CD8, GB21A 
for γδ T-cells, as described in section 2.3.3.1, table 2-1.  Cell subsets were purified 
by flow cytometry using a BD FACSAria Flow Cytometer (BD Biosciences, San 
Jose, California, USA) and FACSDiva software version 5.02.  Purified cell fractions 
were re-analysed and shown to be 95-99% pure.   
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3.3 Results 
3.3.1 Amplification of ovine and bovine orthologous MAIT TCRα 
chains 
The human MAIT TCRVα chain sequence was used to search the NCBI online ovine 
gene databases, using the basic local alignment search tool, BLAST; no similar or 
orthologous sequences were found, indicating that the ovine MAIT TCRα chain had 
yet to be identified.   
A partial bovine TCRα chain sequence orthologous to the human and murine MAIT 
TCRVα chains had previously been identified (Tilloy et al. 1999).  These 
investigators had designed primers for amplifying the partial bovine TCRVα 
(including the CDR3 region) and these were replicated for this study as boovAV19f / 
boovAJ33r.  Using an optimised PCR protocol at a range of annealing temperatures 
(60°C – 66°C), this primer pair was tested on both bovine and ovine PBMC cDNA 
(see figure 3-1).  A strong, single product of expected size (120bp) was produced 
from bovine PBMC cDNA at all annealing temperatures, while a similar single 
product was produced from ovine cDNA at 60 and 62°C.  A negative control using 
distilled water rather than cDNA showed no amplification, although some smearing 
on agarose gel electrophoresis suggested primer-dimer formation.  To positively 
identify the PCR product as an ovine orthologue of MAIT TCRα, DNA was purified 
and cloned into the pGEM-T Easy vector.  Screening of a number of white colonies, 
using boovAV19f / boovAJ33r (see figure 3-1) identified 4 clones (No's. 1, 2, 4 and 
5) that yielded a product of the expected size suggesting the correct insert.  
Sequencing of the DNA inserts in these clones confirmed that the nucleotide 
sequences had close identity with previously described bovine MAIT TCRVα/CDR3 
region sequence.  Detailed analysis of the sequences is covered in section 3.3.2.   
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Figure 3-1: Agarose gels showing: A) Detection of 120bp PCR product, representing MAIT 
TCRα Vα19-Jα33 CDR3, amplified from bovine and ovine PBMC cDNA, using primers 
boovAV19f/boovAJ33r at a range of annealing temperatures.  B) Positive amplification from 
most subclones of ovine Vα19-Jα33 PCR product, using the same primers and annealing 
temperature 60°C.  Autoclaved distilled water was used as a negative control for both PCRs, 
and ovine PBMC was used as a positive control for the PCR in gel B.   
 
To help identify the full-length variable gene and CDR3 sequences for the ovine 
MAIT TCRα chain, and since no matches had been found in the online ovine gene 
databases, the human MAIT Vα gene, Vα7.2, was used to search the NCBI bovine 
gene database.  A total of 13 matching gene segments were identified.  These were 
aligned to the human MAIT TCRα to identify a consensus sequence for the 5‟ 
untranslated region of the potential bovine MAIT TCRα chain.  Based on this 
sequence, a series of forward primers were designed (boovUntr1f, boovUntr2f, 
boovUntr3f, boovUntr4f) for use with the reverse joining region primer, boovAJ33r.  
These primer pairs were tested on cDNA from both bovine and ovine PBMC, at a 
range of annealing temperatures (60°C, 63°C).  Single, positive products of 
anticipated size (400bp) were produced from both bovine and ovine cDNA using 
primers boovUntr1f and boovUntr3f, the latter giving the best results when used at 
Tm:60°C (see figure 3-2).  Products from ovine cDNA were purified and cloned into 
pGEM-T Easy vector, and clones were tested for insert by PCR.  Sequencing of 
inserts from six clones with the correct anticipated insert size identified four clones 
with sequences displaying close identity to the previously defined partial bovine 
MAIT TCRVα sequence (further detailed in section 3.3.2).   
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Figure 3-2: Agarose gel showing PCR amplification of 380bp product, representing the MAIT 
TCR Vα19 gene, using primers based in the Vα19 gene 5‟ untranslated region (boovUntr1f, 
boovUntr2f, boovUntr3f, boovUntr4f) and Jα33 (boovAJ33r), amplified from both bovine and 
ovine PBMC cDNA at a range of annealing temperatures.  Positive results of anticipated size 
from ovine PBMC cDNA are circled in red.  Autoclaved distilled water was used as a negative 
control for all PCRs.   
 
Since these products were obtained using a reverse primer that extended into the 
CDR region, a further PCR assay using the same forward primer boovUntr3f with 
two newly designed ovine TCRα constant region reverse primers, CorovC1r and 
CorovC3r (located at the 3‟ end of the C gene), was conducted in an attempt to 
amplify the full-length variable and CDR3 sequences of the ovine MAIT TCRα 
chain.  The primer pair boovUntr3f / CorovC3r produced a single positive band of 
the anticipated size (820bp) from ovine cDNA (see figure 3-3, A).  Seven out of 12 
cDNA clones examined from this PCR product were found to contain inserts of 
variable size, at, or near, 900bp, when screened by PCR using the same primers (see 
figure 3-3, B).  Sequencing of the inserts from these clones identified two clones 
(clone #2 and #13) with TCRα sequences showing a high level of identity to the 
bovine MAIT TCRα chain, and identical to the partial Vα sequence produced by 
boovUntr3f / boovAJ33r (above).  The other five clones yielded sequences 
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containing the same V gene segment (orthologous to human Vα7.2) but very 
different CDR3 sequences (further details in section 3.3.3).   
 
 
Figure 3-3: Agarose gels showing: A) Amplification, and purification, of a single product from 
PCR of ovine PBMC cDNA using primers based in the Vα19 gene 5‟ untranslated region 
(boovUntr3f), and the TCRα constant region (CorovC3r).  Autoclaved distilled water was used 
as a PCR negative control.  B) Sub-cloning of purified DNA revealed multiple different insert 
sizes between different colonies.  Clones #2 and #13 returned MAIT Vα19-Jα33 sequence, while 
four other clones (#1, #3, #14, #15) returned sequence of Vα19 in combination with different Jα 
exons.   
 
A similar approach was used to obtain the complete sequence of the bovine MAIT 
Vα and CDR3 coding region.  PCR primers “I” and “Jr”, based in the 5‟ untranslated 
region and constant region, respectively, had been concurrently designed by Dr 
Ildiko van Rhijn, University of Utrecht, and were tested on cDNA from bovine 
PBMC at a range of annealing temperatures (56 – 62°C).  Strongest amplification of 
product of the anticipated size (650bp) was at 56°C, although a second smaller band 
was also amplified at 56°C and 59°C.  The 650bp band was excised from the agarose 
gel, and DNA extracted and cloned into the pGEM-T Easy vector.  Sequencing of 
inserts from four clones with the anticipated insert size revealed three almost 
identical sequences; one of these displayed 100% identity to the previously defined 
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partial bovine MAIT TCRVα sequence, Vα19-Jα33, confirming positive 
amplification of the bovine MAIT Vα gene, while sequence from two other clones 
each showed only a single nucleotide difference in the CDR3 region in comparison 
with the first clone.  Sequence from the fourth clone contained Vα19 in combination 
with a different Jα gene (Jα20) and had dramatically altered CDR3 sequence (see 
section 3.3.4).  Detailed discussion of the sequences is presented in section 3.3.2.   
 
 
Figure 3-4: Agarose gel showing amplification of 650bp PCR product representing bovine 
MAIT TCRα from bovine PBMC cDNA using primers I/Jr, based in the 5‟ untranslated region 
of Vα19, and the TCRα constant region, respectively, at a range of annealing temperatures.  
Autoclaved distilled water was used as a PCR negative control.  DNA extracted from the 650bp 
size bands was subcloned, and 3 out of 4 clones were sequenced as Vα19-Jα33; the fourth clone 
was Vα19-Jα20.   
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3.3.2 Variation of CDR3 region coding sequence and high level of 
cross-species similarity 
Sequence data obtained with different primer combinations on ovine PBMC cDNA 
all contained identical or near identical TCRVα gene segment sequences, but showed 
differences within the CDR3 region.  Sequences obtained using the reverse primer 
boovAJ33r, which extended into the CDR3, differed by 2 nucleotides from those 
amplified using a reverse primer in the constant region (CorovC3r), resulting in two 
amino acid substitutions in the predicted CDR3 amino acid sequences: M D G N Y Q 
W I compared to M D G N Y R L I, respectively.  To test whether this discrepancy 
was introduced by primer boovAJ33r, which was sited over the 3‟ end of the CDR3 
region, 3 different reverse primers in the 3‟ end of bovine Jα33 (ovTCRAJ1r, 
ovTCRAJ2r, and ovTCRAJ3r, all 3‟ of the region showing sequence discrepancy) 
were paired with different Vα forward primers (boovAV19f, boovUntr1f, and 
boovUntr3f) to amplify specifically this segment of the MAIT α chain from ovine 
cDNA (see figure 3-5 for primer location summary).   
 
 
Figure 3-5: Summary of primer locations used to identify bovine and ovine MAIT TCRVα gene 
sequence.  Untr: 5‟ untranslated sequence; L: Leader sequence; V: Vα19 gene; J: Jα33 gene; C: 
Constant gene.   
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Products of expected size were amplified by boovAV19f with each reverse primer, as 
well as from boovUntr1f and ovTCRAJ1r.  Sequencing of cDNA clones from each 
of these four products yielded the same nucleotide sequence, which was identical to 
that obtained above using a reverse PCR primer located in the constant region. These 
results confirmed that the bovine and ovine MAIT CDR3 region sequences differ at 2 
nucleotide positions, resulting in two amino acid substitutions near the 3‟end of the 
CDR3 region (see figure 3-6).   
 
 
Figure 3-6: Cross-species comparison of the CDR3 of the potential polypeptides encoded by 
ovine, bovine, human and murine MAIT TCRVα sequences.  The CDR3 region is highlighted 
and demonstrates cross-species conservation, but also differences between the 3‟ amino acids of 
bovine and ovine CDR3 sequences.   
 
Sequence analysis of bovine and ovine MAIT TCRα chain sequences revealed a 
further intra-species discrepancy at the 5‟ end of the CDR3 region, near the site of 
the junction between V and J gene segments.  In both species, the same single base 
pair substitution resulted in a coding change of the first CDR3 codon from 
methionine to isoleucine.  This change was seen in three out of ten bovine sequences 
and three from fifteen ovine sequences.  When these sequences were compared to the 
corresponding bovine genomic V (Vα19) and J (Jα33) gene segment sequences 
(sourced online from Ensembl and confirmed with IMGT databases), the two bovine 
cDNA sequences can be accounted for by differential nucleotide deletions at the VJ 
junction, with in one case deletions at the 3‟ end of the V gene generating a ATG 
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codon primarily from the J segment (encoding methionine), and in the other case 
deletions at the 5‟ end of the J segment resulting in a ATA codon from the V gene 
(encoding isoleucine) (see figure 3-7).  Due to high nucleotide identity between cattle 
and sheep TCRα gene sequences, it is proposed that a similar mechanism accounts 
for the same substitution observed in the ovine translational sequence.  Due to its 
closer identity to human and murine MAIT TCRα chains, the bovine and ovine 
MAIT TCRα chain sequences containing methionine at this position were used for 
subsequent cross-species sequence comparisons.   
 
 
Figure 3-7: Bovine germline sequence for Vα19 and Jα33 gene segments overlap at the site of 
the MAIT TCRα CDR3.  Final MAIT TCRα sequence must be a result of nucleotide deletion.  
Although consensus bovine CDR3 sequence starts with codon ATG encoding methionine due to 
deletions at the 3‟ end of Vα19 germline sequence, some sequences have codon ATA due to 
deletions at the 5‟ end of Jα33 germline sequence, which encodes for isoleucine.  Both of these 
sequences are represented in cDNA from PBMC.   
 
MAIT TCRα chain sequences from different species showed a high level of 
conservation at both the nucleotide and amino acid level (see table 3-3).  The levels 
of nucleotide similarity between the ovine, bovine, murine and human MAIT TCRα 
germline Vα gene elements was >74%, consistent with them belonging to 
orthologous V gene subfamilies, and was >83% for the ovine, bovine and human Vα 
sequences.  The Jα33 germline sequence, which encodes the majority of the CDR3 
region, was highly conserved between the 4 species, at over 91% nucleotide identity 
(see Appendix C for full cross-species nucleotide sequence comparison).  These 
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similarities were reflected by a high level of amino acid identity between the ovine, 
bovine, murine and human MAIT TCRα (V-region) transcripts, which was >70% for 
all species, and was 93% for the two ruminant species.  The CDR1 and CDR2 
regions within the Vα sequence were markedly conserved: CDR1 has 100% amino 
acid identity between all four species, and the CDR2 of ovine, bovine and human 
sequences are identical, while the murine CDR2 contains a single amino acid 
substitution within the first codon.  The CDR3 regions are also highly conserved 
between species, with identical length of 8 amino acids, and conservation of the 
second, fourth, fifth and eighth amino acids between all four species.  However, a 
small number of conservative substitutions are seen in the first, third, sixth and 
seventh amino acids between species (see figure 3-8).   
 
Table 3-3: Cross-species conservation of the MAIT Vα19 (Vα7.2 in humans) and Jα33 gene 
nucleotide sequences, and of the whole V- J- amino acid sequences, including CDR regions.   
 Germline Vα19 Germline Jα33 Vα19-Jα33 protein identity 
Species Nucleotide Nucleotide Amino Acid CDR1 CDR2 CDR3 
Ovine:Bovine 273/283 bp (96%) 54/57 bp (95%) 103/111 aa (93%) 6/6 aa 5/5 aa 6/8 aa 
Ovine:Human 238/283 bp (84%) 53/57 bp (93%) 82/111 aa (74%) 6/6 aa 5/5 aa 5/8 aa 
Ovine:Murine 213/283 bp (75%) 55/57 bp (96%) 79/111 aa (71%) 6/6 aa 4/5 aa 5/8 aa 
Bovine:Human 234/283 bp (83%) 52/57 bp (91%) 82/111 aa (74%) 6/6 aa 5/5 aa 5/8 aa 
Bovine:Murine 209/283 bp (74%) 54/57 bp (95%) 79/111 aa (71%) 6/6 aa 4/5 aa 5/8 aa 
Human:Murine 210/283 bp (74%) 55/57 bp (96%) 78/111 aa (70%) 6/6 aa 4/5 aa 7/8 aa 
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Figure 3-8: Cross-species comparison of ovine, bovine, human, and murine MAIT TCRα V-
region coding sequences, showing cross-species conservation of the CDR1 (purple box), CDR2 
(yellow box) and CDR3 (green box) regions.   
 
3.3.3 No evidence of enrichment for MAIT cells within the CD4- 
CD8- T cell subset 
Previous studies in humans and mice have indicated that MAIT cells are highly 




 T cells. An experiment was undertaken to 




 αβ T 
cells in bovine PBMC was assessed by two-colour immunofluorescence staining and 
flow cytometry, using an antibody specific for CD3 against a mixture of 3 antibodies 





αβ T-cells in PBMC from 6 cattle ranged between 1.9% and 3.8% (see table 3-4). 
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αβ T-cell population and high cell yield and was used for further analyses.   
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 populations purified by cell-sorting, in 
order to analyse the expressed TCRα chains. The staining profile and gates set for 
sorting are shown in figure 3-9.  The resultant populations were 99% and 95% pure, 





cell population was not contaminated with γδ T cells.  RNA was extracted from the 
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Figure 3-9: A) Flow cytometry purification of bovine PBMC, where CD3
+









 cells stain FITC
+

















).  B) Testing for purity of each population (99% 
for sample P2, 95% for sample P3).   
 
These three samples were subjected to 5‟ RACE PCR to amplify a representation of 
the TCRα transcripts within each sample.  RACE-ready cDNA was synthesised from 
RNA through reverse transcription using Moloney murine leukaemia virus reverse 
transcriptase.  The dC-tailing action of this enzyme allowed annealing of an 
additional oligonucleotide to the 5‟ end of the original RNA sequence, which served 
as an extended template for further cDNA synthesis.  RACE-ready cDNA was 
amplified by PCR with a universal primer mix specific for the oligonucleotide 
sequence added to the RNA template, and a reverse TCRα-chain-specific primer 
(BovC4r) based in the bovine constant region (see figure 3-10).  The RACE PCR 
products gave a broad band of between 500 and 1000 bp when run in agarose gels 
(see figure 3-11).   
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Figure 3-10: Summary of application of Rapid Amplification of cDNA Ends (RACE)-PCR for 
amplification of a range of different T-cell variable regions from cDNA.  L: leader sequence; V: 
any Variable gene; J: any Joining gene; C: Constant gene.   
 
 
Figure 3-11: Agarose gel showing amplification of a broad band of PCR product (500-1000bp), 
by 5‟ Rapid Amplification of cDNA Ends (RACE)-PCR using a gene-specific reverse primer 













 T-cells, and overall PBL.  Two negative controls, lacking either the forward 
(RACE USP) or reverse (BovC4r) primers, respectively, were included.   
 
The DNA products of the three RACE reactions were purified and cloned into 
pGEM-T Easy vector.  One hundred and eighty colonies with inserts (white colonies) 
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were amplified and added to the wells of two 96-well plates (90/plate), with 6 wells 
in each plate containing nuclease-free water serving as negative controls.  Plasmids 
were denatured and insert-DNA amplified in the wells by vector-specific primers, 
before being processed for sequencing using another TCRα-specific primer 
(BovCintr) based in the bovine constant region.  The quality of nucleotide sequences 
obtained from these multiple-well sequencing reactions was highly variable; usable 













 samples, respectively.  Negative control wells did 
not produce sequence results.  Sequences were BLAST-searched through an internal 
database of human TCRVα sequences established by Dr Tim Connelley, University 
of Edinburgh.  Since some of the sequence data produced was not of good quality 
and only contained short areas of high quality sequence in the expected location for 
Vα sequence, positive BLAST matches of >50bp length and >90% nucleotide 
similarity were taken as an estimation of the equivalent human TCRVα subfamily of 
DNA from each colony.  The high percentage of nucleotide similarity was set to 
compensate for the inclusion of short areas of matching sequence.  The numbers of 
sequences matching different human TCRVα subfamilies obtained from each cell 
fraction are displayed in figure 3-12.  Overall, thirty different human TCRVα 
subfamilies were represented. Some subfamilies appeared to be represented more 
frequently and there was some variation in subfamily representation between the 
samples but the overall numbers of samples examined were not sufficient to make 
statistically meaningful comparisons.  Nevertheless, the TCRVα7 subfamily, which 
in humans contains two gene members, one of which is expressed by MAIT cells, 
was represented 4 times in 89 cDNA clones from unfractionated PBMC, but not in 












 populations.  Further sequence 
analysis confirmed that these four sequences were an exact match to the previously 
identified bovine MAIT Vα19, and were all used in combination with Jα33.  These 





 T cell population.   
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Figure 3-12: Summary of range of TCRVα subfamilies represented within each of three 












 T-cells (green).  
5‟ RACE PCR was used to amplify the different TCRVα genes within each sample, and product 
DNA was subcloned.  Clone inserts were sequenced and identified by homology to subfamilies of 
human TCRVα genes.  Four matches to the human MAIT Vα7.2 were found in whole PBMC, 
but none in the other phenotypic subsets.  5 sequences could not be matched to human WHO-
IUIS sequence nomenclature and so were identified using the alternative IMGT nomenclature.  
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3.3.4 Non-exclusive usage of MAIT TCRα V and J gene segments 
within the TCRα repertoire 
The frequency of occurrence of the bovine MAIT variable TCRα gene segments, 
Vα19 and Jα33, amongst the TCRα cDNA clones generated by RACE-PCR was 













 T-cells, was tested by 
PCR with three primer pairs: (i) CLov5f / BovCintr - to amplify TCRα constant 
region and hence confirm the presence of an α chain; (ii) boovAV19f / BovCintr - to 
amplify sequences with Vα19 in combination with any Jα gene; (iii) boovAV19f / 
boovAJ33r - to amplify the specific MAIT TCRα chain containing Vα19 and Jα33.  
Each PCR was applied to 180 clones from PBMC (plus 12 negative control wells), 













with 6 negative control wells).  Examples of results obtained with these PCRs in the 
cDNA clones from PBMC are shown in figure 3-13 and a summary of results from 
each PCR reaction is presented in figure 3-14.   













 T-cells.  In clones from 
PBMC, a strong positive product for Vα19 was detected in 4 clones (from a total of 
168 clones positive for TCRα) and all of these clones also gave a positive result with 
the PCR specific for the MAIT sequence, Vα19-Jα33.  Sequencing of these 4 clones 













 (5 clones) T-cell 
populations gave positive products for Vα19, but none of these clones gave positive 







and G10) revealed that they did not contain Vα19, but contained Vα22-Jα17 and 
Vα18-Jα17 respectively, demonstrating that the boovAV19f primer is not completely 
specific for Vα19.  Sequencing of a number of weak or incorrectly sized bands 
obtained with the boovAV19f – boovAJ33r PCR showed that none of them 
represented Vα19-Jα33.   
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Figure 3-13: Agarose gels showing amplification of (A) TCRα constant region (150bp), (B) Vα19 
gene (300bp, N.B. all sample columns show some formation of primer dimer), (C) MAIT 
TCRVα Vα19-Jα33 (120bp), in PCR of plasmid DNA from clones of different TCRVα chains 
amplified in 5‟ RACE PCR from overall PBMC (plate#1 of 2 plates).  Primers used were: A) 
CLov5f-BovCintr, B) boovAV19f-BovCintr, C) boovAV19f-boovAJ33r.  Wells D7 and D9 are 
positive for MAIT TCRVα (120bp), and their respective positive bands for constant region and 
Vα19 are marked by red asterisks; sequencing confirmed that both clones contained Vα19-Jα33.  
Well B10 amplified a large unexpected product (800bp) with primers boovAV19f – boovAJ33r, 
and was positive for TCR constant region, but did not amplify product representing the Vα19 
gene (blue asterisks); sequencing revealed this clone to contain Vα18 and Jα33.  Six negative 
controls consisting of autoclaved distilled water were included for each reaction (marked by 
yellow asterisks).   
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Figure 3-14: Positive (full colour), weak/incorrect (pale colour), or negative (blank) 
amplification of TCRα constant region (blue), Vα19 but unspecific Jα (green), and Vα19-Jα33 
(red) product from DNA of RACE-amplified TCRα sequences.  From PBMC, 4 clones contained 
Vα19-Jα33 sequence from 168 clones positive for TCRα constant region (columns 1 & 2); no 













subset clones (column 4), from 89 and 86 clones positive for TCRα constant region, respectively.   
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Since the Jα33 gene segment contributes the majority of sequence to the MAIT 
TCRα CDR3 region, the sequence data obtained in 3.3.3 above was blasted with the 
bovine Jα33 sequence to identify clones expressing this J gene segment and to 
examine the relationship of Jα33 and Vα19 expression. The Jα33 gene was identified 
in 6 out of 328 clones for which sequence data were available; 4 of these clones also 
incorporated Vα19 gene segment to form the MAIT TCRα chain (as previously 
identified – section 3.3.3).  The other two Jα33
+
 clones, also from unfractionated 
PBMC, contained two different TCRVα genes, which matched to human Vα30 and 
Vα18 respectively (see table 3-5).  The CDR3 regions of these two clones were both 
distinct from MAIT CDR3, and each other, due to changes in length and N-region 
coded amino acids (see figure 3-16).   
To further investigate this question, the cDNA that had been obtained from PBMC 
by RACE PCR was subjected to PCR amplification using the RACE reaction 
universal short forward primer (USP) in combination with the Jα33-specific reverse 
primer (boovAJ33r) at three different annealing temperatures: 56°C, 59°C, 62°C.  
Each PCR product appeared as a broad band of the expected size (450bp) and an 
additional 600bp band on agarose gel electrophoresis.  DNA from these were 
extracted and cloned separately into pGEM-T Easy vector.  The resultant clones 
demonstrated different insert sizes within the expected range (see figure 3-15).  
Seven clones from the 450bp band selected for sequencing all contained Jα33, but in 
combination with a number of different Vα genes – three of them contained the 
MAIT sequence, Vα19-Jα33; the other four clones each contained different V gene 
segments - three matching human TCRVα 2, 9, and 22.  The fourth sequence was 
found to bear high similarity to the IMGT TRAV18 subgroup; this could not be 
annotated using the WHO-IUIS nomenclature applied to this thesis, and is described 
using IMGT nomenclature – see section 2.5.3.  The sequence of a single clone of the 
600bp PCR product contained a V region of increased length (550bp compared to 
approx. 400bp for most other Vα regions identified) which showed close similarity to 
human Vα32, in combination with Jα33 (see table 3-5).   
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Figure 3-15: Agarose gels showing A) PCR amplification of RACE-PCR product TCRα 
sequences containing the Jα33 gene, using RACE USP primer and boovAJ33r at a range of 
annealing temperatures; these produced a broad band of 450bp product (red circle) and a 
discrete 600bp band (green circle); B) DNA extracted from the 450bp band and 600bp band in 
gel A; C) PCR screening of clones containing DNA from the 450bp band, using RACE USP and 
boovAJ33r primers, reveals a range of different insert sizes, representing different TCRα chains 
formed by use of various TCRVα genes in combination with Jα33.   
 
The CDR3 regions of identified MAIT sequences were compared to those of clones 
containing the same J gene segment but different Vα gene segments.  These showed 
at least one, and up to four, codon differences, primarily at or near the „N region‟ at 
the 5‟ end of the CDR3.  CDR3 length varied between 8 and 11 amino acids.  
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Examples of formed CDR3 sequences are shown in figure 3-16.  The CDR1 and 
CDR2 sequences of each associated V gene were very different in comparison to 
those in the MAIT V, suggesting that the TCR is unlikely to be performing the same 
function despite similarities in CDR3.   
 
Table 3-5: Vα genes used in combination with Jα33, in clones of RACE-product from bovine 
PBL (“332…”), or amplified by primers USP-boovAJ33r in PCR from RACE-product DNA 
(“450/600…”).   
 Match to: 
Sequence Human TCRVα Human TCRJα 
332/1 B10 Vα 18 
6 / 10 / 24 
Jα 33 
332/1 D7 Vα 7.2 
1.2 / 1.1 
Jα 33 
332/1 D9 Vα 7.2 
1.2 / 1.1 
Jα 33 
332/2 C6 Vα 7.2 
1.2 / 1.1 
Jα 33 
332/2 F2 Vα 7.2 
1.2 / 1.1 
Jα 33 
332/2 G7 Vα 30 
6 / 10 / 24 
Jα 33 
450 clone#1 TRAV18(*) 
18 
Jα 33 
450 clone#2 Vα 22 
9.2 / 9.1 
Jα 33 
450 clone#3 Vα 7.2 
1.2 / 1.1 
Jα 33 
450 clone#6 Vα 2 
12.3 / 12.2 
Jα 33 
450 clone#9 Vα 7.2 
1.2 / 1.1 
Jα 33 
450 clone#10 Vα 9 
16 
Jα 33 
450 clone#11 Vα 7.2 
1.2 / 1.1 
Jα 33 
600 clone#5 Vα 32 
25 
Jα 33 





 Vα sequence in 450clone#1 did not match any annotated WHO-IUIS human 
TCRVα sequence, but was identified as a match to IMGT hTRAV18.   
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Figure 3-16: Nucleotide and amino acid sequences of clones of bovine TCRVα regions amplified 
by 5‟ RACE PCR, which contain Jα33 in combination with different Vα genes, showing the 
CDR3 sequences (highlighted pink) in comparison to the bovine MAIT CDR3 (“MAIT TCR”).  
CDR3 lengths vary between 8 and 11 amino acids and 5‟ clone CDR3 sequences are in some 
cases dramatically altered in comparison to the MAIT TCRα.   
 
These results showed that use of the Jα33 gene is not specific to Vα19 and detailed 
changes in the CDR3 where Jα33 was used in combination with different Vα genes.  
Similarly, previous experiments in this chapter had identified that use of the MAIT 
Vα19 gene was not specific to Jα33, and identified Vα19 in combination with 
different Jα genes in both cattle and sheep.  Sequences from these experiments were 
compared to the same human TCRVα database to identify genes used (see table 3-6), 
and the CDR3 of these sequences were also studied in comparison to the MAIT 
CDR3 (figure 3-17).  As expected, since Jα33 is responsible for the majority of the 
MAIT CDR3, these sequences contained substantial diversity in CDR3 sequence and 
length (8 – 11 amino acids).  Bovine sequence representing Vα19-Jα20 contained a 
markedly different CDR3 sequence with substantial nucleotide substitution within 
the 3‟ end of Vα19.  Two ovine sequences, composed of Vα19-Jα50 and Vα19-Jα24, 
encoded stop codons with the CDR3 region, and would not encode functional TCRα 
chain protein.   
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Table 3-6: Jα genes used in combination with Vα19 in subclones of bovine PBMC amplified by 
primers I – Jr (IJr…) and ovine PBMC amplified by primers Untr3f – CorovC3r (U3C3…).  
Ovine/bovine MAIT TCRα chain orthologues are highlighted blue.   
  Match to: 
Species Sequence Human TCRVα Human TCRJα 
Bovine IJr clone#1 Vα 7.2 Jα 33 
Bovine IJr clone#4 Vα 7.2 Jα 20 
Bovine IJr clone#7 Vα 7.2 Jα 33 
Bovine IJr clone#8 Vα 7.2 Jα 33 
Ovine U3C3 clone#1 Vα 7.2 Jα 23 
Ovine U3C3 clone#2 Vα 7.2 Jα 33 
Ovine U3C3 clone#3 Vα 7.2 Jα 35 
Ovine U3C3 clone#13 Vα 7.2 Jα 33 
Ovine U3C3 clone#14 Vα 7.2 Jα 50 
Ovine U3C3 clone#15 Vα 7.2 Jα 24 
 
 
Figure 3-17: Nucleotide and amino acid sequences of clones of (A) bovine and (B) ovine TCRVα 
regions which contain Vα19 in combination with different Jα genes, showing the CDR3 
sequences (highlighted pink) in comparison to the MAIT CDR3 for each species (“MAIT 
TCR”).  These sequences were identified from clones of product of PCR using primers I/Jr (A) 
or boovUntr3f/CorovC3r (B) on cDNA from bovine and ovine PBMC, respectively.  CDR3 
lengths vary between 8 and 11 amino acids.  Bovine clone sequence IJr650#4ed shows nucleotide 
substitution within the 3‟ Vα19 sequence.  Ovine clone sequences u3c3-14ed and u3c3-15ed both 
contain a stop codon within the CDR3.   
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3.3.5 Bovine Vα19 is located at the start of the TCRα locus on 
chromosome 10 
Searches of the bovine genome database using the MAIT TCRα Vα19 and Jα33 
sequences confirmed the genomic location of the bovine TCRα locus, including the 
MAIT TCRα genes, to be on chromosome 10, as previously described (Reinink and 
Van Rhijn 2009). Bovine Vα19 mapped to chromosome 10 at 24.94Mb.  The 
assembly of this part of the locus is not complete; however, bovine putative olfactory 
receptor genes (accession numbers: IPI00906644, IPI00911684, and IPI00907989) 
were located on either side of the BLAST location of Vα19 at 24.95Mb, 24.91Mb, 
and 24.90Mb respectively.  A large number of “Ig-like” genes were identified 
downstream from this site, the first of which mapped to 24.86Mb.  These had been 
previously identified as TCRVα genes by Reinink and Van Rhijn, 2009; this study 
also determined that the most 5‟ bovine TCRVα gene on chromosome 10 was 
located at 24.94Mb.   
Comparison of the incomplete bovine assembly to the corresponding region of the 
human genome (Chromosome 14q11.2) revealed a similar organisation.  The bovine 
Cα region, which mapped to chromosome 10 at 22.59Mb, corresponded with the 
human „IG C gene Ig/T-cell receptor‟ gene on chromosome 14.  0.04Mb downstream 
from this on chromosome 14 were human „IG J gene Ig/T-cell receptor‟ genes, which 
corresponded to the location of bovine Jα33 on Bos taurus chromosome 10 at 
22.63Mb, amongst other genes identified as “Ig-like”.  The group of identified 
bovine “Ig-like” V genes at 24.4 – 24.9Mb occupied a corresponding position to a 
large number of human „IG V gene Ig/T-cell receptor‟ genes (see figure 3-18).  At 
the extreme downstream end of this group are the human TCRVα7.2 (AE000658.6) 
and TCRVα7.1 (AE000658.4) genes, identified during genome construction from the 
IMGT database.  These two genes are bordered by olfactory genes: OR10G2 
(between Vα7.1 and Vα7.2), OR4E2 (between Vα7.2 and subsequent TCR Vα 
genes), and OR4E1P (olfactory receptor psuedogene), respectively, which occupy 
very similar positions to the olfactory genes identified on bovine chromosome 10.  
These available data indicate that the respective genes in humans and cattle occupy 
similar positions within the alpha locus.   
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Figure 3-18: Partial Bos taurus genome assembly showing BLAST location of Vα19 (*), and 
comparison to the corresponding region of the Homo sapiens genome.  Human Vα7.2 (*) is 
indicated.  The corresponding neighbouring olfactory genes (black arrows) and other TCRVα 
genes (orange rings) suggest that bovine Vα19 occupies a position at the 5‟ extremity of the 
TCRα locus like its human orthologue.   
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3.4 Discussion 
Human and murine MAIT cells express an invariant TCRα chain incorporating the 
orthologous V and J gene segments and with near identical CDR3 region sequences.  
A partial TCRα sequence had been previously identified as the orthologous Vα gene 
of MAIT cells in cattle (Tilloy et al. 1999), but full-length bovine sequence had not 
been published.  Additionally, searches on online databases showed that no 
orthologous gene had been recognised in sheep.  Using the partial bovine sequence 
as a template, the results in this chapter reveal the full-length MAIT TCRα sequences 
for both cattle and sheep.  This confirms presence of ovine MAIT cells, and extends 
the previous information on MAIT TCRα sequences.   
These new sequence data confirm that there is a very high level of conservation of 
the MAIT TCRα chain between sheep, cattle, humans and mice.  The MAIT 
transcripts utilise the orthologous V and J gene segments in the different species.  
Conservation of the corresponding V genes is especially high between sheep and 
cattle, at 93%.  Importantly, the CDR1 region is completely conserved between all 
species.  The CDR2 region of sheep, cattle and humans is also identical, apart from 
one codon (position one of five) of the murine CDR2 which differs from other 
species.  This change, which involves a substitution of the polar amino acid, 
asparagine, with the non-polar amino acid valine, is potentially significant; the 
hydropathy index of these molecules is widely different (+4.2 compared to -3.5) and 
this substitution may potentially affect the overall nature of the bovine MAIT CDR2 
loop in association with water or lipid, respectively.   
The MAIT CDR3 region is also highly conserved between these species.  CDR3 
length in each is identical, at 8 amino acids long, which is somewhat shorter than the 
average TCRα CDR3 length of 10 residues (Moss and Bell 1995).  A few 
conservative substitutions are observed in the CDR3 sequence between species. As 
previously identified, the codon in position one is different for human, mouse and 
bovine sequences, but the human and murine CDR3 sequences are otherwise 
identical.  The bovine CDR3 sequence contains different amino acids at positions 3 
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and 7, glycine for serine (both weakly hydrophilic) and tryptophan for leucine, 
respectively.  Although tryptophan is weakly non-polar, leucine is a strongly polar 
amino acid and hydrophobic, and it is arguable that this substitution may affect the 
conformation of the CDR3 loop.  The newly identified ovine MAIT CDR3 region 
only differed from the human and murine sequences at position 6, where it contained 
arginine rather than glutamine.  Arginine is strongly basic whereas glutamine is 
neutral, but both of these amino acids are strongly hydrophilic.  In summary, the 
cross-species conservation in the use of orthologous V and J gene segments and the 
high degree of similarity in the sequences of all 3 CDR segments between species 
strongly indicate that both the restriction element and the putative ligand(s) of the 
MAIT TCR are also conserved between species.   
In studying MAIT sequences from cloned DNA, a variation in the first CDR3 codon 
within animals was noted in roughly 1 in 4 bovine and ovine clones.  These clones 
contained a single base pair substitution, A for G, which altered the coding of the 
amino acid at position 1 of the CDR3 from methionine to isoleucine.  These amino 
acids have similar properties, being non-polar and neutral, and hence this substitution 
is unlikely to result in a major structural change in the CDR3 loop.  This variation in 
cDNA sequence can be accounted for by differential nucleotide deletions at the VJ 
junction.  Human and murine genomic Vα19 and Jα33 segments are the same length 
as the bovine genes; hence, their generation of the VJ junctions to form the short 
MAIT CDR3 (8 amino acids) occurs primarily by nucleotide deletions.  In the 
mouse, a short homologous sequence at the 3‟ end of Vα19 and 5‟ end of Jα33 
results in a predominant canonical nucleotide sequence which codes for AVRDS 
over the VJ junction.  This sequence was detected in 80 of 101 murine MAIT clones 
(Treiner et al. 2005); other clones encoded the AVMDS sequence (caused by 
alternate deletion), or other sequences of identical length but with some amino acid 
variability.  In contrast, human genomic Vα19 and Jα33 sequences differ at their 
respective 3‟ and 5‟ ends, which results in some variability of the two N-terminal 
CDR3 amino acids of the human MAIT Vα; these include AVMDS and AVRDS, 
„germline‟ sequences involving deletions but without „N-region‟ additions, as well as 
AVKDS and AAXDS (where X is M, R, K, or L), formed by nucleotide additions.  
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However, the CDR3 region was always of constant length (Treiner et al. 2005).  
Variations in the sequence of the MAIT TCRα CDR3 may allow the TCR to 
recognise slightly different ligands, or may simply suggest that these sequences 
result in TCRs with very similar structure and specificity (Porcelli et al. 1993; Tilloy 
et al. 1999; Illes et al. 2004; Treiner et al. 2005).  Alternatively, variations in the 
MAIT CDR3 region may relate to providing flexibility in combining with different 
TCRβ chains.  Human and murine MAIT cells have been shown to exhibit an 
oligoclonal TCRβ repertoire, consistent with peripheral expansion (Tilloy et al. 
1999).  These cells preferentially express particular Vβ genes: Vβ2 and 13 in 
humans, and Vβ6 and 8 in mice, where murine Vβ6 and 8 represent the murine 
orthologue of human Vβ13.  Treiner et al, 2005, hypothesised that this Vβ repertoire 
was driven by the selecting antigen, since Vα19-Jα33 transgenic mice showed an 




 T-cells, which reverted to control levels when 
the transgenic mice were crossed onto an MR1 KO background (therefore preventing 
MAIT cell selection).  However, the overall TCRβ diversity of each species‟ MAIT 
population remains extensive, since most Jβ genes and 7 (human) / 5 (murine) Vβ 
segments have been demonstrated on MAIT cells, in association with CDR3 of 
variable lengths (Porcelli et al. 1993; Tilloy et al. 1999; Treiner et al. 2005).   





population (Tilloy et al. 1999).  Preliminary studies conducted by these authors also 
suggested that they are enriched in this population in cattle.  However, analyses of 
sequences from sorted subsets of bovine T-cells suggest that MAIT cells are neither 
enriched nor confined to this subset in cattle.  Although the numbers of sequences 
studied were relatively small, any substantial enrichment within this small subset, 
which was shown to represent up to 4% of T cells in cattle, should have been evident 
from these analyses.  One possibility is that MAIT cells may instead be enriched in a 
different subset of bovine T-cells.  Similarly, although the data achieved was not 
quantitative, the detection of 4 MAIT sequences out of a total of 89 examined in 
PBMC indicate that MAIT sequences are present at a much higher frequency than 
would be expected as a result of random rearrangement, in the absence of further 
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expansion of cells bearing the rearrangement.  Studies to estimate the frequencies of 
MAIT cells are described in chapter 4.   
The V and J segments used by the MAIT TCRα were detected in combination with 
other J and V segments, respectively.  However, none of these rearrangements was 
detected more than once; hence, there is no evidence that these cell-populations had 
undergone expansion.  Although some had CDR3 region sequences similar to the 
MAIT sequence, by virtue of sharing the J segment, the CDR1 and CDR2 sequences 
in the associated V genes differed substantially from those of the MAIT V gene.  
These findings demonstrate that the Vα19 and Jα33 segments are not used 
exclusively for generating MAIT TCRα chains in cattle.  Therefore, PCR assays 
specific for these individual gene segments cannot be used reliably to detect and 
quantify MAIT cells.   
Analyses of the bovine genome sequence database suggested that, as in humans and 
mice, the bovine MAIT Vα19 segment is located at the 5‟ end of the TCRα locus.  
Although assembly of the locus is incomplete, a large number of Vα genes are 
identified 3‟ of Vα19 but none are identifiable on the 5‟ side.  The Vα19 gene is also 
bordered by olfactory receptor genes similar in sequence and in relative location to 
olfactory receptor genes found on either side of the human Vα7.2 gene.  The process 
of rearrangement of TCRα V and J gene segments initially involves those V gene 
segments proximal to the J genes  and progresses to those at the 5‟ end of the locus 
(Treiner et al. 2005).  Since the MAIT Vα gene is the most 5‟ V gene segment, there 
is little obvious potential for preferential rearrangement.  If rearrangement is random, 
the large number of Vα genes (estimated to be >300) within the bovine TCRαδ locus, 
coupled with multiple J gene segments (Reinink and Van Rhijn 2009), even in the 
absence of junctional diversity would result in a very low frequency of T cells with 
the Vα19 and the Jα33 gene segments.  This implies that there must be clonal 
expansion of cells expressing the MAIT TCRα chain.  Theoretically, expression of 
the restricting MHC together with a „conserved‟ self ligand within the thymus could 
give rise to positive selection and expansion of the MAIT cells in the thymus.  
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However, recent studies indicate that expansion occurs peripherally following their 
exit from the thymus (discussed in more detail in chapter 4).   
In conclusion, ruminant MAIT TCRα sequences show a high degree of sequence 
similarity to those described for humans and mice.  This conservation is particularly 
apparent in the CDR region sequences, and in the case of CDR3 indicates that there 
is selective conservation of the sequences generated by junctional diversity during 
the process of TCRα rearrangement.  Analysis of TCRα sequences from cDNA 
indicate that, as in other species, cells expressing these TCRα chains are present at a 
much higher frequency than would be expected from random rearrangement, 
indicating that they have undergone multiplication following thymic development.   
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4 Frequency and Distribution of MAIT cell TCRVα 
Expression 
4.1 Introduction 
MAIT cells were originally defined in humans and mice by an invariant TCRα chain, 
which has a CDR3 of constant length, and is highly conserved between species.  
Results presented in chapter 3 demonstrated that MAIT TCRα in sheep and cattle are 
similarly invariant and highly conserved.  The MAIT TCRα is detected in peripheral 
blood at much higher frequencies than would be expected from random TCR 
rearrangement, and hence it has been suggested that they might be capable of 
responding rapidly to appropriate immune stimuli.  The conserved nature of the TCR 
may also allow it to recognise and respond rapidly to conserved antigen/pathogenic 
patterns, in a manner similar to the PRRs of the innate immune system.   
Although some phenotypic data are available for MAIT cells in humans and mice, 
there are no definitive surface markers that can be used to distinguish them from 
other T-cells.  Analyses of their frequencies have therefore relied on the use of qPCR 
assays to measure MAIT TCRα in relation to total TCRα in cDNA prepared from 
cell populations of interest.   
Initial studies using these assays in humans and mice indicated that the frequency of 
MAIT cells is 5-10 times higher in humans than in mice (Treiner et al. 2005).  In 





 T-cell populations of both species; human MAIT cells accounted for 





 T-cells.  Overall, between 0.15 and 0.2% of all human 
peripheral blood T-cells were estimated to express the MAIT TCRα; however, a 
definitive figure for murine MAIT TCRα expression in peripheral blood T-cells has 
not been published (Tilloy et al. 1999).   
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Initial studies on MAIT cells in mice suggested that their development was 
dependent on the thymus and bacterial intestinal flora, as MAIT cells were absent 
from nude, athymic mice (Tilloy et al. 1999), and germ-free mice (Treiner et al. 
2003).  MAIT cell development was also shown to be dependent on B-cells, as 
MAIT cells were absent from both mice and people deficient in B-cells (Treiner et al. 
2003).  However, these early studies failed to detect MAIT cells by qPCR in human 
or murine thymus; they also could not be detected in the spleen of neonatal mice.  
MAIT TCRα transcripts were detected in peripheral blood of young children, but this 
was at a lower level than that detected in adults (Tilloy et al. 1999).  A recent study 
has now shown that MAIT cells with a naïve T-cell phenotype are present at very 
low frequency in human thymus and cord blood, whereas they are more abundant 
and have a memory phenotype in adult peripheral blood (Martin et al. 2009).  These 
recent findings, together with other data, suggest that MAIT cell development 
involves an initial thymic selection which is dependent on MR1 expression, followed 
by a population expansion in the periphery which is dependent on B-cells and 
commensal gut flora.  In contrast, this study demonstrated that murine MAIT cells 
remain in low number with a naïve phenotype in the periphery, even in the presence 
of B-cells and gut flora, suggesting possible absence of clonal expansion in this 
species.  However, B-cells were shown to play a role in the accumulation of MAIT 
cells in the mesenteric lymph nodes of experimental mice, and experimental adoptive 
transfer of MR1
+
 B-cells into mice with a naïve MAIT cell population was sufficient 
to promote MAIT cell accumulation with acquisition of a memory phenotype (Martin 
et al. 2009).   
Analyses of MAIT expression in tissues from humans and mice have revealed 
differences in distribution in peripheral tissues.  MAIT cells are particularly abundant 
in the intestinal mucosa (lamina propria lymphocytes), from whence they derive their 
name, and the mesenteric lymph nodes, in comparison to intra-epithelial and 
peripheral blood lymphocytes.  Murine MAIT transcripts were shown to be ten-fold 
more abundant in intestinal mucosa than in mesenteric nodes.  MAIT cells are also 
present within lung tissue, which suggests that they may also accumulate in other 
mucosal tissues (Treiner et al. 2003).   
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Initial analyses of lymphocyte subsets defined by expression of CD4 or CD8 









 populations (Tilloy et al. 1999).  
However, they were also detected at lower frequencies in other subsets, including 
human CD8αα
+
 T-cells and in murine CD4
+
 T-cells.  More recent publications have 
suggested that MAIT expression is also enriched in the human CD8αβ
+
 population 
(Martin et al. 2009).  In the initial report of a partial bovine MAIT TCRα sequence, 




 population in 
bovine peripheral blood (Tilloy et al. 1999).  However, results presented in chapter 3 
of this thesis suggest that this might not be the case.   
The work described in this chapter aimed to develop a specific qPCR assay that 
could be used to provide a quantitative estimate of the numbers of MAIT cells within 
T-cell populations of cattle and sheep.  This assay was used to determine the 
distribution of MAIT cells in different tissues and within different T-cell populations, 
and to examine the effect of age on their frequency.   
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4.2 Materials and Methods 
4.2.1 Experimental animals 
Blood samples for isolation of PBMC were collected from adult healthy Holstein-
Friesian cattle, as described in section 2.1.1.  Tissue and blood samples for qPCR 
analysis of MAIT cell distribution were taken from two 6-month old Blackface-cross 
ewe lambs and from Holstein-Friesian calves, which were sampled either within 24 
hours of birth (neonatal), or at 3-weeks or 3-months old.  Blood was collected 
immediately ante-mortem (section 2.1.1).   
 
4.2.2 Post-mortem sample collection and RNA extraction 
Tissue samples were collected immediately post-mortem using sterile instruments 
(see section 2.1.2), and trimmed to fragments of <5mm thickness before storage in 
RNAltr (Applied Biosystems, Warrington, UK).  Tissue homogenisation and RNA 
extraction are described in section 2.4.1.2; RNA was extracted from PBMC using 
Tri-Reagent (section 2.4.1.1).  RNA extracted from PBMC and tissue samples for 
qPCR was treated with DNase before reverse transcription (sections 2.4.1.4; 2.4.2.1).   
 
4.2.3 Real-time quantitative PCR 
The qPCR protocol is described in section 2.4.2.4.  qPCR primer sequences are 
shown in table 4-1.  Primers “I”/“Jr” (bovine) and  “boovUntr3f”/“CorovC3r” 
(ovine) were used to generate cDNA clones containing bovine/ovine MAIT TCRα 
chain sequence (each consisting of full-Vα and partial-Cα regions; for these primer 
sequences, see section 3.2.3).  DNA from plasmids containing these clones was used 
as a positive control and to generate qPCR standard curves.  The MAIT-cell V-
region-specific qPCR extended across the V-J junction, utilising the “boovAV19f” 
forward primer (cattle and sheep), located within the V gene segment, with reverse 
primers “boovAJ33r” (bovine) or “ovAJ33r” (ovine) located in the J gene.  A 33bp 
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probe: “boAV19” lying near the 3‟ end of Vα19 was used.  For the α chain constant-
region-specific qPCR, primers “NGconst-f” and “NGconst-r”, and probe “NGconst”, 
were used for both cattle and sheep.  3µg of cDNA was used for each reaction in the 
described protocol.  All qPCR samples for optimisation and experimental use were 
run in triplicate, both for standards and unknowns.  Average results with standard 
errors were used for analysis of results.  The standard error (SE) of relative 
abundance of MAIT cells (MAIT transcript (x) as a percentage of overall αβ TCR 
transcript (y)) was calculated using the formula:  







The qPCR reaction efficiency was calculated using the formula: E = 10
(-1/slope)
-1.   
qPCR data for two 3-month old calves was provided by Dr Ildiko van Rhijn, 
University of Utrecht, using the same methods (see section 2.4.2.4).   
 




5‟ sequence 3‟ 
Taqman Probe 
5‟ sequence 3‟ 
Reverse 




































On Taqman probes, FAM: fluorescent dye; BHQ: quencher.   
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4.2.4 Purification and PCR of T-cell subpopulations 
Immunofluorescence staining and analysis of cells by flow cytometry are detailed in 
section 2.3.3.  Monoclonal antibodies specific for CD3 (MM1A), CD4 (IL-A12), 
CD8 (IL-A51) (IL-A105), and γδ TCR (GB21A) were used for cell staining.  In one 
experiment, cells were stained with a mixture of MM1A, IL-A12, IL-A105 and 

















 populations.  In a second experiment, cells were also stained with 
individual antibodies specific for CD3 (MM1A), CD4 (IL-A12) and CD8 (IL-A51) 
and sorted into positive and negative populations for each marker.  Purified cell 
fractions were re-analysed and found to be 98-99% pure.   
PCR assays were performed using reaction set-up and reagents as described in 
section 2.4.2.2.  A standard reaction was used, consisting of 10 minutes at 95°C, 35 
cycles of (1 minute at 95°C, 1 minute at a 60°C, 1 minute at 72°C), and a final 
extension period of 10 minutes at 72°C.  Primers sequences for 
“boovAV19f”/”boovAJ33r” and “G3PDH1/2” are provided in sections 3.2.3 and 
2.4.3.2, respectively.  PCR products were analysed on 1.5% agarose gels, as 
described in section 2.4.3.3.   
 
4.2.5 Efferent gastric lymph samples from sheep undergoing 
experimental Telodorsagia circumcincta infection 
Ovine gastric lymph samples were provided by Dr David Smith at the The Moredun 
Research Institute, Edinburgh.  These samples had been collected following surgical 
cannulation of the efferent lymphatic draining the gastric lymph node of sheep 
undergoing primary or secondary infections with the abomasal parasite Telodorsagia 
circumcincta (see section 2.1.2). Animals undergoing secondary infection had been 
previously subjected to a trickle infection with Telodorsagia circumcincta.  Both 
groups of animals were treated with anthelmintic 7 days prior to challenge.  The 
sheep were challenged with 50,000 L3 larvae 1-7 days after cannulation.  Samples 
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were provided as total RNA; these were processed for qPCR as for previous samples 
(section 4.2.3).   
 
4.2.6 Statistical analyses 
Real-time PCR results from three neonatal, three 3-week old, and three 3-month old 
calves were assessed using general linear (mixed effect) models on “R” version 2.9, a 
programming language and software environment for statistical computing, available 
from http://www.r-project.org/.   
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4.3 Results 
4.3.1 Design, standards and optimisation of ‘Real-time’ qPCR 
„Real-time‟ quantitative PCR assays were designed to measure expression of the 
MAIT TCRα chain in relation to total TCRα chains, to determine the relative 
abundance of MAIT cells within the overall αβ T-cell population (see figure 4-1). 
The MAIT TCRα PCR utilised a forward primer within the V gene segment and a 
reverse primer in the MAIT CDR3 of the J gene, covering 17/24bp of 3‟ CDR3 
sequence and additional J segment sequence (see figure 4-2).  The pan-TCRα PCR 
used forward and reverse primers within the C gene segment. The specificity of the 
primer pairs was tested by cloning the PCR products obtained from cDNA prepared 
from PBMC and sequencing 4 clones from each: all of four clones for each reaction 
matched the target sequence.   
 
 
Figure 4-1: Location of qPCR primers (arrows) and fluorescent probes (stars) used to detect 
frequency of MAIT TCRα expression: The “Vα” reaction used a forward primer specific for 
bovine/ovine Vα19, a probe specific for 3‟ Vα19, and a reverse primer specific for the MAIT 
CDR3 region in Jα33.  The second “Cα” reaction used forward and reverse primers, and a 
probe, specific for the constant gene segment.  L: Leader; V: Vα19 gene; J:Jα33 gene; C: 
Constant gene.   
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Figure 4-2: V-J junctions of MAIT TCRα sequences (ovine: u3c3-13ed) (bovine: IJr650#8ed) 
used as standards for qPCR.  Vα19 sequence is indicated with a red arrow, and Jα33 sequence 
with a purple arrow; the CDR3 is as marked.  The location of “Vα” reaction primers 
(boovAV19f, position 193-217, and ovAJ33r, position 286-308) and probe (boAV19, position 
221-253) are highlighted in green.  The forward primer and probe sequences were exact 
matches for both ovine and bovine sequence, and were used for assays of cDNA from both 
species.  There were two nucleotide differences between ovine and bovine sequence within the 
site of the reverse primer – these are un-highlighted at 295 and 298 within the highlighted 
reverse primer location – hence a different specific reverse primer was used for each species 
(ovAJ33r and boovAJ33r, respectively).  Primer boovAJ33r shared exact location and length 
with ovAJ33r but contained 2 single nucleotide differences from ovAJ33r to match differences 
in bovine sequence from ovine.  These reverse primers included the 3‟ 17bp of MAIT CDR3 
sequence.   
 
Bovine and ovine standards for qPCR were created from plasmid DNA extracted 
from fully sequenced MAIT TCRα chain cDNAs (see section 3.3.1).  Serial dilution 
of standards was used to establish optimal primer and probe concentrations for qPCR 
reactions, as well as optimal annealing temperature and thermal-cycling conditions, 
which are detailed in section 2.4.2.4.  Primers were tested using a concentration 
matrix at two different annealing temperatures (Tm), and optimal combinations were 
chosen based on speed of amplification (low Ct), accuracy (low standard error (S.E.) 
between results), and change in fluorescence during reaction (high ΔRn) – this was 
53°C and 500nM for all four primers, see table 4-2, A and B.  Subsequently, probes 
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were tested at four concentrations for the same parameters; both probes functioned 
best at 250nM, see table 4-2, C.   
 
Table 4-2: qPCR Optimisation.  
A) Results of qPCR optimisation testing primers boovAV19f/boovAJ33r on MAIT TCRα 
plasmid DNA in a matrix of 50nM, 300nM, 500nM and 900nM concentrations at different 
annealing temperatures (Tm), 53°C and 60°C.  Primer concentrations in the first column are 
denoted for forward / reverse primers.  The selected conditions for use (Tm:53°C, 
500nM/500nM) are highlighted red.  Ct: crossing threshold; S.E.: standard error between 
results performed in triplicate; ΔRn: delta reaction (change in fluorescence during reaction).   
B) Results of qPCR optimisation of primers NGconst-f/NGconst-r, as for table A.  The selected 
conditions for use (Tm:53°C, 500nM/500nM) are highlighted blue.   
C) Results of qPCR optimisation of probes boAV19 and NGconst, tested at a range of 
concentrations, using primer concentrations 500nM/500nM and Tm:53°C.  The selected 
conditions for use are highlighted red and blue, respectively.   
 




Ct S.E. Δ Rn Ct S.E. Δ Rn 
50/50 35.08 0.121 1.31 41.27 0.622 0.52 
50/300 31.66 0.248 2.50 36.80 0.341 1.39 
50/500 31.20 0.085 2.70 35.67 0.432 1.63 
50/900 30.59 0.241 2.88 33.75 0.337 1.92 
300/50 29.63 0.253 1.27 32.10 0.309 0.79 
300/300 27.11 0.098 2.85 28.77 0.259 2.10 
300/500 26.76 0.088 3.04 28.09 0.195 2.54 
300/900 26.32 0.090 3.38 26.96 0.204 2.76 
500/50 29.71 0.131 1.22 31.75 0.415 0.81 
500/300 27.07 0.041 2.64 28.42 0.082 1.85 
500/500 26.82 0.082 3.13 27.45 0.332 2.53 
500/900 26.46 0.136 3.32 26.52 0.112 2.88 
900/50 29.84 0.258 1.14 32.49 0.682 0.71 
900/300 27.19 0.098 2.34 28.35 0.047 1.64 
900/500 26.98 0.019 2.81 27.96 0.217 2.04 
900/900 26.74 0.185 2.96 26.41 0.264 2.86 
NTC - - - - - - 
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Ct S.E. Δ Rn Ct S.E. Δ Rn 
50/50 27.84 0.187 1.33 26.90 0.089 0.97 
50/300 26.07 0.024 2.31 24.34 0.087 1.89 
50/500 25.46 0.068 2.69 24.03 0.056 2.15 
50/900 25.35 0.145 2.59 23.81 0.437 2.18 
300/50 28.29 0.218 1.50 27.73 0.216 1.19 
300/300 25.92 0.101 2.88 24.86 0.091 2.15 
300/500 25.64 0.042 3.12 24.51 0.088 2.54 
300/900 25.15 0.019 3.50 24.23 0.159 2.84 
500/50 28.10 0.097 1.79 27.78 0.108 1.37 
500/300 26.07 0.139 2.91 25.13 0.054 2.17 
500/500 25.62 0.055 3.47 24.76 0.008 2.80 
500/900 25.41 0.245 2.95 24.68 0.066 2.57 
900/50 28.45 0.182 1.57 28.35 0.184 1.18 
900/300 26.53 0.098 2.78 25.44 0.357 2.47 
900/500 25.81 0.046 3.45 25.10 0.018 2.82 
900/900 25.43 0.018 3.46 24.82 0.060 2.90 
NTC - - - - - - 
 
Table 4-2, C) qPCR boAV19 and NGConst probe optimisation 
 boAV19 NGConst 
Probe 
Conc‟n 
Ct S.E. Δ Rn Ct S.E. Δ Rn 
50nM 28.02 0.016 0.79 26.97 0.030 0.57 
100nM 27.20 0.045 1.57 25.73 0.094 1.68 
150nM 26.99 0.079 2.35 26.16 0.068 1.11 




The reaction efficiency was calculated for both standard curves of each qPCR assay 
performed, using the equation E = 10
(-1/slope)
-1.  Only results from qPCR assays with 
reaction efficiencies between 90-110% were used for further analyses.  Table 4-3 
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Table 4-3: Reaction efficiency of each qPCR assay performed.   
 Reaction Efficiency 
qPCR Experiment Vα Cα 
Calf 2511 100.1% 94.3% 
Calf 0312 100.0% 91.8% 
Calf 0412 101.0% 96.1% 
Calf 1776 91.3% 92.5% 
Calf 1777 97.4% 92.0% 
Calf 1803 95.7% 93.2% 
Calf 2703 95.0% 90.4% 
Sheep 3156E – run#1 92.0% 95.0% 
Sheep 3156E – run#2 101.2% 95.0% 
Sheep 3215E – run#1 90.5% 100.0% 
Sheep 3215E – run#2 104.7% 98.1% 
Adult bovine PBMC 90.3% 91.9% 
T-cell subsets: CD3 vs CD4/CD8/γδ 98.0% 107.7% 
T-cell subsets: CD3, CD4, CD8 95.9% 92.5% 
Sheep B092 (T. circ) 99.1% 94.0% 
Sheep B067 (T. circ) 94.0% 100.8% 
Sheep 1063 (T. circ) 95.8% 98.9% 
Sheep B103 (T. circ) 95.5% 98.3% 
Sheep 992 (T. circ) 96.8% 95.1% 
Sheep 955 (T. circ) 93.5% 98.6% 
Sheep B189 (T. circ) 100.8% 101.6% 
Sheep B161 (T. circ) 107.8% 97.2% 
Sheep B1465 (T. circ) 100.5% 100.3% 
Sheep B1408 (T. circ) 102.9% 98.0% 
Sheep B1399 (T. circ) 108.6% 99.4% 
 
Reaction efficiencies were calculated using the formula E=10
(-1/slope)
-1.  Each qPCR experiment 
for an individual animal relates to all blood and tissue samples from that animal.  „Adult bovine 
PBMC‟ relates to peripheral blood mononuclear cells from four adult cattle: #109, #158, #1706, 















 cells, and unfractionated PBMC.  „T-cell subsets: 
CD3, CD4, CD8‟ relates to bovine T-cell sub-populations purified as positive or negative for 
each phenotype (CD3, CD4, CD8).  „Sheep xxxx (T. circ)‟ relate to efferent lymph samples 
collected from sheep experimentally infected with T. circumcincta.   
 
4.3.2 Levels of expression of bovine MAIT TCRα are highest in 
spleen and ileum, and increase after the neonatal period 
The optimised qPCR assay was used to measure MAIT TCRα transcripts as a means 
of assessing MAIT cell prevalence and distribution in cattle.  Neonatal and juvenile 
calves were sampled to assess the effect of age upon MAIT cell levels and location.  
PBMC and samples from intestinal and immunological tissues (thymus, lymph node 
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(prescapular and mesenteric), spleen, small and large intestinal walls) were collected 
from three neonatal calves (within 24 hours of birth), three 3-week old calves, and 
one 3-month old calf.  The results from animals of different ages were first 
considered together.  The levels of expression of MAIT TCRα in comparison to the 
total TCR α pool ranged from 0.1% to 1.8%, depending on tissue and age.  Highest 
levels of MAIT transcripts were detected in spleen and mesenteric lymph node (up to 
1.8% and 0.9%, respectively).  All other tissues showed comparatively lower MAIT 
transcript levels; intermediate expression was seen in small and large intestinal walls 
and peripheral lymph node, while thymus and PBMC showed very low expression 
(see figure 4-3).  Statistical analyses of data from all age groups for each tissue are 
shown in table 4-4, and showed MAIT transcript levels in the spleen to be highly 
significantly raised when compared to thymus (p<0.001), PBMC (p<0.001) and 
peripheral lymph node (p<0.001).  Percentages of MAIT transcript in mesenteric 
lymph node, ileum and colon were highly significantly increased in comparison to 
thymus (p<0.001, p<0.001, p=0.002) and significantly increased in comparison to 
PBMC (p=0.016, p=0.015, p=0.041).   
 
Figure 4-3: Relative abundance of MAIT TCRα expression in different bovine tissues.  Relative 
abundance of MAIT TCRα was calculated by using quantitative PCR to detect MAIT TCRα 
expression in comparison to the total TCRα pool.  Error bars represent the standard error of 
each result.   
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Table 4-4: Results of statistical analyses of relative abundanceof MAIT TCRα transcripts in 
different tissues from calves of varying ages.   
Tissues compared p value 
Per LN – Thymus 0.10049 
Mes LN – Thymus < 0.001 *** 
Spleen – Thymus < 0.001 *** 
SI wall – Thymus < 0.001 *** 
LI wall – Thymus 0.00248 ** 
PBMC – Thymus 0.98084 
Mes LN – Per LN 0.68049 
Spleen – Per LN 0.00105 ** 
SI wall – Per LN 0.75751 
LI wall – Per LN 0.88183 
PBMC – Per LN 0.51266 
Tissues compared p value 
Spleen – Mes LN 0.33190 
SI wall – Mes LN 0.99999 
LI wall – Mes LN 0.99965 
PBMC – Mes LN 0.01567 * 
SI wall – Spleen 0.14216 
LI wall – Spleen 0.10846 
PBMC – Spleen < 0.001 *** 
LI wall – SI wall 1.00000 
PBMC – SI wall 0.01495 * 
PBMC – LI wall 0.04051 * 
*** = very highly significant, ** = highly significant, * = significant.  Tissues included: thymus, 
peripheral lymph node (Per LN), mesenteric lymph node (Mes LN), spleen, small intestinal wall 
(SI wall), large intestinal wall (LIwall), peripheral blood mononuclear cells (PBMC).   
 
The effect of age upon MAIT cell prevalence and distribution was examined by 
comparing the results obtained from the 3 different age groups.  Additional results 
for two 3-month old calves were included in the analysis (although the mesenteric 
lymph node was not tested in these animals); results are presented in figure 4-4.  
Neonatal animals showed consistently low levels of MAIT TCRα expression 
throughout all tissues tested, and statistical analysis of experimental data showed a 
highly significant increase in MAIT transcript abundance in 3-week (p<0.001) and 3-
month (p=0.044) animals when compared to neonates (see table 4-5).  There was no 
significant change in MAIT transcript abundance between 3-week and 3-month 
animals, suggesting that most of the expansion of the MAIT population has occurred 
by 3 weeks of age.   
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Figure 4-4: Relative abundance of bovine MAIT TCRα expression in tissues from three animals 
within each of three age groups: neonatal (2511, 0312, 0412), 3-week old (1776, 1777, 1803), and 
3-month old (2703, 1438, 5524).  Individual tissue results for each animal are shown in the 
order: thymus, peripheral blood mononuclear cells, peripheral lymph node, large intestinal 
wall, small intestinal wall, mesenteric lymph node, spleen.  Relative abundance of MAIT TCRα 
was calculated by using quantitative PCR to detect MAIT TCRα expression in comparison to 
the total TCRα pool.  Error bars represent the standard error of each result.   
 
Table 4-5: Results of statistical analyses of relative abundance of MAIT TCRα transcripts in 
tissues from calves in three different age groups – neonatal, 3-week old and 3-month old.   
Age groups compared p value 
3week – Neonatal < 0.001 *** 
3month – Neonatal 0.0044 ** 
3month – 3week 0.7315 
 
When both individual organ and age of animal are taken into account, spleen and 
mesenteric lymph node show marked increases in MAIT expression by 3-weeks of 
age, while ileum, colon, peripheral lymph node and PBMC show less pronounced 
Chapter 4: Frequency and Distribution of MAIT cell TCRVα Expression 
Characterisation of Mucosal Associated Invariant T-cells and MR1 in Ruminants 117 
increases (see figure 4-5).  MAIT expression in the thymus is consistently low in all 
ages.  Changes in MAIT expression in the spleen between neonates, 3-week and 3-
month old animals are significantly increased in comparison to changes in MAIT 
expression between neonates, 3-week and 3-month old animals in PBMC and thymus 
(p=0.021).   
Table 4-6: Results of statistical analyses of relative abundance of MAIT TCRα transcripts from 
various tissues (thymus, spleen and peripheral blood mononuclear cells (PBMC)) from calves in 
three different age groups (neonatal, 3-week old and 3-month old), and the interaction between 
tissue type and age group.   
Effect / Interaction p value 
Tissue Type < 0.001 *** 
Age Group 0.0057 ** 
Tissue Type:Age Group 0.0216 * 
 
 
Figure 4-5: Relative abundance of bovine MAIT TCRα expression in thymus, peripheral lymph 
node (PerLN), mesenteric lymph node (MesLN), spleen, small intestinal wall (SIwall), and large 
intestinal wall (LIwall), and peripheral blood mononuclear cells (PBMC), from three animals 
within each of three age groups: neonatal, 3-week old, 3-month old.  MAIT expression in the 
mesenteric lymph node was only tested in one of the three 3-month calves.  Relative abundance 
of MAIT TCRα was calculated by using quantitative PCR to detect MAIT TCRα expression in 
comparison to the total TCRα pool.  Error bars represent the standard error of each result.   
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4.3.3 Expression of ovine MAIT TCRα transcript is most abundant 
in prescapular lymph node, spleen and small intestine 
The same qPCR assay, with specific ovine MAIT primers, was used to assess MAIT 
cell prevalence and distribution in sheep.  Tissue samples from thymus, prescapular 
and mesenteric lymph nodes, spleen, and small and large intestinal walls, as well as 
circulating PBMC, were collected from two six-month old sheep.  Samples from 
both animals were analysed twice and provided similar results.  Overall levels of 
MAIT transcript were lower in comparison to cattle (0.1-0.5%), with highest 
expression of MAIT transcript (0.3-0.5%) in prescapular lymph node, spleen and 
ileum.  Levels in thymus, colon and PBMC were all <0.1% (see figure 4-6).   
 
Figure 4-6: Relative abundance of ovine MAIT TCRα expression in thymus, peripheral lymph 
node (PerLN), mesenteric lymph node (MesLN), spleen, small intestinal wall (SIwall), and large 
intestinal wall (LIwall), as well as peripheral blood mononuclear cells (PBMC), from two six-
month old sheep.  Samples from both animals were analysed twice with similar results.   
Relative abundance of MAIT TCRα was calculated by using quantitative PCR to detect MAIT 
TCRα expression in comparison to the total TCRα pool.  Error bars represent the standard 
error of each result.   
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4.3.4 CD4- CD8- γδ- T-cell populations were detected in PBMC 
from all age groups of cattle 
On the basis of qPCR evidence that bovine MAIT cells increase in number within the 
first 3-weeks of life, PBMC from neonatal and 3-week old (“juvenile”) calves were 





 αβ T cells, as well as other T cell subsets, significantly 
changed during the post-natal period.  Three calves were sampled as neonates only, 
and three were sampled as neonates and at three weeks of age.  Six adult (>2-years 
old) cattle were sampled for comparison.  Staining with specific antibodies was used 








) αβ T-cell 
populations.  Results are presented in table 4-3.  The anti-TCR γδ monoclonal 
antibody was accidentally omitted from the assays of one of the neonatal calves and 
therefore data from this animal were not included in the analyses.   
The percentages of DN αβ T-cells were slightly higher in the neonatal calves (mean 
2.9%), compared to the 3-week old calves (mean 1.2%).  However, the values varied 
between individual animals within the groups (0.3% to 4.5% for neonates and 0.6% 
to 1.8% for 3-week old calves).  Moreover, higher levels of DN αβ T cells were 
found in the in adult cattle (mean 3.2%, range 2.0-4.2%) compared to both of the 
younger groups.  High levels of γδ T-cells (mean 40%, range 26.0-61.8%) were 
detected in all of the neonatal animals and although they were slightly higher than 
the levels in 3-week old calves (mean 36%, range 23-43%) this was not statistically 
significant.  The percentages of γδ T-cells in adult cattle (mean 27%, range 19%-
39%) were lower than in the younger groups.  Levels of T-cells (CD3
+
) in PBMC 
from different age groups were fairly similar, ranging from 63.3% to 79.7% in all 
except for one neonatal animal which had 46.6% CD3
+





 cells were more variable between individual animals in the neonatal group 
than in the other groups, but among the 3 calves sampled after birth and at 3 weeks, 




 cells at birth had increased 
percentages at 3-weeks of age.   
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Table 4-7: Percentages of T-cell subpopulations in PBMC T-cell populations of neonatal, 
juvenile (3-weeks old) and adult cattle determined by immunofluorescence staining and flow 
cytometry.  PBMC were isolated from blood collected by jugular venepuncture and data are 
expressed as the percentages of total PBMC. 
  T-cell subpopulation 
































l 2511 63.7% 20.8% 6.7% 29.3% 4.5% 
0312 63.3% 12.4% 11.8% 33.8% 1.4% 
1776 68.2% 33.7% 10.3% 26.0% 3.0% 
1777 46.6% 2.8% 2.4% 49.9% 2.6% 




s 1776 63.8% 31.3% 14.2% 22.9% 1.8% 
1777 76.6% 19.1% 11.8% 42.9% 1.2% 






002 70.8% 17.5% 6.2% 39.1% 3.8% 
332 66.2% 23.3% 9.9% 27.2% 4.0% 
475 79.7% 33.3% 19.5% 28.7% 2.0% 
481 65.9% 19.2% 14.2% 25.3% 2.7% 
851 79.5% 24.4% 11.0% 21.9% 4.2% 
860 71.4% 19.4% 29.1% 18.9% 2.0% 
 
4.3.5 MAIT TCRα expression is highest in the bovine CD8+ T-cell 
subset 
Results of PCR and sequence analyses of expressed TCRα chains in fractionated T-
cell populations, presented in chapter 3,  suggested that MAIT cells may not be 




 population of bovine T-cells, as they are in humans 
and mice (Tilloy et al. 1999).  To investigate this further, an initial experiment was 
conducted to compare the frequency of MAIT TCR transcripts in whole PBMC with 
that in positive and negative fractions obtained following staining with a mixture of 













 fractions).  A standard PCR for MAIT transcripts gave readily detectable product 
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populations, with the 






 fraction yielded much less 
product.  However, the latter would be expected to contain much fewer T cells than 
the former two populations (see figure 4-7).   
 
 
Figure 4-7: Agarose gel showing PCR amplification of MAIT transcript (Vα19-Jα33) in 













 T-cells, and unfractionated PBMC, as well as a negative control of 
sterile distilled water.   
 
The same samples were analysed by qPCR to determine the abundance of MAIT 













 populations were estimated  to 
contain 0.64%, 0.82% and 0.29% MAIT transcripts respectively (figure 4-8).  These 









populations.  Although γδ
+
 T-cells would have been included in the positive sorted 
population, the PCR would not be expected to amplify transcripts from these cells.  
Chapter 4: Frequency and Distribution of MAIT cell TCRVα Expression 
Characterisation of Mucosal Associated Invariant T-cells and MR1 in Ruminants 122 
 
 
Figure 4-8: Relative abundance of MAIT TCRα expression in purified bovine T-cell 
subpopulations.  T-cell populations were identified by primary antibody staining with MM1A 
(CD3), IL-A12 (CD4), IL-A105 (CD8), GB21A (γδ T-cells), and immunofluorescence staining 
using secondary isotype-specific antibodies, and flow cytometry analysis, and were purified by 















population (circled in red).  Relative abundance of MAIT TCRα expression was assessed in each 
of these populations as well as unfractionated PBMC (circled in blue) by using quantitative PCR 
to detect MAIT TCRα expression in comparison to the total TCRα pool; results are shown in 
text on the right of the figure.   
 
Samples of PBMC from a further 4 animals were tested to determine the extent of 
inter-animal variation in MAIT expression.  Samples were tested twice with similar 
results each time.  The average values for relative abundance of MAIT TCR were 
(animal)#109: 0.56%; #158: 0.10%; #1706: 0.22%; #1707: 0.29% (see figure 4-9).  





 T-cell subpopulations, a series of cell sorts were undertaken on PBMC from 













 cells.   
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Figure 4-9: Relative abundance of MAIT TCRα expression in PBMC of 4 cattle.  Samples were 
run twice for accuracy; the results from each experimental run are shown in the same colour.  
Relative abundance of MAIT TCRα was calculated by using quantitative PCR to detect MAIT 
TCRα expression in comparison to the total TCRα pool.  Error bars represent the standard 
error of each result.   
 
 
Figure 4-10: Purification of CD3+ and CD3-, CD4+ and CD4-, and CD8+ and CD8- populations 
from bovine PBMC by flow cytometry.  Populations were identified by staining with primary 
antibodies MM1A (CD3), IL-A12 (CD4), IL-A51 (CD8) and immunofluorescence staining using 
secondary isotype-specific antibodies, and gated as positive (red) or negative (blue).  Figures are 
given for the percentage of PBMC identified as staining positive for each antibody.   
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The cell sorts yielded between 8 x 10
5
 and 4 x 10
6
 cells for each fraction and re-
analysis demonstrated that they were 98-99% pure.  qPCR analysis of equal amounts 
of cDNA extracted from these fractions indicated that MAIT transcripts were 



















: 0.1%) populations (see 







 population.  The detection of 0.2% MAIT expression in the 
CD3
-
 population probably relates to CD3
+
 cells which have low mean fluorescence 
intensity (MFI) of MM1A staining and have been accidentally purified as CD3
-
 due 
to the position of flow cytometry sorting gates at a relatively high MFI.   
 
 
Figure 4-11: Relative abundance of MAIT TCRα expression in bovine T-cell subsets purified as 
positive and negative for each phenotype by flow cytometry and staining with primary 
antibodies MM1A (CD3), IL-A12 (CD4), IL-A51 (CD8) and immunofluorescent isotype-specific 
secondary antibodies, as shown in figure 4-10.   Relative abundance of MAIT TCRα was 
calculated by using quantitative PCR to detect MAIT TCRα expression in comparison to the 
total TCRα pool.  Error bars represent the standard error of each result.   
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4.3.6 Analysis of MAIT TCRVα expression in sheep infected with 
Telodorsagia circumcincta  
To test the applicability of the MAIT qPCR to studies of responses to infection, the 
assay was used to assess MAIT transcript abundance in the efferent gastric lymph of 
sheep undergoing experimental infection with Telodorsagia circumcincta.  This is a 
common gastrointestinal parasite which colonises the abomasal mucosa, causing 
chronic ill-thrift and reduced productivity.  Two groups of previously worm-free 
animals were studied, one subjected to a primary infection and the other to a 
secondary challenge following immunisation by previous trickle infection and 
anthelmintic treatment.  Samples of cDNA prepared from lymph samples collected 
on the day before challenge, and on days 1, 3, 7, 14, 21 in naïve animals, and days 1, 
3, 5, 7, 9 in previously-infected animals were analysed for relative abundance of 
MAIT TCRα by qPCR.  The results obtained were compared to the abomasal worm 
counts obtained following slaughter of the animals on day 21 or day 9, respectively.   
Results from analyses are presented in figures 4-12 and 4-13, and combined in figure 
4-14.  As observed in PBMC and tissues from healthy sheep, the estimated levels of 
MAIT transcript in gastric lymph were low throughout the experiments (<0.2%). In 
general, animals undergoing primary infection showed a small increase in MAIT 
abundance after challenge, which was still increased at day 21; this was greatest in 
animals B103 and 955 (0.05% on day -1 to 0.15% on day 21, and 0.03% on day -1 to 
0.13% on day 21).  Previously-infected animals had relatively low abundance of 
MAIT transcript before challenge (<0.04%) and also at day 9 after challenge 
(<0.04%), but 4 of the 5 animals showed a small increase at day 3 after challenge.  
Overall, however, although MAIT transcripts exhibited these small changes in 
abundance, these were inconsistent and not statistically significant.  Terminal 
abomasal worm burdens were variable and did not significantly correlate with 
changes in MAIT abundance within either group.   
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Figure 4-12: Relative abundance of MAIT TCRα expression in efferent gastric lymph of sheep 
undergoing primary infection with the gut nematode, Telodorsagia circumcincta, before and 
following challenge on day 0.  Relative abundance of MAIT TCRα was calculated by using 
quantitative PCR to detect MAIT TCRα expression in comparison to the total TCRα pool.  The 
standard error of each result is not shown.    
 
 
Figure 4-13: Relative abundance of MAIT TCRα expression in efferent gastric lymph of sheep 
undergoing secondary infection with T. circumcincta; these had been previously-infected with 
the same parasite but treated with anthelmintic before repeated challenge.  Relative abundance 
of MAIT TCRα was calculated by using quantitative PCR to detect MAIT TCRα expression in 
comparison to the total TCRα pool.  The standard error of each result is not shown.   
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Figure 4-14: Relative abundance of MAIT TCRα expression in efferent gastric lymph of sheep 
undergoing primary (red) or secondary (blue) infection with the gut nematode, Telodorsagia 
circumcincta, before and following challenge on day 0.  Relative abundance of MAIT TCRα was 
calculated by using quantitative PCR to detect MAIT TCRα expression in comparison to the 
total TCRα pool.  The standard error of each result is not shown.   
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4.4 Discussion 
A real-time quantitative PCR was designed to examine relative abundance of MAIT 
cells, using primers specific for the Vα and CDR3 of the MAIT TCRα chain, 
together with a second reaction to measure total TCRα transcripts, using constant 
region-specific primers.  This provided estimates of MAIT TCRα expression in about 
0.1-0.6% of T-cells in PBMC of young adult cattle, and in 0.1-0.2% of T-cells in 
PBMC of 6-month old sheep.  These figures might represent an underestimate, as a 
proportion of T-cells in mice and humans have been shown to express two re-
arranged TCRα transcripts (Heath and Miller 1993; Padovan et al. 1993).  
Nevertheless, since preliminary analysis of the bovine TCRα locus has identified 
>300 Vα genes (Reinink and Van Rhijn 2009), these estimates of MAIT TCRα 
abundance are still far in excess of that expected for sequences generated by random 
rearrangement in the absence of further expansion.   
Previous studies have concluded that MAIT cells undergo development in the 
thymus, as they were absent in athymic mice.  However, MAIT expression was not 
detected in human cord blood lymphocytes, nor in the thymus or spleen of neonatal 
mice, using RT-PCR (Tilloy et al. 1999).  The inability to detect these cells in the 
thymus suggested that they may be produced in very small numbers and 
subsequently undergo peripheral expansion.  This would be consistent with the 
finding that MAIT cells have an oligoclonal TCR Vβ repertoire (Treiner et al. 2005).  
In support of this suggestion, recent studies using a monoclonal antibody specific for 
human MAIT Vα7.2 demonstrated the presence of small numbers of MAIT cells 
with a naïve T cell phenotype within the thymus, and larger numbers of circulating 
MAIT cells with a memory phenotype in peripheral lymphoid tissues (Martin et al. 
2009).  Studies in B-cell deficient and germ-free mice have shown that peripheral 
expansion of the MAIT cell population (but not their production in the thymus) is 
dependent on B-cells, as well as an intact gut flora (Treiner et al. 2003).   
To determine whether the numbers of MAIT cells in the peripheral T-cell pool also 
increase following birth in cattle, the qPCR for relative abundance of MAIT TCRα 
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was applied to samples from neonatal, 3-week old, and 3-month old calves.  MAIT 
TCRα expression was uniformly low in all tissues in neonatal animals, but highly 
statistically-significantly increased in 3-week old and 3-month old calves compared 
to the neonates.  Further analyses showed that the increase in MAIT expression with 
age was statistically significant in a number of secondary lymphoid tissues but was 
particularly pronounced within the spleen, and was also significantly increased 
compared to the thymus within the same animal.  The paucity of MAIT transcripts in 
neonates, and subsequent rapid rise in MAIT transcript numbers with age, supports 
the model that this cell population undergoes expansion following birth.  Further, the 
consistently low levels of MAIT TCRα expression in the thymus suggest that this 
expansion occurs extra-thymically.  Given the evidence in mice that MAIT cell 
expansion is dependent on the gut flora (Treiner et al. 2003), expansion of these cells 
in cattle is likely to occur in the immediate post-natal period, since previous work has 
demonstrated that maximal numbers of total faecal flora are reached within 24 hours 
of birth (Gay 1965).  Levels of MAIT transcripts showed no significant increase 
between 3-week and 3-month old calves, and were consistent with older animals, 
suggesting that the initial population expansion was complete by 3-weeks of age.  A 
rapid establishment of the MAIT cell population would be appropriate if these cells 
do possess innate function, as the innate immune system is particularly important 
during this post-natal period.  If, as in mice, MAIT population expansion in cattle is 
dependent on B cells, this cell population is present in neonatal calves, although in 
smaller numbers than in older animals (Kampen et al. 2006).  Rapid activation and 
expansion of the B cell population in response to microbial challenge is also 
expected to occur following birth.   
Analyses of MAIT cell tissue distribution in cattle and sheep demonstrated 
predilections for similar tissues, particularly the spleen and some gut-associated 
tissues.  This is the first evidence that MAIT cells represent a prominent T-cell 
population in the spleen.  A previous study had failed to demonstrate MAIT 
expression within the spleen of neonatal mice (Tilloy et al. 1999); however, in this 
regard, the B-cells in the spleen of clean, healthy mice contain much fewer activated 
B-cells and there are very few germinal centres compared to other species living in 
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their natural environment.  This finding raises important questions concerning the 
role of the gut as a site of expansion of these cells.  The finding that expansion of the 
MAIT cell population in mice is dependent on a gut flora (Treiner et al. 2003) has 
prompted the suggestion that a microbial-derived MR1-associated ligand may be 
involved.  Alternatively, the role of the gut flora may be to activate and expand B-
cell populations, which through migration of the B-cell progeny, is likely to have an 
impact on B-cell populations in systemic lymphoid tissues.  In this model, expansion 
of MAIT cells might occur in response to endogenous ligands expressed by activated 
B-cells.  In this regard, the spleen of ruminants is relatively rich in B cells and in 
active germinal centres.   
qPCR assays showed MAIT cells to represent 0.1-0.2% of all human peripheral T-
cells.  These are approximated to be 5-10 times more abundant in humans than mice, 
since they compose 15% of human DN T-cells in comparison to 2% of murine DN 
T-cells (Tilloy et al. 1999; Treiner et al. 2005).  However, a definitive quantification 
of murine MAIT cells in PBMC has been difficult to perform due to their paucity, 
and this result is only approximate since the size of the DN population and the 
proportion of MAIT cells within the DN population may differ between the species.  
Certainly, recent studies demonstrated that circulating MAIT cells in mice have a 
naïve phenotype, and it has been hypothesised that MAIT do not undergo peripheral 
expansion in this species (Martin et al. 2009).  This study used antibody against the 
human Vα7.2 gene to identify MAIT cells and suggested that these may represent up 
to 4% of human peripheral T-cells.  The estimates of frequency of MAIT cells in 
cattle, based on quantifying expression of the MAIT TCRα chain, ranged from 0.1% 
to 0.6% of αβ T cells in PBMC in different animals, and hence were similar to 
frequencies determined by the same methods in humans.  Interestingly, these levels 
were roughly five times higher than those obtained in sheep where MAIT 
represented only 0.01-0.08% of PBMC (i.e. more similar to the levels in mice).  It 
has been proposed that MAIT cells may perform a similar functional role to iNKT 
cells which are restricted by the class I-like molecule CD1d (Godfrey et al. 2000).  
While humans have higher numbers of MAIT cells than mice, the converse is the 
case for iNKT cells, with mice having 10-fold more of these cells (Treiner and Lantz 
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2006).  In this regard, sheep have been shown to possess a functional CD1d gene 
(Rhind et al. 1999), whereas genome searches have failed to identify a functional 
CD1d gene in cattle and cattle T-cells do not stain with CD1d-ligand tetramers (Van 
Rhijn et al. 2006).  Hence it is possible that the lower levels of MAIT cells in sheep 
compared to cattle may be related to differences between the species in the relative 
functional roles of these invariant T-cell populations.  Further comparative 
knowledge of the characteristics and functions of these cell types would be required 
to address this hypothesis.   





cell population in mice and humans and preliminary results indicated that this was 
also the case in cattle (Tilloy et al. 1999).  In humans, there was evidence that they 
were also present in the CD8αα
+
 population, and conversely some enrichment was 
seen in the murine CD4
+
 population (Tilloy et al. 1999).  However, results from 
sequencing of TCRα cDNAs isolated from T cell subsets in the present study 
(reported in chapter 3) suggested that this might not be the case in ruminants.  Thus, 






purified population whereas 2 MAIT sequences were identified in a similar sample 
of cDNAs from unfractionated PBMC.  To provide more quantitative data on the 
distribution of MAIT cells in bovine T-cell subsets, the qPCR for relative abundance 
of MAIT TCRα was applied to samples of cells purified based on expression of T-
cell surface markers.  In an initial experiment, results again demonstrated that MAIT 
expression was higher in cells sorted as positive following staining with a mixture of 
antibodies specific for CD4, CD8 and γδ TCR, than in the corresponding negative 





 T cells usually represent <4% of PBMC, T-cells representing >50% 
of PBMC.  This finding, together with the MAIT qPCR data, indicates that a large 





Application of the MAIT qPCR in a second experiment confirmed the low 






 population and 
demonstrated that they are enriched in purified CD8
+





 cells compared to CD4
+
 cells.  These results indicate that bovine MAIT 
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cells are found predominantly within the CD8
+
 T-cell population, thus differing from 





population.   
These results suggest that bovine MAIT – MR1 interaction and activation may be 
more reliant on the CD8 molecule as a co-receptor than in humans or mice.  
However, recently published studies have demonstrated the presence of human 
MAIT cells within the CD8αβ population of T-cells as well as the DN and CD8αα T-
cell subsets.  These authors suggested that MAIT cells bearing a CD8αβ molecule 
had been missed during previous flow cytometry sorting due to low levels of staining 
for CD8β (Martin et al. 2009).  IL-A51 and IL-A105 antibodies used to detect bovine 
CD8 molecules are specific for the CD8α chain and therefore detect both CD8αα and 
CD8αβ molecules (MacHugh and Sopp 1991).  A monoclonal antibody specific for 
the bovine CD8β chain, CC-58, has been described and used in two-colour staining 
to identify T cells expressing CD8αα from those expressing CD8αβ (MacHugh and 
Sopp 1991).  Further studies using monoclonal antibodies specific for the different 
forms of CD8 chain are required to determine whether bovine MAIT cells are 
enriched in CD8αα or CD8αβ populations.   
The qPCR assay designed to examine relative abundance of MAIT cells proved a 
useful tool for analysis of MAIT TCRα expression in relation to the total αβ T-cell 
pool.  Results were consistent between triplicates and repeated experiments, with 
relatively low levels of standard error.  Detection of MAIT and TCR transcripts was 
highly sensitive, and allowed detection down to, and including, 1x10
-10
ng/µl.  
However, the assay also had its limitations.  In particular, because MAIT cells are 
usually present in small numbers, and since MAIT transcripts may not correlate 
exactly with cell numbers, the qPCR gives only an approximate estimate of the 
numbers of cells present.  A number of samples were also near the lower threshold 
for detection of MAIT transcript, and for one sample (LI wall of calf 0312) no MAIT 
amplification was achieved.  Also, since the assay is based on analysis of cDNA, 
then increased activation status of αβ T cell populations other than MAIT cells would 
proportionately increase overall TCRα transcript relative to MAIT transcript, and 
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result in an underestimation of MAIT cell number.  In conclusion, although this 
qPCR assay is useful to compare the representation of MAIT cells in different 
populations, it has limitations in providing precise data on the numbers of these cells.  
More detailed studies would be possible by producing a monoclonal antibody 
specific for the MAIT TCRα.  This would allow accurate identification of MAIT, 
and purification of these cells for functional studies.  However, since the studies 
described in chapter 3 showed that use of the germline Vα19 segment is not 
exclusive to the MAIT TCR, an antibody specific for the MAIT CDR3 loop would 
be required to avoid cross-reactivity with other T cells expressing a TCRα chain 
bearing Vα19.   
Since MAIT cells have been previously demonstrated to be increased in abundance 
in the intestinal mucosa of humans and mice, the qPCR assay for MAIT TCRα was 
applied to examine changes in MAIT abundance in sheep infected with the gastro-
intestinal parasite T. circumcincta.  Samples of efferent gastric lymph draining from 
the abomasum of experimentally-infected sheep were available for the study.  This 
allowed assessment of the suitability of this assay as a tool to investigate changes in 
MAIT cell abundance during responses to infection.  No marked change in relative 
abundance of MAIT cells was detected following either primary or secondary 
infection.  This may relate to retention of MAIT cells in the lymph node, or in the gut 
mucosa, in which case changes would not be detected in efferent lymph.  
Alternatively, an increase in abundance of MAIT cells may not have been detectable 
because of similar increases in numbers of activated cells within other T-cell subsets.   
In conclusion, the work in this chapter shows that bovine MAIT cells are present at a 
similar frequency to that observed for human MAIT cells, but in contrast to humans 
are most abundant within the CD8
+





population.  Analyses of tissue distribution and changes with age suggest that bovine 
MAIT also undergo extra-thymic peripheral clonal expansion.  Of particular interest 
was the observation that MAIT cells were most abundant in the spleen.  The 
relatively high frequency of MAIT cells in peripheral lymphoid tissues, coupled with 
the high level conservation of MAIT TCRα chain CDR sequences, support the idea 
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that these cells may participate in innate immune responses by recognition of a 
similarly conserved ligand.   
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5 Molecular Cloning and Characteristics of Ruminant MR1 
5.1 Introduction 
The highly polymorphic classical class I genes involved in presentation of antigenic 
peptides to T-cells are located within the MHC locus.  The human MHC region is 
sited on chromosome 6 (The M. H. C. sequencing consortium 1999), and contains 
classical and non-classical MHC class I-like genes; the latter include a number of 
non-polymorphic class I genes, e.g. HLA-E in man, which presents ligands to NK 
cells and NK-CTL.  Additional class I-like genes are found at other locations in the 
genome – these include the CD1 genes and MR1, which in humans are found on 
chromosome 1q23 and 1q25 respectively, within an MHC-paralogous region 
(Kasahara 1999).  Studies with mice in which the MR1 gene has been deleted 
indicate that development of MAIT cells is dependent on MR1, and in vitro studies 
suggest that MAIT cells respond to an unknown ligand presented by MR1 (Treiner et 
al. 2003).   
Orthologous MR1 genes have been detected in a number of different mammalian 
species and demonstrate a striking level of cross-species sequence conservation at 
both nucleotide and amino acid level.  The extracellular domains of human and 
murine MR1 share up to 90% identity, particularly the α1 and α2 domains which 
form the ligand binding site (Yamaguchi et al. 1997).  This is the highest level of 
inter-species identity of all known class I-related molecules and implies an important 
immunological function which evolved prior to species divergence (Yamaguchi et al. 
1997; Treiner et al. 2003).  The MR1 gene is notably monomorphic (Parra-Cuadrado 
et al. 2000) and has an unusually large first intron in comparison to other class I 
genes (Yamaguchi et al. 1998); it also demonstrates „type I splicing‟, where each 
domain starts with a composite codon whose first nucleotide is contributed by the 
previous exon (Riegert et al. 1998).  A number of alternatively-spliced transcripts of 
MR1 have been reported in humans and mice, in addition to full MR1 sequence; the 
majority of these involve sequence disruption in the α1 (murine) or α3 (human) 
regions (Riegert et al. 1998).   
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The predicted structure of MR1 suggests that it shares structural features with 
classical MHC class I molecules, notably the characteristic MHC class I protein fold 
of the heavy chain comprising 3 extracellular domains, α1, α2 and α3, and an ability 
to associate with β2-microglobulin (Yamaguchi et al. 1997; Yamaguchi and 
Hashimoto 2002).  This also includes a typical groove, formed by the α1 and α2 
domains, that is predicted to accommodate a ligand; however, the nature of this 
ligand has yet to be discovered.  Molecular modelling suggests that the binding 
groove of MR1 is hydrophilic, but comparative analysis to classical class I molecules 
shows differences in MR1 within five of the eight class I residues defined to contact 
peptide termini (Madden 1995), suggesting that MR1 is unlikely to bind to a peptide 
ligand (or if so, it does so in a novel way) (Riegert et al. 1998).  Additionally, MAIT 
cells have been shown to be activated by synthetic glycolipids (Okamoto et al. 2005), 
suggesting that MR1 may present a lipid/glycolipid ligand to MAIT, in a manner 
similar to that presented by CD1d to iNKT cells.   
Analyses of MR1 expression in human and murine tissues by RT-PCR or Northern 
blotting have demonstrated that it is transcribed in a wide range of tissues and in cell-
lines of different lineages (Hashimoto et al. 1995; Riegert et al. 1998).  However, cell 
surface expression of MR1 has yet to be demonstrated in vivo, and following 
transfection into cell lines in vitro, MR1 is expressed internally but usually only at 
low levels on the cell surface (Huang et al. 2005; Treiner et al. 2005). Studies of 
MR1-transfected cell lines demonstrated that most MR1 protein was retained intra-
cellularly and analyses of subcellular localisation also indicated that MR1 is 
transported through the endosomal compartment, leading to the suggestion that it 
acquires its ligand within the endosomes (Huang et al. 2008).   
The work described in this chapter aimed to identify and characterise MR1 genes in 
cattle and sheep to provide further data for cross-species comparisons and for 
subsequent studies of MR1 expression.   
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5.2 Materials and Methods 
5.2.1 Experimental animals 
Samples of peripheral blood were obtained from healthy adult Holstein-Friesian 
cattle and Blackface-cross sheep as described in section 2.1.  Peripheral blood 
mononuclear cells (PBMC) used for total RNA extraction and cDNA synthesis (see 
sections 2.4.1.1 and 2.4.2.1) were prepared as in section 2.3.1.1. 
 
5.2.2 Online resources and sequence analysis 
Online sequence databases from the National Center for Biotechnology Information 
(NCBI), including Entrez Nucleotide, and Ensembl were used to obtain original 
sequence data and search for published gene data.  Sequence analysis was performed 
using DNASIS software (Hitachi Software Engineering Company, Ltd.) (see section 
2.5).   
 
5.2.3 PCR primers and reaction conditions 
The primer sequences used for PCR amplification of bovine and sheep MR1 are 
shown in table 5-1.  PCR were performed using reaction protocols and reagents as 
described in section 2.4.2.2.  Optimal cycling conditions were assessed for each 
individual reaction; based on results, a standard reaction was then used, consisting of 
10 minutes at 95°C, 35 cycles of (1 minute at 95°C, 1 minute at specific annealing 
temperature, 1 minute at 72°C), and a final extension period of 10 minutes at 72°C 
for all reactions except that using primers “ovMR1f” and “ovMR1r”, where a total of 
40 cycles of (1 minute at 95°C, 1 minute at 54°C, 1 minute at 72°C) were performed.  
Optimal annealing temperatures for each primer combination are listed in table 5-1.  
PCR products were analysed on 1.5% agarose gels, as described in section 2.4.3.3.   
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Table 5-1: Primer pairs and optimal annealing temperatures used to amplify partial or full-
length coding sequences of bovine and ovine MR1.   
Target Sequence Forward 
5‟ sequence 3‟ 
Reverse 



































PCR to assess 
splice-variant 
structure:  
   
 
(i) 5‟ Untranslated 




























* These primers were made available by Dr Ildiko van Rhijn, University of Utrecht, during the 
course of this project.   
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5.2.4 Analyses of PCR products  
DNA from PCR products was either purified directly (see section 2.4.3.5) or 
following extraction from bands in agarose gel (2.4.3.4).  The DNA was cloned into 
pGEM-T Easy vector and used to transform Promega JM109 high efficiency 
competent cells (see section 2.4.4).  Transformed E. coli colonies were selected on 
the basis of antibiotic resistance and absence of beta galactosidase, and tested by 
PCR using either pGEM-T Easy primers, T7 and SP6, or primers specific to the 
insert.  Colonies of interest were grown overnight in LB medium and plasmid DNA 
extracted (see section 2.4.1.3).  Sequencing of plasmid DNA from single clones was 
performed by DBS Genomics, Durham University, UK (section 2.4.3.6).   
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5.3 Results 
5.3.1 Amplification of multiple bovine MR1 transcripts 
Genomic and mRNA sequences of human and murine MR1 were used to search the 
NCBI online bovine gene databases, using the basic local alignment search tool, 
BLAST.  A bovine expressed sequence tag (EST) which matched these was 
identified via NCBI Entrez Nucleotide; this showed >80% nucleotide identity to the 
5‟ end of human and murine MR1 sequence, and was taken to represent partial 
bovine MR1 sequence.  Cross-species comparison showed this sequence to represent 
leader, α1, and α2 exons, as well as a short part of the α3 exon (see figure 5-1 for 
representative diagram).  This sequence was compared to the NCBI Nucleotide 
bovine and ovine gene databases using the website‟s Discontiguous MegaBLAST 
tool.  No matches were detected in either Ovis aries (EST) or (other) databases.  
However, a large number of positive matches were found in Bos taurus databases – 6 
expressed sequence tags (EST), 22 whole genome shotgun (WGS) sequences, and 7 
„other‟ genes.  Of these, six WGS, four EST, and 3 „other‟ gene matches bore close 
identity to bMR1.  Eight of these closely matched the partial 5‟ bMR1 sequence and 
included additional 5‟ untranslated sequence, while four also contained sequence 
with close identity to the hMR1 and mMR1 α3 and trans-membrane (TM) exon 
sequences.  One of these sequences, 963575, also included a segment corresponding 
to hMR1 and mMR1 cytoplasmic domain (73% and 58%, similarity respectively) 
and included a stop codon.   
 
 
Chapter 5: Molecular Cloning and Characteristics of Ruminant MR1 
Characterisation of Mucosal Associated Invariant T-cells and MR1 in Ruminants 141 
 
Figure 5-1: Schematic representation of MR1 sequence organisation.  A bovine expressed 
sequence tag which showed a high level of similarity to human and murine MR1 was composed 
of leader, α1, α2, and a small section of α3 exons.  L: Leader; TM: Transmembrane exon; Cyt: 
Cytoplasmic „tail‟.   
 
Sequence from Bos taurus gene matches to MR1 (963575 and 
KN510_9508b20.p1km13F, NCBI accession numbers: CK774785 and FE016126) 
were combined with known bMR1 data to assemble a putative full-length bovine 
MR1 sequence.  This sequence shared a high level of nucleotide identity to human 
and murine MR1 (76-88% in extracellular regions), and blast-searches within a 
preliminary assembly of the bovine genome database (Btau_3.1) using NCBI 
BLAST revealed an exact match within NW_001501825.1/BtUn_WGA3152_3.  
However, no match was made to the cytoplasmic domain, indicating that this part of 
the gene was missing from the genome assembly.  (Full analysis of MR1 location 
within the Bos taurus genome is provided in section 5.3.3) 
This putative bovine MR1 gene sequence was used to identify sites within the 
untranslated regions for location of PCR primers to amplify the full-length MR1 
coding region.  Primers “bovineMR1f” and “bovineMR1r”, designed within the (5‟) 
and (3‟) untranslated regions, respectively, were tested on cDNA from bovine and 
ovine PBMC.  Products were obtained in PCRs utilising a range of annealing 
temperatures.  Several bands were visible in agarose gels.  Bovine cDNA yielded 
products of 1100bp and 900bp, the former corresponding to the predicted full-length 
MR1 sequence, as well as a less abundant product of 650bp and some smaller weaker 
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products.  The ovine PCR produced a range of smaller, less well defined bands, at 
850bp, 725bp, 550bp, 320bp and 280bp.   
 
 
Figure 5-2: Agarose gel showing consistent amplification of multiple PCR products from bovine 
and ovine PBMC cDNA using primers boovMR1f/r at a range of annealing temperatures.  
Sterile distilled water was used as a PCR negative control.  Bands excised from the gel for 
sequencing are shown by red asterisks.   
 
Previous publications (Riegert et al. 1998) had identified a number of alternatively-
spliced forms of human and murine MR1 of varying length. To determine whether 
the multiple PCR bands obtained from cattle and sheep also represented alternatively 
spliced transcripts, DNA was extracted from each distinct band (bovine: 1100bp, 
900bp, 650bp; ovine: 850bp, 725bp, 550bp), and cloned into pGEM-T Easy vector.  
Sequencing of cloned inserts confirmed that the 1100bp bovine product shared 100% 
homology with the putative sequence assembled from EST and genome partial 
sequences, thus confirming the full-length bovine MR1 sequence.  Sequences 
obtained from clones containing the 900bp and 650bp inserts were found to represent 
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different splice variants of bovine MR1.  These sequences were missing either the α1 
(900bp), or the α1 and α3 (650bp) exons, and are discussed further in section 5.3.5.  
Bovine MR1 sequence data is provided in Appendix D.  Sequence data obtained 
from clones containing ovine products were of poor quality, and did not demonstrate 
any similarity to bovine MR1 sequence, suggesting that these did not represent ovine 
MR1.   
During these experiments, communication with Dr. Ildiko Van Rhijn, University 
Utrecht, Netherlands, revealed that she was investigating MR1 and had designed a 
different set of primers, iboMR1f and iboMR1r, for bovine MR1 based over the 5‟ 
start codon and 3‟ stop codon, respectively.  These primers were compared to the 
original bovine MR1 primer pair MR1f/r on cDNA extracted from PBMC of three 
different cattle.  Results demonstrated marked differences between animals in both 
the intensity and number of products obtained with the two sets of primers – 
bovineMR1f/r produced multiple bands including the predicted full-length sequence 
from PBMC of animals 216 and 481, but no product from animal 002; in contrast, 
iboMR1f/r produced two strong products from animal 002, representing full-length 
MR1 and the splice variant missing the α1 exon, but weaker products from animals 
216 and 481 (see figure 5-3).  This experiment was repeated with similar results. 
Sequencing of the prominent bands (1100bp and 900bp) confirmed that the products 
obtained with both primer pairs represented MR1 and had identical nucleotide 
sequences.  These results suggest that there may be sequence polymorphism between 
animals in one, or both, of the primer sites in the untranslated regions used by the 
bovine MR1f/r PCR (bovineMR1f, for example, is >50bp from the initiation codon).  
However, no differences were detected between sequences from different animal 
PCRs in the short pieces of untranslated sequence amplified by this set of primers.   
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Figure 5-3: Comparison of PCR products obtained from bovine PBMC cDNA using two pairs of 
primers (bovineMR1f/r and iboMR1f/r) designed to amplify the full-length coding region of 
bovine MR1.  Sterile distilled water was used as a negative control for PCR.  A similar result 
was obtained when the experiment was repeated.   
 
5.3.2 Amplification of multiple ovine MR1 transcripts 
PCRs using primer pair bovineMR1f/r failed to amplify full-length products of the 
predicted size from sheep cDNA. Comparison of human, murine and bovine MR1 
sequences demonstrated that the α2 region was most highly-conserved between 
species.  A pair of primers based on conserved segments within the MR1 α2 region 
was therefore designed and tested on cDNA from ovine PBMC.  cDNA from bovine 
PBMC was used as a positive control.  These primers, “boovMR1f2” and 
“boov(n)MR1r”, produced a single product of the anticipated size from both species 
(see figure 5-4). Sequencing of the products confirmed that the bovine product bore 
100% identity to the previously obtained sequence, and the ovine product was 95% 
identical to bovine, confirming that it represented ovine MR1 α2 region.   
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Figure 5-4: Agarose gel showing products amplified from ovine and bovine PBMC cDNA using 
primers boovMR1f2/boov(n)MR1r located in the α2 region of MR1.  These bands were excised 
and sequenced to confirm that they represented ovine and bovine MR1, respectively.  Sterile 
distilled water was used as a negative control for the PCR.   
 
No Ovis aries gene matches to human MR1 nor murine MR1 had been detected in 
initial searches of gene databases.  The partial ovine MR1 α2 sequence, as well as the 
full-length bovine MR1 sequence, was used to search the ovine gene database using 
a discontiguous BLAST search on the NCBI website.  Three almost identical positive 
matches were found in Ovis aries (EST) (NCBI accession numbers: EE793373, 
DY502438, EE859755); a high level of similarity to bovine MR1 5‟ untranslated, 
leader, α1, α2 and α3 region sequence was demonstrated, although all sequences 
stopped in the α3 region.  To confirm the presence of these sequences in sheep, a 
forward primer sited in the 5‟ untranslated region, and reverse primer sited in the α3 
exon (“ovMR1f”/”ovMR1r”), were designed from the EST sequences and tested on 
ovine PBMC cDNA.  Following optimisation of the PCR protocol, three bands of 
650, 400 and 200 bp were obtained (figure 5-5).  Sequencing of the two largest bands 
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showed that they had >95% similarity to bovine MR1 and were truncated in the α3 
region at the site of the reverse primer; the smaller product was missing the α1 region 
(L, α2, start α3).  As with cattle, these data suggested the presence of ovine MR1 
splice variants (see section 5.3.5).   
 
 
Figure 5-5: Agarose gel of PCR products amplified at two different annealing temperatures 
from sheep cDNA using primers ovMR1f/ovMR1r located in 5‟ untranslated and α3 regions, 
respectively, of Ovis aries database EST genes identified using BLAST searches of known ovine 
MR1 α2 region sequence.  Sterile distilled water was used for PCR negative controls.   
 
At this point in the studies, the bovine primers iboMR1f and iboMR1r, based over 
the 5‟ start codon and 3‟ stop codon of bovine MR1, were made available by Dr 
Ildiko van Rhijn (see section 5.3.1, above).  These primers were tested at a range of 
annealing temperatures (Tm:60°C-64°C) for their ability to amplify the full-length 
coding region of ovine MR1 from ovine cDNA.  Again, cDNA from bovine PBMC 
was used as a positive control.  Primers iboMR1f and iboMR1r produced two clear 
bands of 1100bp and 900bp at Tm:60°C, the former corresponding to the expected 
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full-length product (figure 5-6), similar to those obtained previously from bovine 
cDNA.  Sequencing of cDNA clones derived from DNA extracted from the gels 
confirmed that the 1100bp product contained the full coding region of ovine MR1, 
which bore 100% similarity to the previously obtained partial ovine sequences and 
>94% similarity to bovine MR1.   Sequence data from clones containing the 900bp 
insert were shown to represent an ovine MR1 splice variant missing the α1 exon.  
The full coding region sequence of ovine MR1 was deposited in the GenBank 
database of the NCBI (http://www.ncbi.nlm.nih.gov) with the accession number 
FJ423039.  Ovine MR1 sequence data is provided in Appendix D.   
 
 
Figure 5-6: Agarose gel showing PCR products amplified at different annealing temperatures 
from bovine and ovine PBMC cDNA using primers iboMR1f/r.  Sterile distilled water was used 
as a PCR negative control.  DNA from the two circled bands of product from ovine PBMC at 
Tm:60°c were extracted, cloned and sequenced, and confirmed to represent full coding sequence 
of MR1, and an MR1 splice variant missing the α1 exon.   
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5.3.3 Identification of genome location and exons of bovine and 
ovine MR1  
In humans and mice, the MR1 gene is located in paralogous regions of the respective 
genomes in close proximity to other non-classical class I genes.  In humans this 
includes the CD1 family, and the iNKT cell restriction element CD1d.  Similarly, 
while the bovine MHC is located on chromosome 23, searches within the current 
assembly of the bovine genome (Btau_4.0, available at www.ensembl.org) showed 
that MR1 sequence maps to chromosome 16 (L: 59794055-109; α1: 59783103-363; 
α2: 59782169-444; α3: 59780867-1142; TM: 59780158-260).  This is sited between 
the bovine syntaxin 6 gene (Accession number: NP_001075900.1), at 59.71-
59.76Mb, which functions in trans-Golgi network vesicle trafficking, and the nuclear 
protein immediate-early-response 5 gene (IER5) at 59.83Mb.  Another identified 
bovine gene (Acc: IPI00694315), noted as „similar to xenotropic and polytropic 
murine leukaemia virus receptor‟, is sited nearby at 59.56-59.63Mb.  Comparison to 
the corresponding region of both the human genome on chromosome 1q25 and 
murine genome on chromosome 1G3 shows a similar location of MR1, between the 
syntaxin 6 and IER5 genes.  However, in contrast to humans but similar to mice, the 
latest assembly of the bovine genome has mapped the bovine CD1 family to a 
different chromosome, chromosome 3: boCD1a (DQ192541) at 13.13Mb; boCD1b3 
(DQ192542) at 12.85Mb; boCD1d psuedogene (DQ192544) at 13.19Mb. Thus, the 
bovine MR1 gene and the CD1 gene family appear to be located on different 
chromosomes.   
Table 5-2: Genomic locations of the MHC locus and MR1 and CD1 genes in different species.   
Class I MHC and 
MHC-like genes: 
Chromosomal Location 
Human Murine Bovine 
MHC locus 6 17 23 
MR1 gene 1q25 1G3 16 
CD1d gene         1q23 3F1 - 
CD1 family 1q22-23 3 3 
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Human and murine MR1 genes demonstrate „type I splicing‟ where each domain 
starts with a composite codon whose first nucleotide is contributed by the previous 
exon (Riegert et al. 1998).  Comparison of bovine MR1 sequence to bovine genomic 
data enabled identification of distinct MR1 exon sequences, and indicated that these 
also exhibit type 1 splicing.  The different exons of bovine MR1 are shown in 
Appendix E.  Intron/exon boundaries for sheep are likely to be the same as for cattle, 
because of the high level of similarity between these species‟ MR1 sequences.   
 
5.3.4 MR1 is highly conserved between species 
Full-length sequences of the coding regions of ovine, bovine, human and murine 
MR1 were compared at the nucleotide and amino acid level; results are shown in 
table 5-3.  The most striking feature of the data is the high level of sequence 
conservation in the α1, α2 and α3 gene/protein segments (over 75% and up to 97%), 
which form the extracellular part of the mature protein.  In contrast, the leader, 
transmembrane and cytoplasmic regions show rather low levels of similarity between 
the species (>55%).  Bovine and ovine MR1 sequences exhibited a remarkably high 
level of nucleotide similarity, which was always >94% in all exons.  The α2 region 
amino acid identity was particularly well conserved at >84% between all species.   
Table 5-3: Levels of nucleotide similarity and amino acid identity between species of different 
segments of the MR1 gene/protein.   















Ov.:Bov. 100%/100% 97% / 97% 95% / 91% 96% / 91% 94% / 88% 95% / 83% 
Ov.:Hum. 82% / 74% 84% / 83% 88% / 87% 83% / 73% 79% / 71% 75% / 50% 
Ov.:Mur. 76% / 58% 79% / 78% 86% / 87% 75% / 68% 58% / 47% 55% / 25% 
Bov.:Hum. 82% / 74% 83% / 82% 88% / 87% 84% / 75% 80% / 71% 73% / 42% 
Bov.:Mur. 76% / 58% 78% / 77% 86% / 84% 76% / 72% 58% / 47% 58% / 17% 
Hum.:Mur. 73% / 53% 86% / 90% 87% / 89% 82% / 72% 64% / 50% 65% / 25% 
Ov: ovine; Bov: bovine; Hum: human; Mur: murine.  TM: transmembrane; Cyt: cytoplasmic.   
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Figure 5-7: Comparison of the amino-acid sequences of MR1 from different species.  Different 
gene/protein segments are indicated; TM: transmembrane; Cyt: cytoplasmic tail.  Identical 
codons between species are identified by a dot, and missing codons by a dash.  (Cross-species 
comparison of full nucleotide sequences are shown in Appendix D).   
 
5.3.5 Analyses of alternatively-spliced variants of MR1   
Further analysis was conducted on the splice variants of bovine and sheep MR1 
described above, namely the 900bp products from cattle and sheep (named 
boMR1.900 and ovMR1.900 - NCBI GenBank accession numbers FJ423041 and 
FJ423042), and the 650bp cattle product (named boMR1.650 - NCBI GenBank 
accession number FJ423040).  These alternatively spliced forms are summarised in 
figure 5-8 and compared with previously described human and mouse splice variants.  
Identification of the genomic exon sequences confirmed that the sequences missing 
from boMR1.900, ovMR1.900 and boMR1.650 corresponded exactly to the complete 
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α1 exon for the former and the α1 and α3 exons for the smaller cDNA.  The 
corresponding ends of bordering exons were joined by type 1 splicing, as for the full 
length gene.  These sequences did not contain internal stop codons and retained the 
original reading frame.  Hence, they potentially can generate truncated forms of the 
MR1 protein.  Full nucleotide sequences for each bovine and ovine splice variant are 
provided in Appendix F.   
Following the initial discovery of multiple MR1 transcripts in bovine PBMC, the 
existence of MR1 splice variants was confirmed by testing reverse and forward 
primers based in the α2 exon (boMR1a2-r1/r2 and boMR1a2-f1/f2), in combination 
with a forward primer in the 5‟ untranslated region (bovineMR1f) or a reverse primer 
in the 3‟ untranslated region (bovineMR1r), on bovine PBMC cDNA.  Each PCR 
produced two products of anticipated size (600 and 300bp, and 700 and 400bp, 
respectively), representing full MR1 and a form missing either the α1 or α3 exon 
(data not shown).   
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Figure 5-8: Diagrammatic representation of alternatively spliced transcripts of bovine and ovine 
MR1 compared with splice variants previously described in humans and mice (Riegert et al. 
1998).  The presence of a stop codon is indicated by an asterisk.   
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Additional results have demonstrated the potential for other splice variants of MR1.  
In experiments to study MR1 expression (see chapter 6), cloning of full-length 
bovine MR1 into vector, and sequencing of multiple inserts, revealed one clone 
(from four) with missing sequence in the α3 exon.  A discrete 87bp of sequence 
extending from the 5‟ intron/exon junction of α3 to the middle of the α3 exon (bp593 
to bp680) was excluded, although sequencing data on either side was 100% identical 
to the anticipated full MR1 sequence (see Appendix G for nucleotide sequence).  
Sequencing of the plasmid DNA was repeated on two occasions with matching 
results.  This deletion also did not alter the open reading frame of the sequence, or 
result in any internal stop codons, suggesting the ability to produce potentially 
functional protein.   
 
 
Figure 5-9: A further splice variant of bovine MR1 identified by subcloning of cDNA thought to 
represent full MR1 transcripts.  Clone (#10) contained an MR1 transcript with a shortened α3 
region, missing a 90bp sequence, but retaining an open reading frame.  
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5.4 Discussion 
Orthologous MR1 genes have been detected in a number of species, including 
humans, primates, mice and rats.  The work described in this chapter identified the 
full sequences for the coding regions of bovine and ovine MR1, and demonstrated a 
high level of sequence conservation between species.  A number of abundant 
alternatively-spliced variants of MR1 were also detected in both cattle and sheep.  
Additionally, the genomic location of MR1 was identified as being within a 
paralogous region of the bovine genome but on a different chromosome than CD1.   
Prior to this study, MR1 had not been identified in ruminants.  Human and murine 
MR1 sequences were used to search online bovine and ovine sequence databases 
and, using a combination of EST and genomic partial sequences, PCR primers were 
designed to amplify fragments and eventually the full coding regions of bovine and 
ovine MR1.  These data confirmed that MR1 is highly conserved between 
mammalian species.   
Bovine MR1 was mapped to Bos taurus chromosome 16 (BTA16).  Although the 
MR1 sequence in the genome is incomplete, the available data indicate that it has an 
intron-exon structure similar to that seen in other species, including a large intron 
between the first two exons (Yamaguchi et al. 1998).  The genomic location of 
bovine MR1 and the identity of the adjacent genes indicate that it occupies a region 
paralogous to the genomic regions of mice and humans containing MR1.  
Additionally, the upper third of BTA16 has been shown to correspond to murine 
chromosome 1, where murine MR1 is located (Schmutz et al. 2001).  Although a 
majority of the gene sequences located near the site of MR1 on BTA16 have yet to 
be fully identified, the adjacent genes to MR1 were identified as syntaxin 6 and 
IER5, and these are also the adjacent genes to MR1 on human chromosome 1q25 and 
murine chromosome 1G3.   
There is evidence that class I MHC-like genes in humans are clustered in at least two 
of four MHC paralogous regions of the genome and it has been proposed that these 
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represent ancient duplication events (Shiina et al. 2001; Abi-Rached et al. 2002).  
The region (1q21-25) of human chromosome 1 which contains MR1 and the CD1 
family of genes has been shown to contain a significant number of other 
immunological genes, including SPTA1, MNDA, IFI-16, AIM2, BL1A, FY and 
FCERIA (Shiina et al. 2001).  It is interesting to note that the majority of these react 
with lipids/glycolipids, as has been hypothesised for MR1 (Shimamura et al. 2007), 
prompting the suggestion that the genes within this region represent a gene cluster 
dedicated to processing and presentation of lipid/glycolipid antigens.   
BTA16 has been identified to contain four evolutionary breakpoint regions (EBR) 
which are specific to the ferungulata cohort, suggesting that the chromosomal 
regions were rearranged before divergence of the Artiodactyla and Carnivora, and 
thus have probably been retained in the ancestral form within the human genome 
(The Bovine Genome Sequencing and Analysis Consortium et al. 2009).  However, 
although both MR1 and the CD1 family of genes both map to the paralogous region 
of human chromosome 1, the identified bovine CD1 genes map to a different area of 
the Bos taurus genome from MR1, at chromosome 3.  This is similar to the situation 
in mice where MR1 is located on chromosome 1 but the CD1 family of genes is 
located on chromosome 3 (Moseley et al. 1989).  This contradicts the proposal that 
these genes remain closely linked because of their functional relatedness.  The 
separate chromosomal location of the bovine CD1 genes confirms that further 
breakpoints have occurred in bovine chromosome 16 subsequent to divergence of 
Artiodactyla and Carnivora (as suggested by Womack and Moll 1986; Womack and 
Kata 1995).   
Comparison of MR1 coding sequences identified a high level of sequence 
conservation between species.  The combined α1 and α2 domains of bovine MR1 
showed 81% and 85% amino acid identity to murine and human MR1 respectively; 
the murine and human sequences were 90% identical.  This compares with 73% 
identity for the corresponding domains of bovine and human CD1b, and 61% for 
murine and human CD1d.  Overall, the most striking aspect of these comparisons 
was the high level of conservation of the sequences encoding the extracellular 
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domains of the protein (α1, α2 and α3), in comparison with the leader, 
transmembrane and cytoplasmic regions, which in some cases show very low levels 
of conservation.  This suggests evolutionary pressure to conserve the extracellular 
structure of the protein.   
Although the way in which MAIT cells interact with MR1 has not been defined, the 
likely interaction can be inferred from knowledge of how conventional T-cells 
recognise classical class I MHC, where the CDR loops of the TCR chains interact 
with the α-helices of the peptide binding groove and with residues in the bound 
peptide protruding from the groove (Garboczi et al. 1996; Garcia et al. 1998).  The 
α1 and α2 domains make up the binding groove, and these are highly polymorphic in 
classical class I proteins to provide the capacity to bind a large variety of TCRs.  The 
high degree of conservation of MR1 between species suggests that it may bind a 
conserved ligand, or set of ligands.  Currently, the chemical nature of the MR1 ligand 
is unknown.  It is likely that, like other ligand binding class Ib molecules, MR1 binds 
both exogenous and endogenous ligands; however, although MAIT cells have been 
shown to be activated in vitro by a synthetic glycolipid (Okamoto et al. 2005), 
molecular modelling of the α1/α2 regions suggests that they are hydrophilic and 
more similar to classical class I molecules than the lipid-binding CD1 molecules 
(Riegert et al. 1998).   
Cross-species conservation of MR1 is consistent with the highly-conserved nature of 
the CDR sequences of the MAIT TCRα chain between species.  During antigen-
presentation to conventional αβ T cells, the α2 domain of classical class I MHC 
molecules interacts with the α chain of the cognate TCR, in a process which mediates 
the interaction and orientation of TCR-MHC binding (Garboczi and Biddison 1999; 
Garcia et al. 1999).  If the MAIT TCR interaction with MR1 adopts a similar 
orientation, the MR1 α1 domain, which although less so is also highly conserved 
between species, would be expected to interact with the CDR1and CDR2 of the 
MAIT TCRβ.  MAIT TCRs have an oligoclonal Vβ repertoire and utilise 
predominantly Vβ2 or Vβ13 in humans, and Vβ6 or Vβ8 in mice; however, MAIT 
TCRVβ chains show no restriction in Jβ usage or CDR3 length (Tilloy et al. 1999).  
Chapter 5: Molecular Cloning and Characteristics of Ruminant MR1 
Characterisation of Mucosal Associated Invariant T-cells and MR1 in Ruminants 157 
The restricted nature of the MAIT Vβ repertoire may be important with regard to the 
ability of MAIT cells to interact with the MR1 α1 domain.  Also, by inference from 
TCR-classical class I structure, diversity in the CDR3 of the β chain would allow 
some flexibility for recognition of different MR1-bound ligands.  The MR1 α3 
domain is not involved in ligand binding but interacts with β2-microglobulin.  
Hence, there may be less selective pressure for conservation of this region, and 
indeed, since β2M shows some variation in sequence between species, some of the 
variation in α3 sequence may be related to differences in the sequence of β2M.   
A striking feature of the analysis of MR1 transcripts in both cattle and sheep was the 
detection of an alternatively-spliced variant lacking the α1 exon; this was highly 
abundant both in PBMC and in several bovine cell lines (see section 6.3.1).  A 
second less abundant transcript, which lacked both the α1 and α3 domains, was also 
identified in cattle.  Confirmation of MR1 splice variant structure was made through 
use of additional PCR primers based within the α2 exon.  A number of alternatively 
spliced variants of MR1 have also been described in humans and mice (Riegert et al. 
1998).  Although many of the splice variants in the mouse also had disrupted α1 
domains, these mouse variants retained a small part of the α1 exon; however, these 
all contained aborted open-reading frames.  By contrast, the two human MR1 
variants which maintained an open-reading frame exhibited omission of the α3 exon.  
This current study also revealed an additional cattle transcript with in-frame 
disruption of α3 domain sequence, which may represent a further potential splice 
variant of bovine MR1.  A number of the human and murine splice variants display 
differences in the length of the 3‟ untranslated region sequence, and preliminary data 
in cattle suggests that further splice variants may also exist in this species dependent 
on 5‟ untranslated sequence length.   
A consistent feature of the abundant MR1 splice variants is that they retain an intact 
α2 exon.  Both of the ruminant splice variants retained the original reading frame and 
would be predicted to encode polypeptides with intact transmembrane and 
cytoplasmic domains, although they are unlikely to retain any function in relation to 
presentation to MAIT cells.  However, given the abundance of the α1-deleted 
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transcript in ruminants and the evidence that surface expression of MR1 may be 
tightly regulated, it is possible that the product of this splice variant is somehow 
involved in regulating surface expression of the intact protein.  Current data indicate 
that MR1 is transported through the endoplasmic reticulum and Golgi apparatus to 
endosomal compartments, where it has been suggested that it acquires a ligand 
(Huang et al. 2008).  If indeed the splice variants have some functional role, the 
consistent retention of α2 may suggest that this domain is required for endosomal 
targeting.   
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6 Analysis of Bovine MR1 Expression 
6.1 Introduction 
MR1 shows similarity in sequence and protein structure to classical class I MHC 
proteins.  The extra-cellular portion of the MR1 heavy chain consists of three 
domains, α1, α2 and α3, two of which (α1, α2) form a groove bounded by α-helices 
into which a ligand is believed to bind.  The α3 domain, which adopts an 
immunoglobulin fold structure, associates with the light chain, beta-2-microglobulin 
(β2M).  Analysis of MR1 RNA expression by Northern blotting and rtPCR has 
demonstrated ubiquitous expression in a variety of human and murine tissues, as well 
as in human cell-lines of different lineages.  Full-length as well as truncated 
alternatively spliced transcripts of MR1 were observed in all cell-lines and tissues 
tested (Hashimoto et al. 1995; Yamaguchi et al. 1997; Riegert et al. 1998).   
Despite the ubiquitous expression of MR1 transcript, cell surface expression of the 
protein has not been demonstrated in vivo, and has been difficult to achieve in cells 
transfected with the MR1 heavy chain in vitro.  Cell surface expression has been 
shown to be dependent on β2M (Yamaguchi and Hashimoto 2002; Huang et al. 
2009).  However, sequence analysis has suggested that MR1 lacks the 
phylogenetically-conserved motifs implicated in β2M association with classical class 
I molecules, and therefore is predicted to have a weaker association with β2M (Miley 
et al. 2003).  Most cell-lines transfected with MR1 cDNA express the protein 
intracellularly, but low levels or in some cases no MR1 is expressed on the cell 
surface.  Recent evidence shows that, like CD1d, MR1 is transported from the Golgi 
to the endosomal compartment, and only limited amounts of the protein reach the 
cell surface from there (Huang et al. 2008).  Hence, these observations suggest that 
MR1 is dependent on endogenous ligand for surface expression and that this may be 
acquired within the endosomal compartment.  Since peripheral expansion of MAIT 
cells is dependent on the presence of a commensal gut flora (Treiner et al. 2003), it 
has been hypothesised that gut micro-organisms may either provide exogenous 
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ligands or induce endogenous ligands for MR1, or induce translocation of MR1 to 
the cell surface via a cellular „stress‟ signal (Hansen et al. 2007).   
Previous studies of cells transfected with the murine MR1 heavy chain showed that 
replacement of the α3, transmembrane (TM) and cytoplasmic (Cyt) domains of 
murine MR1 with the corresponding domains of a classical class I molecule (murine 
L
d
) increased levels of cell-surface expression (positive cells increasing from 10% to 
26% of the transfected mouse L cells) (Miley et al. 2003).   
The aims of the studies described in this chapter were, firstly to determine whether 
the levels and type of MR1 transcript expressed varies between bovine cell lines 
belonging to different leucocyte lineages, and secondly to prepare constructs to study 
in vitro expression of MR1 in transfected cells.  The latter was undertaken to provide 
eukaryotically expressed protein to examine potential cross-reactivity of antibodies 
raised against MR1 in other species and with the eventual aim of investigating the 
factors that influence cell surface expression of the protein.   
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6.2 Materials and Methods 
6.2.1 Bovine cell lines and PCR for MR1 transcripts 
Generation and maintenance of cell-lines are described in section 2.3.1.4.  Cell lines 
used were: BL20, a lymphoma cell line believed to be of B-cell origin; 592TPM, a 
B-cell line infected with T. parva; 663TA/B, a B-cell line infected with T. annulata; 
592TAA and 663TA, monocyte cell lines infected with T. annulata; 109TPM, a CD8 
T-cell line, 158TPM, a T-cell line of mixed CD8/γδ phenotype, and 951TPM, a γδ T-
cell line, were all infected with T. parva.  A further two cell lines of undefined 
phenotype infected with T. annulata and T. parva respectively, were also used.  RNA 
was extracted from cell-lines using Tri-Reagent (see section 2.4.1.1) and reverse-
transcribed to cDNA (section 2.4.2.1).  The PCR protocol for detection of MR1 
transcripts in cell-lines was as described in section 2.4.2.2: this utilised primer pairs 
“bovineMR1f” / “bovineMR1r” and “iboMR1f” / “iboMR1r”, using melting 
temperatures of 58°C and 60°C, respectively.  Products were analysed by 1.5% 
agarose gel electrophoresis (section 2.4.3.3).   
 
6.2.2 Classical MHC class I in pcDNA3.1 / V5-His TOPO TA 
expression vector 
Plasmid DNA from a bovine classical MHC class I (N*02401) transformed into the 
TOPO TA expression vector was provided by Dr. Jane Hart, University of 
Edinburgh.  This had been previously demonstrated to be transfectable and 
recognised by a number of class I-specific monoclonal antibodies (Ellis et al. 1996), 
and was used as a positive control for the transfection reaction and analysis of MR1 
protein expression.   
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6.2.3 Preparation of cDNA constructs for incorporation into the 
pFlag-CMV-3 vector 
Full MR1 coding sequence, as well as a chimaera of MR1 α1 and α2 regions in 
combination with the α3, TM and Cyt regions of a classical MHC class I, were 
ligated into a pFlag-CMV-3 vector.  This vector was chosen for transfection studies 
as it contains a sequence encoding a peptide tag at the N–terminus, allowing 
detection of cell surface-expressed protein with an anti-tag antibody (M2).  The 
vector also contains a methionine start codon and „leader‟ sequence, and therefore 
primers were designed to omit this region from each insert gene during PCR 
amplification.   
6.2.3.1 Preparation of the construct containing the full coding region of 
MR1 
The full MR1 coding sequence (without the signal sequence) was amplified from 
cDNA of bovine PBMC from animal #332, with primers “fMR1f” and “fMR1r” (see 
table 6-1), using standard PCR reaction mixture (see section 2.4.2.2) but cycling 
conditions of 95°C for 10 minutes, 40 cycles of (1 minute at 95°C, 1 minute at 60°C, 
1 minute at 72°C), 10 minutes at 72°C.  These primers were designed to add HindIII 
and XbaI restriction sites to the beginning and end, respectively, of the amplified 
MR1 sequence.   
6.2.3.2 Preparation of the class I/MR1 chimaeric construct 
Bovine PBMC from an animal (cow 641) known to be homozygous for the haplotype 
carrying the N*01301 class I gene, which encodes the A18 serological specificity, 
were used as a source of cDNA to isolate the relevant segment of the N*01301 gene.  
The full coding sequence was initially isolated by PCR using primers “Bo7” and 
“Bo3-1_rev” specific for classical MHC class I sequence (see table 6-1; designed by 
Dr. Niall MacHugh, University of Edinburgh), employing standard reaction mixtures 
and cycling protocol of 95°C for 3 minutes, 5 cycles of (95°C for 1 minute, 65°C for 
1 minute, 72°C for 2 minutes), 25 cycles of (95°C for 1 minute, 55°C for 1 minute, 
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72°C for 2 minutes), 72°C for 10 minutes.  The PCR product was purified and 
subcloned into pGEM-T Easy vector (see section 2.4.4), and the N*01301 sequence 
was confirmed by sequencing at DBS genomics (section 2.4.3.6).   
The original bovine N*01301 and MR1 sequences were checked to confirm that they 
did not contain the BsiWI restriction site.  A partial MHC sequence containing the 
α3, TM and Cyt regions was PCR amplified from N*01301 DNA, with primers 
“cMHCf” and “cMHCr” (see table 6-1), using a standard PCR protocol (see section 
2.4.2.2) and Tm:70°C.  These primers were designed to add restriction enzyme sites 
BsiWI immediately before the start of the α3 region, and XBaI after the stop codon 
in the cytoplasmic tail.  A partial MR1 sequence containing the α1 and α2 regions 
was PCR amplified from bovine DNA using primers “cMR1f” and “cMR1r” (see 
table 6-1) using cycling conditions of 95°C for 10 minutes, 40 cycles of (1 minute at 
95°C, 1 minute at 62°C, 1 minute at 72°C), 10 minutes at 72°C, and standard 
reaction mixtures.  These primers added a HindIII restriction site before the α1 
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Target sequences were – Full MR1: MR1 coding sequence without the leader sequence; 
Chimaera MR1: α1 and α2 regions of MR1; N*01301: Full coding sequence of the N*01301 
gene; Chimaera MHC: α3, TM and Cyt regions of the N*01301 gene.   
 
6.2.4 Transformation of the MR1 and the MR1/MHC chimaera 
constructs into the pFlag-CMV-3 expression vector 
Products of predicted size obtained from PCR reactions were excised from agarose 
gels and further amplified by PCR, using the same primers and PCR protocols, and 
the DNA was purified (see section 2.4.3.5).  This additional step was to increase 
concentration and purity of product without the use of subcloning, since additional 
vector sequence and nucleotide fragments may have reduced the success of 
subsequent reactions.  Consensus DNA sequences were confirmed by direct 
sequencing of purified PCR product.  Vector and the full length coding sequence of 
MR1 cDNA were digested using HindIII and XbaI; the Chimaera MR1 DNA was 
digested using HindIII and BsiWI; Chimaera MHC DNA was digested using BsiWI 
and XbaI (see section 2.4.1.5).   
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Ligation reactions, transformation into JM109 competent cells, and PCR-screening 
of colonies for inserts are covered in sections 2.4.4 and 2.4.5.  Positive colonies were 
expanded overnight in LB medium and plasmid DNA extracted by either MiniPrep 
or MaxiPrep reactions (section 2.4.1.3).  Insert DNA was sequenced by DBS 
Genomics, Durham University, UK (section 2.4.3.6) and assessed for correct 
sequence and an intact open reading frame using DNASIS software (Hitachi 
Software Engineering Company, Ltd.) (see section 2.5).   
 
6.2.5 Transfection into Cos-7 cells 
Cos-7 cells were maintained and passaged as described in section 2.3.2.1.  
Transfection of plasmid DNA was performed using FuGENE HD Transfection 
Reagent (Roche Applied Science, Burgess Hill, UK) (see section 2.3.2.2).   
 
6.2.6 Analysis of protein expression 
Monoclonal antibodies used for immunofluorescence staining of transfected cells, 
and their specificities, are shown in table 6-2 (see also section 2.3.3.1, table 2-1).  
Transfected Cos-7 cells were assessed for cell surface expression using flow 
cytometry analysis (as described in section 2.3.3.2), and intracellular expression was 
examined by fluorescent microscopy of cytospin preparations and in-well adherent 
cells, which were fixed prior to staining with acetone or acetone/ethanol (see section 
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Table 6-2: Specificities of monoclonal antibodies used for primary antibody staining for protein 
expression analyses.   
Antibody Specificity 
IL-A88 Bovine MHC Ia heavy chain 
IL-A19 Bovine MHC Ia in association with β2M 
MR1 26.5 Human MR1 
W6-32 Human MHC Ia  
and some bovine MHC Ia alleles 
JG-9 Bovine β2M 
BG10 Bovine β2M 
M2 pFlag-CMV-3 Vector tag 
 
Aliquots of monoclonal antibody 26.5 in the form of hybridoma supernatant were 
provided by Ted Hansen, Washington University School of Medicine, Missouri, 
USA.  Supernatant was used undiluted in all analyses. Antibody 26.5 had been 
produced in mice against soluble human MR1/β2M molecules secreted from 
transfected insect cells (Miley et al. 2003; Huang et al. 2005).  This antibody had 
previously been reported to detect, with varying affinity, surface expression of 
transduced mouse, rat, human and bovine MR1 on human and murine cell lines, 
following their transduction into these cell lines using a recombinant retrovirus 
system (Huang et al. 2009).   
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6.3 Results 
6.3.1 Bovine MR1 is abundantly transcribed in different bovine 
cell lineages 
The protozoan parasites T. parva and T. annulata infect and transform different 
lineages of leucocytes, the former T and B lymphocytes and the latter B lymphocytes 
and monocytes.  The availability of a series of Theileria-transformed cell lines 
representing these different lineages, including different subsets of T cells, provided 
an opportunity to investigate whether expression of MR1 differed according to cell 
lineage.  Transcription of MR1 was assessed by PCR.  Initial experiments utilised 
single T. parva-transformed and T. annulata-transformed lines of unknown 
phenotype and a bovine lymphoma cell line, BL-20.  Initial testing of two primer 
pairs “bovineMR1f/r” and “iboMR1f/r”, which had had previously been shown to 
give different results with PBMC from different cattle, showed that the primers 
“bovineMR1f/r” produced only weak product and demonstrated poor amplification 
in all reactions.  However, primers “iboMR1f/r” produced abundant product of the 
expected size for the full MR1 coding region from all 3 cell lines and PBMC cDNA 
(Figure 6-1); a weaker band corresponding in size to the previously described MR1 
splice variant missing the α1 exon was observed in the 3 cell-lines, but not in the 
PBMC cDNA.   
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Figure 6-1: Expression of multiple transcripts of MR1 (1100bp, 900bp) in two cell-lines of 
unknown phenotype derived from bovine PBL and infected with either Theileria parva or T. 
annulata (T.p.-inf‟d and T.a.-inf‟d, respectively), and a bovine lymphoma cell-line (BL20), in 
comparison to PBL, and a PCR negative control of sterile distilled water.  Two different primer 
pairs (“bovineMR1f/r” and “iboMR1f/r”) were used to amplify MR1, and assessed in 
comparison to the amplification of the housekeeping gene, G3PDH (420bp).   
 
To investigate the effect of cell lineage on MR1 expression, seven cell lines 
transformed with T. parva or T. annulata, representing T cell, B cell and monocyte 
lineages, were examined by PCR using primers “iboMR1f/r”.  The results shown in 
figure 6-2 demonstrated abundant amplification of the full coding region of MR1 
product from all seven cell-lines, and less abundant amplification of smaller product 
corresponding to the MR1 splice variant lacking α1 (see figure 6-2).  Amplification 
was performed using equal amounts of cell-line cDNA, and was compared to the 
housekeeping gene, G3PDH.  MR1 product amplified from B-cell lines was more 
abundant than that from monocyte or T cell lines.  There was no apparent association 
with the animal from which the cell line was derived, since the same two animals 
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were each the source of a B cell line and a monocyte cell line.  Moreover, the three T 
cell lines, which were derived from different animals (and represented different T 
cell lineages), gave similar PCR products.   
 
 
Figure 6-2: Ubiquitous expression of full MR1, and an MR1 splice variant, in specific bovine 
leucocyte cell-lines infected with Theileria spp..  B-cell and monocyte cell-lines were isolated 
from the same two animals, 592 and 663; T-cell lines were phenotyped by flow cytometry as 
pure CD8
+
 (109), pure γδ
+




 (158) T-cell subpopulations.  MR1 was 
amplified using primers “iboMR1f/r”, and assessed in comparison to amplification of the 
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6.3.2 Generation of MR1 and MR1/MHC chimaeric constructs for 
incorporation into a 5’-tagged expression vector 
The pFlag-CMV-3 expression vector was used to study expression of MR1 in 
transfected cells because it encodes a tag on the 5‟ end of the protein that allows both 
intracellular and cell surface detection of expressed protein using a tag-specific 
antibody (M2).  Since previous studies in mice showed that grafting of the α3, 
transmembrane and cytoplasmic domains of a classical class I gene onto the α1 and 
α2 domains of MR1 enhanced cell surface expression, a similar chimaeric construct 
was produced for the bovine gene.  The monoclonal antibody IL-A88 is specific for 
bovine classical class I heavy chain; hence, it was anticipated that this antibody 
might also be used to detect expression of the chimaeric protein.  An expression 
construct containing a classical bovine class I gene within a TOPO vector was also 
used as a positive control.   
The full length coding sequence for MR1, missing the signal sequence, was cloned, 
sequenced and inserted into the pFlag-CMV-3 vector as described in sections 6.2.3 
and 6.2.4.  The previously described protocol for preparing a murine MR1 chimaeric 
gene involved creating a BsiWI restriction enzyme site for ligating the MR1 and 
MHC segments.  Following this protocol, PCR primers for amplifying the bovine 
MR1 and MHC segments were designed to generate enzyme restriction sites and to 
retain the original amino acid sequences, but with the addition of two novel amino 
acids at the junction of the two segments (representing the BsiWI site).  Since both 
MR1 and classical class I molecules undergo type-I intron/exon splicing, where each 
domain starts with a composite codon whose first nucleotide is contributed by the 
previous exon, to avoid altering the original amino acid sequence around the BsiWI 
site it was necessary to remove a guanine nucleotide from the 3‟ end of the MR1 α2 
region, and include this at the start of the N*01301 α3 region.   
Products of the expected sizes were obtained using these primers, and consensus 
DNA sequences were confirmed by direct sequencing of purified PCR product, 
before the inserts were excised by digestion with HindIII, XbaI and BsiWI enzymes.   
Chapter 6: Analysis of Bovine MR1 Expression 
Characterisation of Mucosal Associated Invariant T-cells and MR1 in Ruminants 171 
 
 
Figure 6-3: Production of DNA segments of MR1 α1 and α2 regions (cMR1), and the α3, trans-
membrane and cytoplasmic regions of a classical class I MHC, N*01301 (cMHC).  A) Full- 
length N*01301 cDNA (MHC) amplified from bovine PBMC cDNA.  cDNA used was from an 
animal known to be homozygous for the MHC haplotype carrying this gene.  B) Amplification 
of cMR1 regions from bovine PBMC cDNA, and of cMHC regions from a subclone of the 
N*01301 gene obtained in gel A.  DNA was extracted from the bands of the correct size and re-
amplified by the same primers, and PCR product consensus DNA was confirmed by sequencing.   
 
The MR1 and N*01301 segments were added together and ligated into the pFlag-
CMV-3 expression vector in the same reaction, and the ligation product was 
transformed into JM109 competent cells.  PCR analysis of 39 colonies with vector-
specific primers showed inserts of the size expected of a chimaeric-insert in 31 
colonies.  Sequencing of the inserts in 12 of these colonies confirmed that in 5 clones 
the two components of the insert were in the correct order, that they had an intact 
open reading frame and had correct nucleotide sequences (see figure 6-4).  The 
remaining 7 clones showed one or two single nucleotide substitutions, possibly as a 
result of PCR errors.   
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Figure 6-4: A) Schematic representation of MR1/MHC chimaeric sequence (blue:MR1; 
red:MHC N*01301) and endonuclease restriction sites employed for annealing the fragments 
(BsiWI) and ligation into the vector (HindIII, XbaI).  B). Confirmation of the sequence of two 
MR1/MHC chimaera clones, B3ed and B7ed, and comparison with sequences of the fragments 
used to create the chimera, bMR1-a2 and MHC1 A18 a3.  Green highlighting indicates an exact 
match to the MR1α2 and MHCα3 sequences.  The two codons added by creating the BsiWI 
restriction site sequence CGTACG are shown (unhighlighted) at the junction of α2 and α3.  To 
ensure that this sequence did not affect the original reading frame, and since the original 
molecules both undergo type-I splicing where each domain starts with a composite codon whose 
first nucleotide is contributed by the previous exon, the guanine nucleotide at the 3‟ end of 
bMR1-a2 sequence (highlighted pink) has been moved to the 5‟ start of the chimaera α3 exon 
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6.3.3 Transfected MR1 is expressed intracellularly but not on the 
cell surface 
Cos-7 cells transfected with a classical class I gene or MR1 or the chimaeric 
construct, were stained by immunofluorescence, either as live cell suspensions or as 
fixed cells on slides or in culture plates.  Both types of preparation were analysed 
with four monoclonal antibodies: M2, specific for the vector 5‟ tag, 26.5 raised 
against human MR1, IL-A88 specific for bovine classical MHC class I heavy chain, 
and IL-A19 specific for bovine MHC class I in combination with β2M.  Transfected 
cells analysed by flow cytometry were also assessed with a further 3 antibodies: W6-
32, specific for human MHC class I heavy chain and cross reactive with some alleles 
of bovine MHC class I,  and JG9 and BG10 both raised against bovine β2M (see 
section 2.3.3.1, table 2-1).   
Since Theileria-infected cell lines were found to contain abundant MR1 transcripts, 
one of these lines (592TPM) was initially tested by flow cytometry for surface 
staining with antibody 26.5 raised against human MR1.  Antibodies IL-A88 and IL-
A19 were also tested and both were found to give strong staining of the majority of 
cells.  By contrast no surface staining was detected with antibody 26.5 (see figure 6-
5).   
 
 
Figure 6-5: Flow cytometry analyses of a Theileria-transformed cell-line stained with primary 
antibodies specific for bovine class I MHC heavy chain  (IL-A88), bovine class I MHC heavy 
chain in association with β2M (IL-A19), human MR1 (26.5), and an immunofluorescent 
secondary antibody.  A negative control was incubated with FACS medium and secondary 
antibody.   
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Analysis by flow cytometry of untransfected Cos-7 cells stained with the different 
antibodies (as a negative control) confirmed negative results for M2, 26.5 and IL-
A88.  However, the cells were weakly positive for IL-A19 (16%), and strongly 
positive for W6-32 (99%), JG9 (99%) and BG10 (95%) (see figure 6-6).  The 
intensity of staining with these antibodies on cells transfected with MR1 and the 
chimaeric MR1 was similar to that obtained with the untransfected cells.  These 
results suggest that bovine β2M within the bovine calf serum used in the cultures was 
interacting with simian MHC class I molecules on the Cos-7 cells, and that W6-32 
was able to detect simian class I MHC.   
 
 
Figure 6-6: Flow cytometry analyses of non-transfected Cos-7 cells stained with antibodies 
specific for pFlag-CMV-3 vector tag (M2), bovine MHC (IL-A88), human MR1 (26.5), bovine 
MHC/β2M (IL-A19), human MHC (W6-32), and bovine β2M (JG9 and BG10), and an 
immunofluorescent secondary antibody.  A negative control was incubated with FACS medium 
and secondary antibody.   
 
Flow cytometry analysis results of transfected Cos-7 cells are summarised in table 6-
3.  Cells transfected with a classical MHC class I showed a discrete subset of cells 
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(11%) that stained positively with IL-A88, confirming success of the transfection 
reaction and cell-surface expression.  These cells were negative for 26.5 (see figure 
6-7, A).  Cos-7 cells transfected with full MR1 did not give any detectable staining 
with IL-A88,  M2 or 26.5 (figure 6-7, B).  Cos-7 cells transfected with the 
MR1/MHC chimaera also did not stain with 26.5 or the M2 antibody, but weak 
staining of a small percentage of cells (~5%) was observed with IL-A88 (figure 6-7, 
C).   
 
 
Table 6-3: Summary of results of % positive fluorescence cells obtained from flow cytometry 
analyses of untransfected Cos-7 cells and Cos-7 cells transfected with a classical class I MHC, 
MR1, or an MR1/MHC chimaera.   
 Primary Antibodies 
Transfected Construct None M2 IL-A88 IL-A19 26.5 
Non-transfected 0.1% 0.1% 0.0% 16.2% 0.1% 
Classical Class I MHC 0.3% N/A 10.7% 14.9% 0.4% 
Full MR1 0.3% 0.7% 0.3% 31.7% 0.3% 
MR1/MHC Chimaera 0.7% 1.0% 5.0% 34.0% 0.8% 
M2 antibody was specific for the 5‟ pF3 vector tag; IL-A88 is specific for bovine MHCIa heavy 
chain; IL-A19 is specific for bovine MHCIa in association with β2M; 26.5 is specific for human 
MR1 with some reported cross-reactivity between species.  The percentage of positively staining 
cells for each antibody/construct were established by „gating‟ cells as positive and negative on 
mean fluorescence intensity of secondary antibody staining, as shown in figure 6-7.   
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Figure 6-7: Flow cytometry analyses of Cos-7 cells transfected with: A) classical class I MHC in 
a TOPO TA expression vector, B) full MR1 coding sequence, C) an MR1/MHC chimaera.  
Primary antibodies used were specific for bovine MHC α3 region (IL-A88) and human MR1 
(26.5), as well as pFlag-CMV-3 vector tag (M2); an immunofluorescent secondary antibody was 
used.  A negative control was incubated with FACS medium and secondary antibody.   
 
Results obtained with fixed cells stained by immunofluorescence and analysed by 
fluorescence microscopy are summarised in table 6-4.  Cos-7 cells transfected with a 
classical class I MHC molecule gave strong staining with IL-A88.  Those transfected 
with full MR1 demonstrated positive fluorescence of cells stained with the tag-
specific M2 antibody, but no staining with IL-A88 or the putative MR1-specific 
antibody 26.5.  Cos-7 cells transfected with the MR1/MHC chimaera stained strongly 
with M2 and also IL-A88 but were still negative for 26.5 (see figure 6-8).  These 
results indicate that IL-A88 is able to detect the MHC α3 region of the chimaera.  
They also demonstrate that both the MR1 and the MR1/MHC chimaeric constructs 
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are expressed in transfected cells but fail to detect any reactivity of the 26.5 antibody 
with bovine MR1.   
 
Table 6-4: Summary of results obtained following immunofluorescence staining of fixed Cos-7 
cells transfected with either a classical class I MHC, MR1, or an MR1/MHC chimaera.   
 Primary Antibodies 
Transfected Construct None M2 IL-A88 IL-A19 26.5 
Classical Class I MHC - NT + NT NT 
Full MR1 - + - - - 
MR1/MHC Chimaera - + + - - 
M2 antibody was specific for the 5‟ pF3 vector tag; IL-A88 is specific for bovine MHCIa heavy 
chain; IL-A19 is specific for bovine MHCIa in association with β2M; 26.5 is specific for human 
MR1 with some reported cross-reactivity between species.  Positive and negative staining were 
defined as detectable and non-detectable fluorescence of the secondary antibody, respectively.  
NT: not tested.   
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Figure 6-8: Immunofluorescence staining of fixed Cos-7 cells transfected with an MR1/MHC 
chimaera or full MR1 coding sequence, with primary antibodies specific for the 5‟ vector tag 
(M2), bovine MHC heavy chain (IL-A88), human MR1 (26.5), and bovine MHC/β2M complexes 
(IL-A19).  The negative control sample cells were incubated with medium and secondary 
antibody only.   
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6.4 Discussion 
A number of bovine cell lines belonging to different leucocyte-lineages were tested 
for expression of MR1 at the mRNA level using RT-PCR techniques.  All but one of 
these lines were transformed by infection with Theileria parasites and included lines 
of the monocyte, B-cell and T-cell lineages.  Results showed that, as for humans, 
MR1 was abundantly transcribed in all cell-lines tested.  In addition to the predicted 
full-length transcript, a second smaller product corresponding in size to the MR1 
splice variant lacking α1 exon (identified in chapter 5) was also ubiquitously 
expressed, although at lower levels.  As discussed in the previous chapter, the 
ubiquitous detection of this alternatively spliced variant suggests that it may have a 
functional role in regulating expression of the intact protein.   
Although MR1 transcripts were readily detected in all of the cell lines tested, they 
appeared to be more abundant in the two B-cell lines than in the T-cell or monocyte 
lines.  Direct comparison of the B-cell and monocyte lines is particularly valid since 
these consisted of pairs of lines (B-cell and monocyte) derived from the same 
animals.  Further experiments using quantitative PCR assays applied to a larger 
number of cell lines are required to quantify these differences in expression.  
However, given the evidence that in mice expansion of the MAIT cell population is 
dependent on B-cells (Treiner et al. 2003), these observations suggest that the 
observed increased transcription of MR1 in B-cell lines may relate to a functional 
role of MR1 expressed in activated B-cells.   
Studies of MR1 expression in ruminants have been limited by lack of specific 
antibodies.  This study tested a number of different antibodies known to react with 
bovine classical class I MHC, as well as an antibody raised against human MR1, 
which had been reported, in a paper published during the course of the current 
studies, to recognise bovine MR1 (Huang et al. 2009).  These antibodies were tested 
for recognition of cells transfected with the full coding sequence of bovine MR1 and 
with a chimaeric cDNA containing the α3, transmembrane and cytoplasmic segments 
from a bovine classical class I gene.  The latter was included because previous 
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studies in mice using a similar chimaeric construct (Miley at el, 2003) demonstrated 
a 3-fold increase in surface expression in transfected cells in comparison to the native 
MR1.  The inclusion of a classical class I α3 domain also provided the possibility 
that the MR1 chimaera heavy chain might react with the IL-A88 antibody, which is 
specific for a non-polymorphic determinant on bovine classical class I heavy chains 
(Toye et al. 1990). The expression vector used in the experiments also encoded an N-
terminal peptide tag that would allow detection of both intracellular and cell surface 
expression.  Several of the antibodies examined reacted with the untransfected Cos-7 
cells; these included W6-32 which recognises human classical class I and is known 
to cross-react with class I in some other species (Maziarz et al. 1986).  Recognition 
of the Cos cells by antibody IL-A19, which recognises classical class I heavy chain 
in association with β2M and has also been shown to recognise other species‟ heavy 
chains associated with bovine β2M (Bensaid et al. 1989), as well as the two bovine 
β2M-specific antibodies, was probably due to association of the monkey class I 
heavy chains with bovine β2M in the culture medium.  Further experiments using 
serum-free medium or medium supplemented with mouse serum instead of bovine 
serum are required to confirm this suggestion. 
Cells transfected with both MR1 constructs exhibited strong and specific intracellular 
staining with the antibody directed against the peptide tag, but no cell surface 
staining was detected with the same antibody.  Similar intracellular staining of cells 
transfected with the chimaeric construct, but not the native MR1, was obtained with 
antibody IL-A88, confirming that this antibody reacts with the bovine α3 domain of 
class I heavy chains.  Although there was also a suggestion of low level cell surface 
staining with IL-A88 of a small percentage (~5%) of cells transfected with the 
chimaeric construct, the absence of staining of these cells with the tag-specific 
antibody suggested that this may have been non-specific.  Hence, although MR1 was 
clearly expressed intracellularly, no evidence of cell surface expression was detected.   
Studies of MR1 expression in human cells and tissues obtained ex vivo have yet to 
provide convincing evidence of cell surface expression of this protein (Treiner et al. 
2005).  Moreover, in vitro transfection and transduction studies with mouse and 
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human MR1 have reported low and variable levels of cell surface expression, despite 
readily detectable intracellular protein (Huang et al. 2005).  While early studies 
suggested that MR1 was retained within the endoplasmic reticulum (Miley et al. 
2003), a more recent study employing microscopy with markers to sub-cellular 
compartments has demonstrated that a large quantity of MR1 protein is retained 
within the late endosomal compartments (Huang et al. 2008).  Based on these and 
other findings, it has been proposed that surface expression of MR1 is strictly 
regulated, possibly dependent on availability of ligand within an intracellular 
compartment (see below). The subcellular localisation of MR1 was not examined in 
the current study.   
Classical class I molecules are usually expressed on the cell surface in a folded 
conformation, which is dependent on the binding of an appropriate peptide ligand.  
However, under some circumstances they can be expressed in an open conformation 
in which there is no bound ligand.  Previous studies of MR1 demonstrated that 
human Hela cells and B6/WT-3 cells transduced with MR1 showed low levels of 
expression of the molecule at the cell surface.  By using antibodies that were shown 
to be specific for open and folded forms of MR1, which are indicative of empty and 
antigen-bound forms respectively, Huang et al. were able to show that both forms of 
the protein were present on the cell surface.  By using the antibodies to inhibit T cell 
recognition, they also obtained evidence that only the folded conformer of MR1 was 
able to activate two MAIT cell hybridomas (Huang et al. 2005).  More recently it has 
been shown that acid eluates from MR1 contain an unidentified self-ligand which 
enhances activation of MAIT cell hybridomas (Huang et al. 2009).  These findings 
support the hypothesis that MR1 is dependent on endogenous ligand for folding and 
possibly for efficient cell surface expression.   
The monoclonal antibody, 26.5, was raised against a soluble ectodomain of human 
MR1 (Miley et al. 2003) and has been shown to specifically recognise a fully folded 
form of the protein, presumed to contain a bound ligand (Huang et al. 2005).  
Recently, these workers independently reported the isolation of a bovine MR1 cDNA 
and, based on flow cytometry analyses of human and murine cell lines transduced 
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with a recombinant retrovirus, they claimed that the 26.5 antibody cross-reacted with 
bovine MR1 (Huang et al. 2009).  The current study failed to detect any reactivity of 
this antibody against transfected bovine MR1 sequence or the MR1/MHC chimaera, 
by either intracellular or cell surface staining.  This may reflect lack of sensitivity of 
staining due to lower affinity of the antibody for bovine MR1 compared to human 
MR1, or it may be due to failure of the antibody to detect intracellular protein that 
has not adopted a folded conformation.  The author‟s original method of retroviral 
transduction, rather than transfection, may also have affected the findings.   
Hence, the failure to detect cell surface expression in the current study may relate to 
lack of an appropriate endogenous ligand to allow appropriate folding of the protein 
and transport to the cell surface.  Although it has been hypothesised that microbial 
colonisation of the gut stimulates cells to produce endogenous MR1 ligands which 
may allow or increase MR1 cell-surface expression, no experiments on the effects of 
bacterial extracts on MR1 expression have been performed.  Similarly, certain 
conditions of cellular stress or infection state may be required to stimulate MR1 
expression.  The ability to express MR1 efficiently on the cell surface may also be 
dependent on cell type and/or interaction with other cells such as antigen-presenting 
cells.   
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7 General Discussion  
Mucosal Associated Invariant T-cells are a subset of αβ T-cells characterised by 
expression of an invariant TCRα chain, and their restriction by the non-classical 
MHC class I-like molecule, MR1 (Treiner et al. 2003).  Both of these elements are 
highly conserved in humans and mice.  The MAIT orthologous TCRα chain 
rearrangements have a CDR3 of constant length and sequence and are used in 
combination with a limited repertoire of Vβ chains.  MAIT cells are notably more 





cell subset of both species (Tilloy et al. 1999).  Studies in various gene knock-out 
mice indicate that MAIT cells undergo stepwise development (Martin et al. 2009); 
they are initially selected in the thymus, where they are present in small numbers and 
have a naïve T cell phenotype.  Intra-thymic development is dependent on MR1 and 
a non B-cell, non T-cell, haemopoietic-derived cell-type.  They then undergo clonal 
expansion in the periphery, which is dependent on B-cells and commensal intestinal 
flora, and adopt a memory phenotype.  Mature MAIT cells also display a variety of 
NK cell surface markers.  Following maturation, MAIT cells localise in specific 
tissues, notably the intestinal mucosa (Treiner et al. 2005).  Like cells of the innate 
immune system, they produce a rapid, diverse cytokine response upon activation 
(Kawachi et al. 2006).  However, the function of MAIT cells remains unclear.   
The results obtained in the current study have confirmed the presence of MAIT cells 
and the restriction element MR1 in ruminants and provided further evidence that this 
system is highly conserved between mammalian species, suggesting that it plays a 
key role in the immune system of mammals.   
 
Conservation of the MAIT TCRα and MR1 amino acid sequences: The present 
study has confirmed the presence of MAIT cells and MR1 in both cattle and sheep.  
Both the invariant TCRα and MR1 sequences are highly conserved between 
ruminants and humans and mice, and the TCRα chains use orthologous V and J gene 
segments.  Indeed, the cross-species conservation of MAIT/MR1 sequence is much 
higher than that seen for other immune elements, including iNKT/CD1d.  The CDR 
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sequences of the MAIT TCRα are also highly conserved, suggesting that they have 
very similar specificities in the different species.  Additionally, the extracellular 
domains of MR1 (α1, α2 and α3) show a particularly high level of conservation, 
suggesting that this molecule has a highly conserved function in antigen presentation.  
Since these domains form the antigen-binding groove of the protein, this suggests 
that the cognate ligand for MAIT cells is also highly conserved between species.  
Since murine MAIT cell hybridomas have been shown to respond to both murine and 
human MR1, the possibility that they also can respond to bovine MR1 could be 
investigated in future studies.  The conservation of MAIT TCR and MR1, coupled 
with the relatively high frequency of MAIT cells in peripheral lymphoid tissues and 
evidence from mice that their activation results in a rapid cytokine response, suggests 
that these cells may be capable of mounting an innate immune response against a 
conserved ligand.  Although the current studies have demonstrated expression of a 
conserved TCRα chain, the extent to which the associated TCRβ chains are 
conserved was not investigated.  This should be investigated in future work, but will 
require the development of methods to purify bovine MAIT cells.   
Studies in mice have provided evidence that the ligand for MAIT cells is lipid in 
nature, since they are activated by the synthetic glycolipid αManCer, and αManCer-
loaded murine MR1 has been shown to stimulate MAIT cells (Okamoto et al. 2005; 
Shimamura et al. 2007).  Given these findings, and the evidence that MAIT cell 
peripheral expansion is dependent on commensal bacterial flora, it has been 
hypothesised that MAIT cells may interact with bacterial cell-wall lipids and play a 
role in mucosal immune responses and/or prevention of immune responses to 
commensal gut flora.  However, it is interesting to note that although MAIT clonal 
expansion is dependent on gut flora, none of the published studies of MAIT cell 
activation have examined responses to bacteria or bacterial products.  This provides 
an area for potential future work on MAIT cells and MR1, which may provide vital 
clues to the ligand for, and function of, the MR1-MAIT cell system.  However, again 
methods to identify MAIT cells are required to undertake such studies in ruminants.  
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Expansion and distribution of the bovine MAIT cell population in the post-natal 
period:  The work described in chapter 4 successfully developed quantitative PCRs 
for measuring MAIT TCRα transcripts and total TCRα transcripts, thus permitting 
estimation of the percentages of T-cells expressing the MAIT TCR.  Using this 
assay, T-cells in PBMC from adult (>2 years) cattle were estimated to contain 0.1-
0.6% MAIT cells.  By contrast, very few MAIT cells were detected in PBMC and 
tissues of neonatal calves.  However, MAIT cell levels were already significantly 
increased by 3-weeks of age and the levels were maintained in 3-month old animals.  
Despite this increase, the levels of MAIT TCR in thymus remained low in all age 
groups.  These results support the evidence in humans and mice that MAIT cells 
undergo peripheral expansion, and suggest that this occurs in the immediate post-
natal period.  Consistent with findings in humans and mice (Tilloy et al. 1999; 
Treiner et al. 2003; Treiner et al. 2005), relatively high levels of MAIT were found in 
some gut associated lymphoid tissues.  However, the highest levels of MAIT cells 
(>2%) were found in the spleen of post-neonatal calves, and the spleen was also a 
rich source of MAIT cells in sheep.  This raises the interesting question of where the 
peripheral expansion of MAIT cells occurs.  Since this process has been shown in 
mice to be dependent not only on MR1 but also on the presence of B cells and an 
intact gut flora (Tilloy et al. 1999; Treiner et al. 2003), it has been hypothesised that 
expansion may occur in the intestinal mucosa.  However, it is possible that 
commensal flora may serve to induce MR1 expression on B-cells (through either a 
bacterial ligand or stimulation of an endogenous ligand) and that these MR1-
expressing B cells migrate to other lymphoid tissues including the spleen, which is a 
highly vascular organ and contains numerous B-cell follicles (van Ewijk et al. 1977; 
Nieuwenhuis and Opstelten 1984).  Thus, expansion of the MAIT cell population 
could occur throughout the lymphoid system but be most pronounced in tissues, such 
as the spleen, that are rich in activated B cells.   
It would be of interest to determine whether MAIT cells are also abundant in human 
and mouse spleen.  However, because mice are kept in very clean environments, the 
spleens of healthy animals tend to contain very few germinal centres or activated B 
cells.  Thus, if the presence of activated B cells is important for expansion or 
accumulation of MAIT cells, the findings may not be the same in the mouse.  Indeed, 
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it is possible that the overall lower numbers of MAIT cells seen in mice is related to 
a less active immune system than that in outbred species.  This could be further 
assessed in mice by examining the numbers of MAIT cells in animals experimentally 
immunised to activate the immune system.   
 
Bovine MAIT cells are enriched in the CD8
+




 T-cell populations in humans and mice are both enriched for MAIT cells in 
comparison to other T-cell populations, although significant populations are also 
found in the CD8αβ
+
 T-cell population in humans, and CD4
+
 T-cells in mice (Tilloy 
et al. 1999; Martin et al. 2009).  However, neither qPCR nor sequencing of multiple 
cDNAs revealed any evidence of enrichment of MAIT TCRα expression in this small 
population of bovine PBMC.  Instead, bovine MAIT TCRα transcripts appeared to be 
enriched in the CD8
+
 T-cell population.  These results suggest that bovine MAIT 
cells may utilise CD8 as a co-receptor, in which case bovine CD8 would be predicted 
to interact with MR1.  However, no evidence has been found for the interaction of 
human (or murine) CD8 with MR1, and the residues at positions 223 to 229, 245, 
and 247 of the classical class I MHC α3 domain, which are indispensable for 
interaction with the CD8 coreceptor (Sun et al. 1995; Neveu et al. 2006) and are 
present in both human and murine MHC-encoded class I molecules, are absent from 
human and murine MR1 (Riegert et al. 1998).  Comparison of bovine MR1 α3 region 
and bovine classical class I MHC α3 sequences shows similar disparity in these 
residues; only 2 of the 9 residues are conserved, suggesting that MR1 is unlikely to 
interact with CD8.   
The CD8 protein comprises α and β chains and most T-cells express both chains, 
which combine to produce a surface heterodimer.  However, the α chain can also 
generate a homodimeric form of the protein and a small subset of T-cells have been 
shown to express the CD8α but not the CD8β chain (Wheeler et al. 1992).  In cattle 
such cells are identifiable using the α chain-specific monoclonal antibody CC-58 
(MacHugh and Sopp 1991).  Further studies are required to determine whether the 
bovine MAIT cells express CD8α only or CD8αβ.  Provision of more information on 
the phenotype and functional characteristics of MAIT cells is dependent on the 
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development of a monoclonal antibody specific for the MAIT TCRα chain, 
specifically the MAIT CDR3 region.  This could be attempted using either 
recombinant bovine MAIT TCRα chain protein (or the extracellular domains) or 
synthetic peptides representing the CDR3 of the α chain as immunogens in mice.  
Specific antibodies would be expected to detect a small but discrete population of T-
cells in PBMC or lymphoid tissues.   
 
Detection of abundant alternatively spliced transcripts of bovine MR1.  The 
consistent detection of MR1 transcripts in PBMC and in each of a number of 
different bovine cell lines tested suggests that, as in other species (Hashimoto et al. 
1995; Yamaguchi et al. 1997; Riegert et al. 1998), the MR1 gene is ubiquitously 
transcribed.  In addition to the full-length transcript, shorter alternatively spliced 
forms, lacking either the α1 exon, or α1 and α3 exons, were consistently detected.  
These bore similarity to alternatively spliced forms of MR1 detected in humans and 
mice, in which all or part of the α1 or α3 exons are omitted (Riegert et al. 1998).  All 
detected ruminant splice variants retained an intact open reading frame and would be 
expected to generate a polypeptide.  The ubiquitous transcription and abundance of 
the splice variant lacking the α1 exon suggests that this molecule may have some 
functional role.  Although it is unlikely to be able to present antigen, it may somehow 
play a role in regulating expression of the intact MR1 on the cell surface.   
Further work is required to investigate the functional significance of these 
alternatively-spliced MR1 transcripts.  Quantitative PCR could be employed to 
quantify expression in cells of different lineages and to examine the effects of 
different activation stimuli on the levels of expression compared to that of the intact 
MR1 transcript.  Also, if an in vitro expression system were to be developed for 
bovine MR1, it would be possible to examine the effect of co-transfection with the 
alternatively-spliced cDNAs on expression of MR1 protein.   
 
Transfected MR1 is expressed intracellularly but not on the cell surface.  Results 
in chapter 6 demonstrated successful transfection of bovine MR1 in Cos-7 cells; 
however, transfected MR1 and an MR1/MHC-chimaera were only expressed 
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intracellularly.  The latter was demonstrated using antibody to an N-terminal peptide 
tag and also using a monoclonal antibody that recognised the MHC α3 domain in the 
chimaeric protein.  Previous transfection studies with mouse MR1 had demonstrated 
low levels of cell surface expression (<10% of transfected cells) in some cell lines, 
and that expression was increased to 26% following transfection of an MR1/MHC 
chimaera containing the α3, transmembrane and cytosolic domains of a classical 
class I MHC protein (Miley et al. 2003).  Later studies showed that the majority of 
the MR1 protein in transfected cells was retained intracellularly in the late 
endosomal compartment (Huang et al. 2008).  The work in chapter 6 did not include 
analysis of the subcellular site of MR1 protein expression.  Further work applying 
two-colour confocal microscopy using markers for sub-cellular compartments is 
required to define the intracellular sites of MR1 protein localisation.  Transfection of 
different cell lines should also be investigated, to determine whether cell type and 
species of transfected cells influences expression.  Given the evidence that B-cells 
influence peripheral expansion of MAIT cells (Treiner et al. 2003), these 
experiments should include transfection of bovine B-cell lines.  The effects of 
various cell activation stimuli on expression could also be examined.  Success in any 
of these reactions would enable experiments to define precisely what determines cell 
surface expression, and would provide cells that could be used to test the 
responsiveness of MAIT cells and ultimately analysis of potential ligands.   
Such studies of MR1 would be aided by the development of a specific monoclonal 
antibody.  The studies with cells transfected with bovine MR1 failed to confirm that 
the human MR1-specific monoclonal antibody 26.5 cross-reacts with the bovine 
protein.  Production of a specific antibody could use recombinant polypeptide 
incorporating the extracellular domains of MR1 as an immunogen, as has been used 
successfully for human MR1 (Huang et al. 2005).  A monoclonal antibody specific 
for MR1 could be used to answer a number of unresolved questions: Which cell 
types in the thymus express MR1 during selection of MAIT cells?  Can cell surface 
expression of MR1 be detected in vivo and on what cell types?  What factors regulate 
cell surface expression and do the transcriptional splice-variants of MR1 play a role 
with regard to function or regulation of expression of the intact protein?   
Chapter 7: General Discussion 
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In summary, ruminant MAIT cells and MR1 appear to share many features with their 
human and murine orthologues.  The cross-species conservation of both is startling, 
and suggests evolutionary conservation of structure, and therefore, potentially, 
function.  The ruminant MR1-MAIT cell system is more similar to the human system 
than mice, where MAIT cells remain in low numbers in the periphery, and may 
therefore provide a better functional model to identify the ligands and functions of 
these molecules/cells.   
 
 
Post-script: Following submission of this thesis, two publications (Gold et al. 2010; 
Le Bourhis et al. 2010) have demonstrated in-vitro activation of human and mouse 
MAIT-cells by antigen-presenting cells infected with various strains of bacteria and 
yeast, but not virus, in an MR1-dependent manner.  Activation was independent of 
both classical MHC class I and II pathways, as well as the main innate immune 
receptors.  Additionally, numbers of circulating MAIT cells were reduced in the 
blood of patients with certain bacterial infections, corresponding with migration of 
these cells into infected tissues.  These results suggest that MAIT cells are involved 
in either the direct control, and/or the subsequent development of adaptive immunity, 
to bacterial infection.   
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8 Appendix A: Materials and Methods 
8.1 Solutions and media 
8.1.1 Alsever’s Solution 10x stock 
D-glucose     205.0g  (113.8mM) 
Citric acid    5.5g  (2.9mM) 
Sodium chloride   42.0g  (71.9mM) 
Tris-sodium citrate di-hydrate 80g  (27.2mM) 
Made up to 1 litre with double-distilled water (DDW).   
Diluted to 1x solution by adding 100ml stock solution (filter sterilised through 
0.45µm Minisart single-use filter (Sartorius, Goettingen, Germany)) to 900ml sterile 
DDW.   
 
8.1.2 RBC Lysis Buffer 
Buffer composed of 1 part 0.175M TRIS pH7.4 and 9 parts 0.16M ammonium 
chloride, and filter sterilised through 0.45µm Minisart single-use filter.   
 Trizma base   10.6g  (0.175M) 
pH adjusted by addition of concentrated HCl to pH7.4; made up to 500ml volume 
with DDW. 
 Ammonium chloride  8.55g  (0.16M) 
Made up to 1 litre volume with DDW.   
 
8.1.3 Standard Culture Medium 
RPMI 1640 medium + 25mM HEPES + L-Glutamine (Gibco, Paisley, UK) 
10% foetal bovine serum (Gibco, Paisley, UK) 
100u/ml penicillin, 100µg/ml streptomycin, 292µg/ml L-glutamine, as 
Penicillin-Streptomycin-Glutamine (100x) solution (Gibco, Paisley, UK) 
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8.1.4 DMEM-Cos Medium 
DMEM (Gibco, Paisley, UK) 
 (Dulbecco‟s Modified Eagle Medium 1X,  
   + 4.5g/L Glucose + L-Glutamine + Pyruvate)   
 10% foetal bovine serum (Gibco, Paisley, UK) 
100u/ml penicillin, 100µg/ml streptomycin, 292µg/ml L-glutamine, as 
Penicillin-Streptomycin-Glutamine (100x) solution (Gibco, Paisley, UK) 




8.1.5 Phosphate Buffered Saline (PBS) / 
Ethylenediaminetetraacetic acid (EDTA) 
25ml 20 x PBS stock solution and 54ml 0.5M EDTA stock solution mixed into 
400ml DDW.  Adjusted to pH7.2; made up to 500ml volume with DDW; filter 
sterilised through 0.45µm Minisart single-use filter.  Stored at 4°C.  PBS tablets used 
in accordance with manufacturer‟s instruction (Unipath Ltd., Bedford, UK) 
0.5M EDTA:  Na2 EDTA 2 H20   93.05g  (0.5M) 
Soluted in 400ml DDW; adjusted to pH8 with sodium hydroxide; made up to final 
volume 500ml with DDW; filter sterilised through 0.45µm Minisart single-use filter.   
 
8.1.6 FACS Medium 
RPMI 1640 medium + 25mM HEPES + L-Glutamine (Gibco, Paisley, UK) 
2% foetal bovine serum (Gibco, Paisley, UK) 
0.2% sodium azide 
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8.1.7 Phosphate Buffered Saline 
PBS tablets used in accordance with manufacturer‟s instruction (Unipath Ltd., 
Bedford, UK) 
 
8.1.8 SM-0005 PCR Buffer 
Produced by Abgene, Surrey, Uk. 
45mM Tris-HCl (pH8.8 at 25°C) 
11mM ammonium sulphate 
4.5mM magnesium chloride 
0.113mg/ml bovine serum albumin 
4.4µM EDTA 
1.0mM each of dATP, dCTP, dGTP, dTTP 
 
8.1.9 Tris-acetate/EDTA (TAE) electrophoresis buffer (50x stock) 
Trizma base   242g   (2M) 
Glacial acetic acid  57.1ml   (2M) 
EDTA   100ml of 0.5M solution (50mM) 
Adjusted to pH7.0 with 5M sodium hydroxide; made up to 1 litre volume with 
DDW; autoclaved.   
 
8.1.10 Loading Buffer for Agarose Gel Electrophoresis 
 15% ficoll (Type 400) in DDW 
0.25% bromophenol blue 
0.25% xylene cyanol 
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8.1.11 20% Polyethylene glycol (PEG) / 2.5M NaCl 
 Sodium chloride  58.44g  (2.5M) 
 PEG (MW8000)  100g  (20%) 
Made up to 0.5 litres volume with DDW.   
 
8.1.12 5 x CSA Buffer 
 Trizma base   4.840g  (400mM) 
 Magnesium chloride  0.203g  (10mM) 
Adjusted to pH9 with concentrated HCl; made up to 100ml volume with DDW; 
autoclaved.   
 
8.1.13 3M Sodium acetate pH5.2 
 Sodium acetate.3H20  40.81g  (3M) 
Adjusted to pH5.2 with glacial acetic acid; made up to 100ml volume with DDW; 
autoclaved.   
 
8.1.14 SOC Medium 
 Tryptone   20g 
 Yeast extract   5g 
 Sodium chloride  0.5g 
 Potassium chloride  0.19g 
 Glucose   4g 
Adjusted to pH7.0 with 5M sodium hydroxide; made up to 1 litre volume with 
DDW; autoclaved.   
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8.1.15 LB agar plates with ampicillin 
 Sodium chloride  10g 
 Yeast extract   5g 
 Tryptone   10g 
 Agar    7.5g 
Adjusted to pH7.0 with 5M sodium hydroxide; made up to 1 litre volume with 
DDW; autoclaved.  Melted for use; once solution temperature <55°C, ampicillin was 
added to give a final concentration of 100µg/ml.  Melted media was poured into 
sterile petri dishes to set.   
 
8.1.16 LB medium with ampicillin 
 Sodium chloride  10g 
 Yeast extract   5g 
 Tryptone   10g 
Adjusted to pH7.0 with 5M sodium hydroxide; made up to 1 litre volume with 
DDW; autoclaved.  Ampicillin was added before use to give a final concentration of 
100µg/ml.   
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8.2 Vector Maps 




8.2.2 pcDNA3.1 / V5-His TOPO vector 
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8.2.3 pFlag-CMV-3 expression vector 
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9 Appendix B: TCR Vα nomenclature 
The table below shows the corresponding names between human TCR Vα genes 
according to the IMGT and WHO-IUIS nomenclature systems, and is derived from 
the IMGT website (http://imgt.cines.fr).  Genes are presented in the 3‟ to 5‟ order in 
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10 Appendix C: Cross-species comparison of MAIT TCRα 
nucleotide sequences 
Nucleotide sequences for the full coding regions of the MAIT TCRα of sheep, cattle, 
humans and mice are shown on the following page.  A”.” is used to indicate when a 
sequence for comparison contains the exact same base pair at that location as the top 
sequence.   
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11 Appendix D: Cross-species comparison of MR1 nucleotide 
sequences 
Nucleotide sequences for the full coding regions of MR1 of sheep, cattle, humans 
and mice are shown on the following two pages.  A”.” is used to indicate when a 
sequence for comparison contains the exact same base pair at that location as the top 
sequence, whereas a “-“ indicates a gap in that sequence at that location.   
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12 Appendix E: Exons of bovine MR1 
Nucleotide sequences for the exons within the full coding sequence of bovine MR1 
are shown below: 
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13 Appendix F: Splice variants of bovine and ovine MR1 
Nucleotide sequences for coding sequences of the identified splice variants of bovine 
and ovine MR1 are shown below, in comparison to full MR1 coding sequences: 
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14 Appendix G: Potential splice variant of bovine MR1 
Nucleotide and amino acid sequences for the coding regions of the potential splice 
variant of bovine MR1 identified through cloning of bovine MR1 in a TOPO TA 
expression vector, in comparison to full MR1 coding regions: 
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15 Appendix H: Publications from the thesis 
Publications in journals: 
Nick Goldfinch, Peter Reinink, et al (2010) “Conservation of mucosal associated 
invariant T (MAIT) cells and the MR1 restriction element in ruminants, and 
abundance of MAIT cells in spleen” Vet. Res. (2010) 41(62).  
 
Announcements in conferences: 
Goldfinch, N. G., Connelley, T., Morrison, W. I. (2008) “MAIT cells and MR1” 
(Proceedings of the The Association for Veterinary Training and Research Work 
annual conference, Scarborough, 2008) 
Goldfinch, N. G., Connelley, T., Morrison, W. I. (2007) “MAIT cells and MR1” 
(Proceedings of the The Association for Veterinary Training and Research Work 
annual conference, Scarborough, 2007) 
 
Nucleotide sequences submitted in public databases: 
Novel nucleotide sequences submitted in NCBI GenBank were given the accession 
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